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ABBREVIATIONS
A b b rev ia tio n s
A = delta
Q  = om ega
95% C I = 95%  confidence interval
ACV  = active circulation volume
ALI = acute lung injury
A PC C O  = Arterial pressure based continuous cardiac output m easurem ent
APV = arterial pressure variation
ARD S = adult respiratory distress syndrome
BP = blood pressure
bpm  = beats per m inute
BSA = body surface area
c a o 2 = arterial oxygen content
c v o 2 = venous oxygen content
CBV = central blood volume
CI = cardiac index
C O  = cardiac output
c o 2 = carbon dioxide
c o TpTD = cardiac output m easured with T PT D
c o Ufp = cardiac output m easured with UFP
CPB = cardiopulm onary bypass
CSA = cross sectional area
CV P = central venous pressure
DAP = diastolic arterial pressure
D o 2 = oxygen delivery
D St = down slope time
EV  = electrical velocimetry
EVLW  = extravascular lung water
EVLW I = extravascular lung w ater index
EVLW ItpDD = extravascular lung w ater index m easured with TPD D
EVLW Itptd = extravascular lung water index m easured with T PT D
FAP = finger arterial pressure
F io 2 = inspired oxygen fraction
FR  = fluid responsiveness
GEDV = global end diastolic volume
GEDVI = global end diastolic volume index
H R  = heart rate
IAP = in tra  arterial pressure
IC G  = im pedance cardiography
IC G  = indocyanine green
ITB V  = in tra  thoracic blood volume
ITB V I = in tra  thoracic blood volume index
IT T V  = in tra  thoracic therm al volume
LOA = limits o f agreem ent
MAP = m ean arterial pressure
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ABBREVIATIONS
m m H g = millimeters o f m ercury
M O D S = multiple organ dysfunction syndrome
M Tt = m ean transit time
NIBP = non-invasive blood pressure
O E R = oxygen extraction ratio
PAC = pulm onary artery catheter
PATD = pulm onary artery therm odilution
PEEP = positive end expiratory pressure
PBV = pulm onary blood volume
PC C O = pulse contour cardiac output
PDD = pulse dye densitometry
PIC U = pediatric intensive care unit
PLR = passive leg raising
PPV = pulse pressure variation
PTV = pulm onary therm al volume
reBAP = reconstructed brachial arterial pressure
SAP = systolic arterial pressure
s a o 2 = arterial oxygen saturation
s c v o 2 = central venous oxygen saturation
s v o 2 = m ixed venous oxygen saturation
SD 2 = standard deviation
SMD = signal m inute distance
SPV = systolic pressure variation
SV = stroke volume
SVI = stroke volume index
SVV = stroke volume variation
SVR = systemic vascular resistance
TED = transoesophageal D oppler ultrasound
TEDV = total end-diastolic volume
TPD = transpulm onary dilution
TPD D = transpulm onary double indicator dilution using ice-cold indocyanine green
TPLD = transpulm onary lithium dilution
T PT D = transpulm onary therm odilution using ice-cold saline
TPU D = transpulm onary ultrasound dilution
T T E = transthoracic echocardiography
U D C O = ultrasound dilution cardiac output
U FP = ultrasound transit tim e flow probe
V o 2 = oxygen consum ption
V c o 2 = carbon dioxide consum ption
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chap ter 1
General introduction and outline of this thesis

CHAPTER I
In tro d u ctio n
In  the N etherlands approxim ately 4800 children between 0 and 16 years are adm itted to a 
pediatric intensive care unit (PICU) each year (1,2). O f  these children approxim ately 20% 
suffer from  circulatory insufficiency which is, for an im portant part, caused by sepsis (1,2). 
T he overall m ortality rate o f the D utch patient population is around 3 to  4%  (1,2). The 
general m ortality o f sepsis in children is around 5 to 10% (3,4). Younger children appear 
to be m ore vulnerable to the sequelae of sepsis. This is partly explained by a m ore pro­
nounced sepsis induced myocardial dysfunction (5-8).
shock has m any causes and can lead 
to the multiple organ dysfunction 
syndrome (M ODS) (figure 1). Since 
shock and M o D s  are im portant 
causes of pediatric m orbidity and 
mortality, early recognition, prom pt 
treatm ent and, when applicable, re­
trieval to a tertiary care center are 
m ost im portant (4,9-12).
pediatric circulatory shock can be 
characterized by cardiac output and 
blood pressure levels being either 
low, norm al or high (13-15). O b ­
viously, this requires different ther­
apeutic strategies. In this respect 
aggressive fluid therapy in critically 
ill children can be advantageous and 
is also advised by advanced support 
life courses and current sepsis p ro­
tocols (11,16). O n  the other hand  
overzealous fluid therapy can be det­
rim ental (17-20). A lthough m ea­
surem ent o f cardiac output m ay 
guide the am ount o f fluid therapy, the latest guideline for treating sepsis in  children advise 
to m easure cardiac output only at the end of the algorithm, when fluids and vasoactive 
m edication have already been given (16,21).
T he general approach to  children in shock consists of assessment o f tissue and organ per­
fusion using physical exam ination and basic hem odynam ic m onitoring supplem ented by 
laboratory m easurem ents and quantification of urine production. Thereafter adequate 
therapeutic m easures must be employed. These include fluid adm inistration, titration of 
vasoactive drugs and often m echanical ventilation (figure 2). Sine the above m entioned 
approach does no t adequately reflect the nature of the circulatory insufficiency advanced 
hem odynam ic m onitoring m ight be beneficial (22,23). A dvanced hem odynam ic m onito­
ring  consists, am ong others, o f m easuring cardiac output, predicting fluid responsiveness,
Figure 1
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Figure 2
Hemodynamic assessment and therapeutic approach
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calculating systemic oxygen delivery in relation to oxygen dem and and quantifying (pulmo­
nary) edema. A dvanced hem odynam ic m onitoring in critically ill children could be more 
useful than  currently judged  or advised and could attribute to a lower m ortality rate and a 
shorter intensive care length of stay. Unfortunately, m any of the available technologies are 
either still not validated for children or not applicable for all pediatric patients.
This thesis addresses the validity and clinical usefulness of several m ethods of advanced he­
m odynam ic m onitoring in critically ill children. It tries to  answer the following questions:
1. W hich cardiac output technique can be used as a clinical reference m ethod in young 
children for adequately guiding fluid and vasoactive therapy?
2a. Is lung w ater m easurem ent in  children reliable and clinically feasible?
2b. W hy do younger children have higher values of indexed lung water but a lower global 
end diastolic blood volume index com pared to adults?
3. Is non-invasive advanced hem odynam ic m onitoring feasible in  young children?
O u tlin e  o f  th is  th e s is  
Part A
This p art describes the use o f the transpulm onary  therm odilu tion  (TPTD ) technique 
in  children. T P T D  m easurem ents require a  special arterial catheter, a central venous 
catheter for injections of the ice-cold saline indicator and a special device (PiCCO , Pul­
sion, M unich, Germ any). T P T D  m easurem ent offers the clinician th ree variables, cardiac 
ou tpu t (CO), global end diastolic volume (GEDV) and  extravascular lung  w ater (EVLW). 
These m easurem ents have been validated in  adults and  have shown to be reliable and
16
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potentially beneficial du ring  m ajor surgery or critical illness. However, no t m uch research 
has been done to validate these m easurem ents in  children or to  study their clinical use­
fulness.
Chapter 2 is an experim ental validation study in  a controlled pediatric anim al m odel of 
cardiac output m easurem ent using the T P T D  technique. In finding the optim al reference 
m ethod for cardiac output we used a  perivascular ultrasound flow probe around the m ain 
pulm onary artery of new born lambs. T he aim  was to validate the T P T D  technique under 
various hem odynam ic conditions with special emphasis on hypovolemic circulatory shock 
and the capability o f reliably tracking changes in  cardiac output. Furtherm ore, we com ­
pared  G EDV  and central venous pressure in relation to cardiac stroke volume and studied 
the course of EVLW  during the experiment.
Chapter 3 describes th e “cross-talk phenom enon” . This phenom enon  occurs w hen the 
tem peratu re indicator reaches the arterial therm istor directly after injection because of 
diffusion th rough  tissues. Based upon  one clinical and  one experim ental observation 
we describe this phenom enon  and  discuss the causes and the po tential clinical conse­
quences.
In  Chapter 4 we validated the m easurem ent o f extravascular lung w ater using the T PT D  
technology against the transpulm onary double indicator dilution m ethod (TPDD) using 
ice-cold indocyanine green as reference m easurem ent. We m easured extravascular lung w a­
ter in young children, undergoing cardiac catheterisation, and com pared the results o f the 
T P T D  m easurem ents with the TPD D  technique. We also com pared T P T D  m easurem ents 
perform ed with injections through a  central venous catheter inserted in the fem oral vein 
with injections through a  catheter positioned close to the right atrium.
Chapter 5 describes the clinical value of lung w ater m easurem ents in critically ill children. 
We com pared the EVLW  m easurem ent with m arkers o f oxygenation (P /F  index and A-a 
gradient) and a  chest-x-ray score of pulm onary edema. Furtherm ore, we also com pared 
both  the EVLW I and the chest x-ray score with collected m arkers of oxygenation, severity 
o f illness scores and length of stay.
Chapter 6 is a theoretical study Since EVLW I is higher and GEDVI is lower in  young 
children, in terpretation  o f these m easured values is difficult since reference or norm al values 
are not available. We used existing data  from  the literature concerning lung development, 
lung mass, growth, cardiac dimensions and body dimensions in children and adults. By 
com bining these available d a ta  we offer an explanation, based upon physiology, why young 
children have a higher EVLW I and a lower GEDVI. Subsequently we propose pediatric 
correction factors for use in children.
Part B
T he second p art of this thesis describes a  new non-invasive b lood pressure m easurem ent 
in  children. As the insertion of an in tra -arte rial ca theter is sometim es difficult o r tim e 
consum ing requiring  extensive expertise, we studied non-invasive continuous finger blood
17
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pressure m easurem ent using the Nexfin device (BMEYE, A m sterdam , T he Netherlands). 
It can  be used as a rep lacem ent o f an in tra -arte rial catheter bu t also as a  tem porarily  
m onitoring  device until m ore advanced m ethods can be deployed. A part from  n o n ­
invasive continuous finger blood pressure m easurem ent, this technology also provides a 
continuous cardiac ou tpu t m easurem ent. We studied the feasibility o f this m ethod  in 
children and focussed prim arily  on the blood pressure m easurem ent. We used a b e ta  type 
research device (Nexfin-pediatric) and b e ta  type finger cuffs.
Chapter 7 describes the accuracy of blood pressure m easurem ent in young children using 
the Nexfin-pediatric system. We com pared the Nexfin-pediatric blood pressure m easure­
m ent with intra-arterially m easured blood pressure in critically ill children. In  a subgroup, 
we also com pared intra-arterial pressure m easurem ents with the standard non-invasive os- 
cillometric (NIBP) technique.
In Chapter 8 we studied the accuracy of the Nexfin-pediatric system in detecting rapid 
blood pressure changes in young children undergoing congenital cardiac surgery.
Part C
This part consists o f two clinical reviews addressing two im portant subjects.
Chapter 9 describes the cardiac output m easurem ent in children. At present, cardiac out­
put is the most im portan t advanced hem odynam ic m easurem ent in  children. This chapter 
gives an overview of all available technologies for use in  children together with their advan­
tages and disadvantages.
Chapter 10 gives an overview of the currently available advanced hem odynam ic m onito­
ring technologies in  children. It focusses not on the technology but merely on the physiolo­
gical background and clinical usefulness.
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Part A
Transpulmonary thermodilution in children

Chapter 2
Validation of transpulmonary thermodilution cardiac output 
measurement in a pediatric animal model
Joris Lem son1,2, Willem P. de Boode3, Jeroen  C.W. H opm an3, Sandeep K. Singh4 and
Johannes G. van der H oeven1
Pediatr C rit C are M ed 2008; 9: 313—319
1 D ep artm en t o f Intensive C are  M edicine, 2 D ep artm en t o f Anesthesiology, 3 D ep artm en t o f Pediatrics,
4 D ep artm en t o f C ard io thoracic  Surgery 
R a d b o u d  U niversity N ijm egen M edical C entre, the N etherlands

CHAPTER II
A b stra c t
Objective
This study was undertaken to validate the transpulm onary therm odilution cardiac output 
m easurem ent (COTpTD) in  a controlled new born anim al m odel under various hem odynam ic 
conditions with special em phasis on low cardiac output.
Design
Prospective, experim ental, pediatric anim al study.
Setting
Animal laboratory of a  university hospital.
Subjects
Twelve lambs.
Interventions
We studied 12 lam bs under various hem odynam ic conditions. C ardiac output was m ea­
sured using the transpulm onary therm odilution technique with central venous injections of 
ice-cold saline. An ultrasound transit tim e perivascular flow probe around the m ain pulm o­
nary  artery served as the standard reference m easurem ent (CO Ufp). D uring the experiment, 
animals were resuscitated from  hem odynam ic shock using fluid boluses. C ardiac output 
m easurem ents were perform ed throughout the experiment.
Measurements and main results
The correlation coefficient between C O TpTD and C O Ufp was 0.97 (95% confidence interval 
0.94 — 0.98, p < 0.0001). Bland A ltm an analysis showed a m ean  bias of 0.19 l/m in  w ith lim­
its of agreem ent of 0.04 and 0.43 l/m in  (12.0% and 14.7%, respectively). The correlation 
coefficient between changes in  C O TpTD and C O Ufp during volume loading was 0.95 (95% 
confidence interval 0.91 — 0.96, p < 0.0001). T here was a significant correlation between 
changes in global end-diastolic volume and changes in stroke volume (r = 0.59) but not 
between changes in central venous pressure and changes in  stroke volume (r = 0.03).
Conclusions
The transpulm onary therm odilution technique is a  reliable m ethod of m easuring cardiac 
output in  new born animals. It is also capable of tracking changes in cardiac output.
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In tro d u ctio n
Invasive hem odynam ic m onitoring in  critically ill children is cum bersom e, and therefore 
clinical indices, such as capillary refill tim e or central to peripheral tem perature difference, 
are com m only used to estimate hem odynam ic status (1). However, clinical assessment of he­
m odynam ic variables agrees poorly with invasive techniques (2,3). A lthough cardiac output 
(CO) is an im portan t com ponent of hem odynam ic status, it cannot be predicted by easily 
obtainable variables, such as blood pressure and heart rate (4,5). Therefore, a reliable m ea­
surem ent o f C O  is im portant in the hem odynam ic m anagem ent o f critically ill children.
In contrast to adults, the pulm onary artery catheter is infrequently used in infants. This 
technique has several lim itations as it requires a ra ther large introducing sheath and has 
several specific com plications such as tricuspid valve insufficiency, right-sided endocarditis, 
and pulm onary artery rupture. Furtherm ore, some congenital cardiac defects preclude the 
use of a  pulm onary artery catheter. O nly a few new C O  m easurem ent techniques are avail­
able for use in small children, and validation of these techniques is insufficient.
Recently, a  special pediatric 3-Fr 7-cm arterial catheter equipped with a therm istor was 
introduced to m easure cardiac output in small children using the transpulm onary therm o­
dilution (TPTD) m ethod (Pulsion, M unich, Germany). Clinical validation in  patients has 
shown an acceptable accuracy, although a true gold standard is lacking (6-8). Validation in 
predom inantly small subjects with emphasis on low cardiac ou tput against a standard ref­
erence m ethod has, to our knowledge, not been done.
Because of their high reproducibility, high accuracy, and fast response, u ltrasound flow pro­
bes (UFP) offer an excellent reference technique for cardiac output m easurem ent (9,10).
The T P T D  technique also offers the opportunity to m easure global end diastolic volume 
(GEDV) and extravascular lung w ater (EVLW). G EDV  is a  m ore reliable indicator o f car­
diac preload in adult patients com pared with central venous pressure (11). M easurem ent of 
EVLW  could offer the clinician valuable inform ation regarding the am ount o f pulm onary 
edem a (12). However, the usefulness o f EVLW  m easurem ent in  children is unknown.
This study was prim arily undertaken to validate the T P T D  technique in a controlled new­
born  anim al m odel under various hem odynam ic conditions with special emphasis on hypo­
volemic circulatory shock and the capability o f reliably tracking changes in cardiac output. 
Furtherm ore, we com pared G EDV  and central venous pressure in relation to cardiac stroke 
volume and studied the course of EVLW  during the experiment.
M eth o d s
General
This experim ent was perform ed in  accordance with D utch national legislation concerning 
guidelines for the care and use of laboratory  animals and was approved by the local ethics
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com m ittee on anim al research of the R adboud  University Nijmegen. Twelve lam bs with 
a m edian body weight o f 6 kg (range 4.2—12.5 kg) were studied under general anesthe­
sia. P rem edication consisted of the in tram uscular adm inistration of m idazolam  2 m g/kg, 
pen tobarb ita l 15—20 m g/kg , and  ketam ine 10—15 m g/kg. G eneral anesthesia was institu­
ted  using continuous intravenous adm inistration of sufentanil 20 ^ g /k g /h r , m idazolam  
0.2 m g /k g /h r, ketam ine 0.16 m g /k g /h r, and pancuronium  0.02 m g /k g /h r  after a  loa­
ding dose of 0.05 m g/kg. T he trachea was in tubated  using a 5- to 6-m m  (inner diameter) 
cuffed endotracheal tube (Kruuse, Marslev, Denm ark), and the lungs were mechanically 
ventilated in a  pressure-controlled m ode using tidal volumes of approxim ately 10 m l/k g  
(Babylog 8000 Plus ventilator, Drager, Germ any). N orm ocapnia, guided by capnography, 
was achieved by adjusting the respiratory frequency to  m ain ta in  an end-tidal C O 2 tension 
between 30 and 38 to rr (4—5 kPa). At the end o f the experim ent, the anim als were killed. 
T he body surface area (BSA) of the anim als was calculated using the following formula: 
BSA = weight(2/3) x 0.121 (13).
Instrumentation
Immediately after induction of anesthesia, the animals received a  femoral artery catheter 
(3-Fr 7 cm, PV2013L07,Pulsion, Germany) and central venous catheters in  the inferior and 
superior caval veins positioned by m eans o f a  cut-down procedure. Positioning was guided by 
recording appropriate pressure tracings. The correct positions o f the central venous catheters 
were also visually and m anually confirm ed postm ortem . Thereafter, left-sided thoracotom y 
was perform ed, and the ascending aorta, pulm onary artery, and descending aorta  were ex­
posed and the ductus arteriosus was ligated. An ultrasonic perivascular flow probe (PAX se­
ries 12 m m , Transonic Systems, Ithaca, NY) was placed around the m ain pulm onary artery 
to measure reference cardiac output (CO Ufp). Reference cardiac index ( C I p) was calculated 
by dividing C O Ufp by BSA. T he stroke volume index (SVI) was subsequently calculated by
dividing CIUfp by heart rate. 
The flow probe was checked 
for zero flow value directly 
postm ortem . U ltrasound 
transit time flow probes use 
a  two-way ultrasound tech­
nique. By calculating the 
difference between transit 
times upstream  and down­
stream, the blood flow is 
m easured. Care was taken 
to avoid any air within the 
flow probe by applying suf­
ficient quantities o f acoustic 
gel and flooding the tho ra­
cic cavity with saline during 
m easurem ents. An overview 
over the operating theatre is 
shown in figure 1.
Figure 1
Picture o f research operating theatre
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Transpulmonary Thermodilution for Measuring Cardiac Output
Transpulm onary therm odilution cardiac output (COTpTD) is m easured by injecting a known 
quantity o f ice-cold saline into a central venous catheter. This injectate, m ixed with blood, 
is transported  by the blood flow through the right heart, the pulm onary system, and the left 
heart. Tem perature changes are detected by the therm istor- tipped arterial catheter inserted 
in the fem oral artery and connected to a commercially available device (PiCCOplus, soft­
ware version 6.0, Pulsion, M unich, Germany). U sing blood tem perature, injectate tem pera­
ture, injectate volume, area under the therm odilution curve, and a correction constant, the 
cardiac output can be calculated using the Stewart H am ilton equation (14).
Transpulmonary Thermodilution for Measuring Blood Volume and Lung Water
The time span between injection of the indicator and the time point when half of the indicator 
has passed the detection point is known as the m ean transit time (MTt). By multiplying M T t 
by cardiac output, the volume between injection point and detection point, known as the in- 
trathoracic therm al volume (ITTV), is calculated (ITTV  = C O  x M Tt [ml]). The pulmonary 
blood volume and the EVLW  comprise the largest fraction of the intrathoracic fluid volume. 
Therefore, this volume can be considered the largest mixing chamber, and it predominantly 
influences the rate of decline of the dilution curve. In this way, the exponential downslope time 
(DSt) of the therm odilution curve represents this mixing chamber. It is known as the pulm o­
nary therm al volume (PTV) and is calculated by multiplying the DSt by cardiac output (PTV = 
C O  x DSt [ml]). By subtracting the P T V  from the ITTV, it is possible to calculate GEDV. 
GEDV represents a  virtual volume of the heart and great vessels within the thoracic space and 
reflects myocardial preload in adult patients (11). Its use might also be of importance in deter­
m ining preload in children (5,15). The relationship between the intrathoracic blood volume 
(ITBV) and GEVD has been studied in adult patients and appears to be linear (16). There­
fore, the ITB V  is calculated by multiplying GEDV by 1.25 (ITBV = GEDV x 1.25 [ml]). The 
EVLW  is calculated by subtracting the ITBV from the IT T V  (EVLW = IT T V  - ITBV [ml]). 
Dividing these variables by BSA indexes these variables and makes a comparison between lar­
ger and smaller subjects possible. However, lung water is indexed by dividing EVLW  by body 
weight instead of BSA. These calculations are described in detail elsewhere (14).
We used the m ean value of four bolus injections of 3—5 m L of ice-cold saline to measure 
C O TpTD. All therm odilution m easurem ents were perform ed by m anual injection through 
the central venous catheter with injectate tem perature < 10°C. Care was taken not to posi­
tion the venous injection point close to the arterial catheter therm istor tip in order to avoid a 
local change in tem perature during injection, as this can influence the reading of the arterial 
therm istor, especially when cardiac ou tput is low (17).
M easurem ents were stored using specially designed software (PiCCO-Volef D ata  Acquisi­
tion version 6.0, Pulsion, M unich, Germany). Before a series of therm odilution m easure­
ments, the central venous catheter was flushed with 1—2 m L of ice-cold saline. Afterward, all 
therm odilution m easurem ents were visually inspected for a  norm al therm odilution curve.
Other Measurements
O ther m easurem ents included invasively m easured arterial blood pressure and central 
venous pressure, electrocardiogram , heart rate, capnography, arterial oxygen saturation,
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respiratory frequency, tidal volume, airway pressure, and body core tem perature. D uring 
C O TpTD m easurem ent, all other hem odynam ic variables, including C O UFp, were recorded 
simultaneously with a 200-Hz sam pling rate using a com puter system with special biom edi­
cal registration software (Poly, Inspektor Research Systems, A m sterdam , The Netherlands). 
The exact tim e span of the therm odilution m easurem ent was m arked in  the registration. 
The difference between C O TpTD and C O UFp was calculated using the m ean value of four 
consecutive T P T D  m easurem ents and the m ean value of C O UFp in the tim e span between 
the start of the first T P T D  m easurem ent and the end of the last T P T D  m easurem ent. Also, 
the values of C O UFp for the first injection and the m ean of the first two and first three injec­
tions were determ ined. These were com pared with the value of C O UFp obtained during 
these periods. In this way, bias and accuracy of C O TpTD, based on one, two, three, or four 
injections, could be established. To analyze whether changes in C O UFp are adequately re­
flected by changes in C O TpTD, we selected m easurem ents only perform ed during volume 
loading or institution of inotropic therapy.
Protocol
The first therm odilution m easurem ents were m ade shortly after finishing the instrum enta­
tion phase when the animals were stable and normovolemic. Thereafter, the animals were 
subjected to  a separate experim ent in which a large aortic-pulm onary shunt was instituted. 
At the end of this experim ent, the shunt was closed and the animals were left in hypo­
volemic shock. Subsequently, therm odilution m easurem ents were continued. Thereafter, 
several fluid challenges with 20 m L /k g  hydroxyethyl starch H ES 130/0 .4  6%  (Voluven) 
were given to m im ic clinical volume loading and to  achieve a  large range of cardiac output 
values per animal. C O TpTD was determ ined before and after every fluid challenge. W hen 
the c o UFp did not increase as a  result o f fluid loading, one or two further fluid boluses were 
given. In  four animals, dobutam ine 10 ^ g /k g /m in  was additionally adm inistered to further 
increase cardiac output.
Statistical Analysis
Com parison between the two flow m easurem ent techniques was perform ed using correla­
tion statistics (Pearson correlation) after confirm ing norm al frequency distribution of the 
data. Correlation between the two m easurem ent techniques was calculated with absolute 
values but also w ith changes in CO. In  addition, the m ethod described by Bland and Altm an 
was used. H ereby the difference between the two m ethods (bias) was calculated by subtrac­
ting the value of C O UFp from  C O TpTD. T he bias was plotted against the m ean C O  ([C O UFp 
+ C O TpTD]/2 ). The limits o f agreem ent were calculated by m ultiplying the SD (s) o f the bias 
with 1.96. T he 95%  confidence interval (CI) of the bias was determ ined by first calculating 
the standard error (Vs2/n). Subsequently, the appropriate point o f the t distribution with 
n - 1 degrees of freedom  was determ ined. The t value was then  multiplied by the standard 
error. T he 95%  CI of the limits of agreem ent was calculated in the same m anner, except for 
the calculation of the standard error. This was determ ined by V3 s2/ n  (18). The percentage 
error between C O TpTD and C O UFp m easurem ents was used to perform  the Bland Altman 
analysis for percentage errors. T he percentage bias was calculated by dividing the m ean bias 
by m ean cardiac output x 100%. T he percentage error was calculated by 100% x (1.96 x SD 
of the b ias)/m ean  cardiac output (19).
29
CHAPTER II
Differences between consecutive lung w ater m easurem ents were calculated using the paired 
S tudent’s t-test.
Calculations and data  m anagem ent were perform ed using Excel for W indows (Office 2003, 
Microsoft, Seattle, WA). Statistical calculations were perform ed with M edCalc (Medcalc 
Software, M ariakerke, Belgium).
R e su lts
O ne anim al (no. 9) died during  the surgical p rocedure before m easurem ents could be 
undertaken. D eath  was related  to  in tractable hem odynam ic shock as a  result o f a large 
aortic-pulm onary  shunt. Table 1 shows the characteristics o f the rem ain ing  11 animals. 
A to tal o f 78 sim ultaneous C O  m easurem ents were suitable for analysis. T he coefficient 
of variation (as percentage of m ean) for the various C O TpTD m easurem ents was 6.9%  
(95% C I 6.2%  to 7.7%; p < 0.001). Figure 2 shows the correlation betw een C O TpTD and 
C O UFp. T he correlation  coefficient was 0.97 (95% CI 0.94 -  0.98; p < 0.0001). Figure 3 
shows the Bland-Altm an plot o f the absolute values o f C O TpTD and C O UFp. T he m ean 
bias was 0.19 l/m in , and  limits o f agreem ent were -0.04 and 0.43 l/m in . T he percentage
Table 1
Characteristics o f  animal subjects (n = 11). The table shows weight, total flu ids received during volume 
resuscitation, number o f  thermodilution cardiac output measurements, cardiac output measured with ultra­
sound flo w  probe, mean arterial blood pressure, heart rate, global end diastolic volume index (G ED VI) and 
extravascular lung water index (E V L W I) per animal.
L a m b W eight
(kg)
i-J$ 
¿4 
i
l
l
C O TFTD
(number)
C O „FF
(l/min)
M AP
(mm H g)
H R
(bPm)
GEDVI
(m l/m 2)
EVLW I
(ml/kg)
1 5.0 100 9 1.4 (0.9-2.3) 42 (35-49) 194 (183-206) 430 (360-590) 36.1 (25.0-49.7)
2 4.2 160 8 1.1 (0.4-1.6) 48 (33-56) 146 (117-171) 411 (314-471) 25.3 (22.1-36.1)
3 6.5 140 6 1.3 (0.8-1.5) 46 (36-53) 147 (141-153) 365 (241-452) 24.4 (18.3-33.0)
4 7.7 20 1 1.0 43 181 298 25
5 6.0 120 8 1.6 (0.8-2.0) 70 (49-79) 168 (157-180) 369 (254-459) 8.2-
o
8.3.2
6 5.8 120 8 1.7 (0.5-3.1) 85 (60-101) 162 (125-240) 402 (263-442) .6)2.2-
O':8.
co0.2
7 9.2 120 5 1.3 (0.6-1.6) 60 (39 - 89) 135 (115-143) 426 (315-491) 24.2 (18.7-29.7)
8 9.4 120 8 1.8 (1.0—2.5) 62 (46-81) 156 (148-167) 482 (346-581) 31.6 (27.8-35.4)
10 12.5 40 5 1.4 (0.8-1.9) 58 (28-82) 161 (143-196) 284 (236-347) 15.9 (12.9-19.5)
11 5.7 160 12 1.6 (0.8-2.5) 44 (35-58) 169 (129-268) 416 (327-480) 30.7 (23.4-35.7)
12 4.7 120 8 1.8 (1.0—2.3) 41 (32-50) 179 (147-201) 388 (284-540) 40.3 (21.3-63.4)
Data are expressed as mean (range). COTPTD = transpulmonary thermodilution cardiac output measurement; CO = 
cardiac output measured with ultrasound flow probe around the pulmonary artery; M A P  = mean arterial pressure; H R  
= heart rate; bpm = beats per minute.
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Table 2
The transpulmonary thermodilution cardiac output based upon the mean o f  the first, first two, first three or 
all fo u r  thermodilution injections compared to the cardiac output measured with the ultrasound flo w  probe 
around the pulmonary artery. The table shows absolute bias, relative bias, absolute limits o f  agreement and 
relative limits o f  agreement.
C O TPTD
(1 injection)
C O TPTD
(2 injections)
C O TPTD
(3 injections)
C O TPTD
(4 injections)
M ean bias (l/min) 0.25 0.23 0.21 0.19
M ean bias (%) 16.66 15.33 14.18 13.46
LOA + / -  (l/min) 0.40 0.30 0.24 0.24
LOA + / -  (%) 25.63 20.79 18.28 18.05
CO — cardiac output measured with transpulmonary thermodilution; LOA — limits o f agreement.
Figure 2
Scatterplot o f  cardiac output measured with transpulmonary thermodilution (C 0 7P7D)  and cardiac output measured 
with ultrasound flow  probe around the pulmonary artery (COUf.J (n = 78).
4
0  - T - ------------------------------------------- 1---------------------------------------------- 1----------------------------------------------1----------------------------------------------1
0 1 2  3 4
COUFp (l/min)
Solid line = regression line; dotted line = line of equality.
Correlation coefficient is 0.96 (95% confidence interval 0.94 -  0.98;p  < 0.0001).
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Figure 3
Bland-Altmanplot o f  cardiac output measured with transpulmonary thermodilution (COTPTD)  and cardiac output 
measured with ultrasound flow  probe around the pulmonary artery (COUFJ  (n = 78).
1,0
0,5
-0,5
i,o -I---------------------1---------------------1---------------------1---------------------1
0 1 2  3 4
( COTPTD + COypp) /  2 (l/m in )
Straight lines — bias and limits of agreement; dotted lines — 95%  confidence intervals.
The mean bias is 0.19 l/min and limits o f agreement are between -0.04 and 0.43 L/min.
bias was 12.02%  w ith limits o f agreem ent (percentage error) o f ±14.7% . T here  were no 
significant correlations betw een m ean  arte rial pressure, h ea rt rate, body weight, an d  the 
bias betw een c o TpTD an d  c o UFp Table 2 shows the com parison betw een cardiac ou tpu t 
m easured w ith U FP  and  T P T D  (n = 78). T he  m ean  cardiac output, m ean  bias, and  limits 
o f agreem ent o f the first one to three T P T D  m easurem ents and  all four T P T D  injecti­
ons were com pared  w ith the U FP  m ethod. To study the ability o f T P T D  for m onitoring 
small changes in C O  during  volum e loading, percentage changes in C O tptd and  c o Ufp 
were calculated during  this procedure. A to ta l o f 58 C O  changes were identified. Figure
4 shows the correlation  o f the relative changes betw een the two m ethods. T he  correlation 
coefficient was 0.97 (95% C I 0.95 -  0.98; p < 0.0001). T he  overall sensitivity for C O TpTD 
to reflect changes in C O Ufp was 85%  and  the specificity 83% . W hen only changes in 
c o TpTD o f > 5%  were analyzed, these num bers im proved to 92%  an d  86% . Both num ­
bers im proved fu rther to 100% w hen only changes in C O TpTD > 10% were analyzed.
T he correlation between changes in sV I and  changes in GEDVI or central venous pressure 
is depicted in Figure 5. T he course o f EVLW I during the experim ent from baseline to the 
hypovolemic phase and  the consecutive fluid resuscitation and  deliberate fluid overload is
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Figure 4
Scatterplot o f  relative changes between cardiac output measured with transpulmonary thermodilution (C 0 7p7D)  
and cardiac output measured with ultrasound flo w  probe around the pulmonary artery (COUFp) in 5 8  paired 
measurements during volume loading.
50
Correlation coefficient — 0.97 (95% confidence interval 0 .9 5 -  0.98;p  < 0.0001).
Solid line = regression line; dotted line = line of equality.
shown in Figure 6. D uring volume loading, the correlation coefficient between changes in 
EVLW I and SVI was -0.21 (95% CI -0.45 to -0.05; p = 0.11). The correlation coefficient 
between changes in  EVLW I and changes in  GEDVI was 0.40 (95% CI 0.16 -  0.60; 
p  < 0.002). T he bias between C O TpTD and c o Ufp in relation to EVLW I values is shown in 
Figure 7.
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Figure 5
Scatterplots between changes in central venous pressure and stroke volume index (figure A ) and between changes in 
global end-diastolic volume index and stroke volume index (figure B ) during flu id  resuscitation (n = 57).
Correlation coefficient between ACVP and A SV Iis 0.03 (95% confidence interval 0.23 to 0.29;p  — 0.80). Correlation 
coefficient between AGEDVI and A SV I is 0.59 (95% confidence interval 0.39 -  0.74; p  < 0.0001).
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Figure 6
Course o f  extravascular lung water index (E V L W I) during the experiment (n = 78). 
E V L W I  measurements are presented as means; error bars reflect SD.
*Significantfrom baseline; **significantfrom cardiac output (CO) maximized.
Figure 7
Scatterplot between extravascular lung water index (E V L W I) and the bias o f  cardiac output measured with 
transpulmonary thermodilution (COTpTE)  and cardiac output measured with ultrasound flow  probe around the 
pulmonary artery (COUFp) (n = 78).
Correlation coefficient is 0.006 (95% confidence interval 0.23 to 0.22;p — 0.96).
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D isc u ss io n
O ur experim ent shows that the T P T D  technique adequately m easures cardiac output in 
this new born anim al model. D uring volume loading, T P T D  is able to track changes in 
cardiac output w ith acceptable accuracy. O ptim um  results were achieved with the m ean of 
three bolus injections with ice-cold saline.
Transit tim e ultrasound flow probes are considered the standard reference m ethod for car­
diac output m easurem ents in  an anim al m odel (9). However, positioning of these probes is 
o f great im portance. Resting coronary blood flow is around 5%  of the total cardiac output 
but m ay increase when heart rate increases (20,21). Therefore, only positioning the flow 
probe only around the m ain pulm onary artery reflects true cardiac output in contrast to 
positioning around the ascending aorta. By using this standard reference m ethod, we were 
able, for the first time, to determ ine the accuracy of T P T D  in small animals.
The accuracy of T P T D  in the present study agrees with the results of others in  larger ani­
mals and children and is well within the acceptable limits o f 30% as described by Critchley 
and Critchley (7,8,19,22,23). A clinical study that included small children showed com pa­
rable accuracy but a smaller bias (6). In  this study, the Fick m ethod was used as the standard 
reference technique, which m ight overestimate true C O  in cases of pulm onary disease (24). 
In general, therm odilution cardiac output m easurem ent overestimates true CO. This is 
caused by loss of indicator due to injectate w arm ing by the environm ent. Because of the 
longer indicator route, the transpulm onary technique is m ore sensitive to  this phenom enon 
com pared with therm odilution using the pulm onary artery catheter (22,25). The loss of 
indicator could be enhanced by larger am ounts o f pulm onary edem a. M ost o f the indicator 
dispersal occurs during transit through the pulm onary capillary bed, and alveolar gas space 
surrounding these structures provides an effective therm al insulation. T herm al loss in  the 
lung is therefore < 1% (26). However, in  severe pulm onary edem a it could be anticipated 
that therm al loss could increase, leading to overestimation of the cardiac output. In the pre­
sent study, up to EVLW I values of 60 m L /kg , the am ount of lung w ater had  no influence 
on the bias between c o Ufp and c o TpTD. To our knowledge, this has not been dem onstrated 
before. A large am ount of blood loss within the thoracic cavity, however, has been shown to 
cause overestimation of C O TpTD (27).
The coefficient of variation for the T P T D  m easurem ents in  the present study was 6.9% 
and is in agreem ent with other studies in children and adults (6-8,28). This variation m ay be 
explained by the averaging process and by variations in  am ount of injectate and speed of 
the injection. Also, therm odilution is less accurate in pulsatile flow conditions (29). The vari­
ation with the T P T D  technique could worsen in  clinical situations com pared with a control­
led laboratory setting. This m ight be caused by additional variations in  speed of injection, 
small variations in volume, and patient-related factors, such as movements or hem odynam ic 
and respiratory alterations. Im proving the signal to noise ratio by increasing the volume of 
the injectate will only lead to a small im provem ent and could artificially increase C O  (30). 
Increasing the num ber of injections will only lead to a small increase in accuracy but may 
increase the workload of the nursing staff and could cause fluid overloading in small chil­
dren. Because fluid overloading is a serious risk, particularly in small children, the smallest
36
CHAPTER II
num ber of therm odilution m easurem ents is desirable. O ur results showed a small decline in 
accuracy when fewer m easurem ents were done (Table 2). The central venous catheter was 
always flushed with ice-cold saline ju st before a  series of m easurem ents, which prevented the 
first bolus from  being less cold than  the following ones. Therefore, the difference between 
the m ean of two and three injections was probably very small. However, we advise that the 
m ean of three m easurem ents be taken as this is standard clinical practice and is also recom ­
m ended for the use of pulm onary artery catheter (30). W hen fluid overload is a  serious 
problem , the m ean of two m easurem ents can be used but accuracy and reproducibility will 
be less.
This is also the first study that com pares changes in  C O TpTD and c o Ufp during volume 
loading. We feel that the capability of tracking changes in cardiac output determ ines the cli­
nical value of the technique (31). The high correlation coefficient and acceptable specificity 
and sensitivity prove that c o TpTD is capable of guiding volume loading when maxim ization 
of cardiac output is desired. Because of the variation of the T P T D  technique, very small 
changes in cardiac output of < 5%  are m ore difficult to  determine.
There was no significant correlation between changes in  central venous pressure and chan­
ges in SVI (Figure 5A). Apparently, changes in central venous pressure do not reflect changes 
in preload, which has been dem onstrated before in  animals, adults and children (5,15,25,32­
35). Also, the m oderate correlation between changes in GEDVI and changes in SVI is in 
agreem ent with other studies (32-35).
EVLW I increased during the experim ent (Figure 6). The initial increase of EVLW I during 
hypovolemia is probably related to the separate experim ent in which a large aortic-pulm o­
nary  shunt was m ade. This caused a tem porary  in- crease in  pulm onary blood flow with 
possibly a concom itant increase in lung w ater that becam e apparent after discontinuation 
of this separate experim ent. An increase in lung w ater as a result of shock has not been 
described by others (32) (36). D uring volume resuscitation guided by CO, the EVLW I did 
not increase; however, during deliberate fluid overloading, there was a small but significant 
increase. This has also been found in other studies (37,38). However, changes were small and 
variation am ong subjects was large (Table 1). EVLW I m easurem ents in  animals appear to 
be different from  those in  hum ans (39). In  this study, values of EVLW I were m uch higher 
that those considered norm al in adult patients (< 8 ml/kg).
O ur anim al m odel is com parable to the critically ill pediatric population regarding weight, 
blood pressure, and cardiac output. Cum ulative fluid loading was also com parable when re­
lated to children with severe septic shock. T he maximally increased h eart rate and probably 
low hem oglobin level in our anim al m odel were less physiologically similar to children and 
also infrequent in clinical practice, but we consider this of m inor influence on the overall 
bias between c o Ufp and c o TpTD. A lthough T P T D  appears to be a useful technique to m ea­
sure cardiac output in children, it still requires central venous catheters and several injec­
tions of saline and will only interm ittently pro- vide a  C O  value. Also, in several congenital 
cardiac defects, predom inately with left to  right shunt, T P T D  does not provide an accurate 
m easurem ent. A faster, preferably beat-to-beat technique like arterial wave analysis seems 
therefore m ore attractive, although perform ance in congenital cardiac defects rem ains to  be
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determ ined (40-42). Further research in adapting the algorithm  to the pediatric population
seems necessary (43).
C o n c lu sio n s
The T P T D  technique is a reliable m ethod of m easuring cardiac output in  small new born 
lambs. It is also capable of tracking changes in cardiac output, thereby m aking goal-directed 
hem odynam ic therapy in small children possible. D uring a process of volume resuscita­
tion, G EDV  reflects changes in  cardiac stroke volume m ore reliably com pared with central 
venous pressure.
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CHAPTER III
A b stra c t
T ranspulm onary  therm odilu tion  (TPTD ) using the injection of ice-cold saline is a  reliable 
technique for m easuring cardiac ou tpu t in  adults and children. We describe two cases in 
which these m easurem ents were erroneously influenced by diffusion of the tem perature 
indicator.
If  the therm istor-tipped  arterial catheter is in  close proxim ity to the central venous ca the­
ter, the injection o f an ice-cold indicator m ight lead to an early tem peratu re drop in  the 
arterial catheter thus producing  a biphasic dilution curve. This is called the “cross-talk 
phenom enon” . In  the first case, concern ing  a child undergoing congenital cardiac surgery, 
we show th a t this phenom enon  is dependen t on b lood flow. In  the second case we dem on­
strate an anim al experim ent in  which the cross-talk phenom enon  occurred  during  a very 
low flow state. H ow ever in this case the venous catheter was positioned in  the inferior 
caval vein and no t in  close proxim ity to the arterial catheter. T he cross-talk phenom enon 
can also occur w hen the arterial ca theter is no t in  close position to  the central venous 
catheter.
We conclude tha t w hen using T p T D  m easurem ents w ith arterial and  venous catheters 
bo th  positioned in  the lower body, the cross-talk phenom enon  m ay occur. Therefore the 
therm odilu tion  curve should always be closely m onitored  for a biphasic shape, especially 
w hen the cardiac ou tpu t is low.
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In tro d u ctio n
T ranspulm onary  therm odilu tion  (TPTD ) is a reliable technique for m easuring cardiac 
ou tpu t in adults and children (1-4). U sing a therm istor-tipped  arterial catheter and  a 
m onitoring  device (PiCCO, Pulsion M edical Systems, M unich, G erm any) a tem perature 
dilution curve can be registered w hen an ice-cold solution is injected into a central venous 
catheter. C ard iac ou tput is calculated according to the Stew art H am ilton  equation  (5). By 
using the T P T D  technique it is also possible to  detect a right- to-left in tra -card iac shunt 
because, in these instances, the T P T D  curve becom es biphasic (6). However, a biphasic 
curve can also occur if the injection po rt of the central venous catheter and the therm is­
to r-tipped  arterial line are positioned closely together. This is described as the “cross-talk 
phenom enon” (7). T he cross-talk phenom enon  occurs w hen the tem peratu re indicator 
reaches the arterial therm istor directly after injection because of diffusion th rough  tissues. 
After the indicator has travelled in the bloodstream  through  the h eart and  great vessels it 
reaches the therm istor for the second tim e causing a biphasic therm odilu tion  curve.
Based upon  two observations, we conclude tha t the cross-talk phenom enon  is dependent 
on b lood flow (e.g. cardiac output).
C a se  1
A 10-month-old child, weighing 6.5 kg and 66 cm  in length, underw ent a  valvulotomy 
for congenital pulm onary valve stenosis. T he preoperative diagnostic work up revealed no 
intra- or extra-cardiac shunts nor was there any significant valvular regurgitation present. 
After induction of general anesthesia and the initiation of m echanical ventilation, a 7-cm- 
long 3-Fr arterial catheter was inserted into the right fem oral artery. An 8-cm-long triple 
lum en 5.5-Fr fem oral central venous catheter was inserted on the same side. A fast bo­
lus injection of three milliliters of ice-cold saline was used for T P T D  m easurem ent. The 
p ic c o p lu s  device was used together with a laptop com puter with the special p ic c o w in  
software (Pulsion, M unich, Germany). This equipm ent allows the user to  store not only all 
P iC C O  m easurem ents but also the therm odilution curves for analysis afterwards. The first 
T P T D  m easurem ent showed a huge biphasic shape (Figure 1, upper curve). It was noted  
that the tim e interval between injection and first detection of the indicator was very short. 
It took 3.3 seconds to reach the first lowest blood tem perature whereas it took 10 seconds to 
reach the second lowest value. A reliable calculation of cardiac output (CO) was impossible. 
The heart rate (HR) was 125 bpm  and the m ean arterial pressure (MAP) was 56 mmHg. 
Clinically, cardiac output (CO) was low as the child was peripherally cold and m ottled. Also 
the child was hypotherm ic after induction of anesthesia, w ith a blood tem perature of 35.7 
C. N o other clinical signs of serious circulatory failure were recorded.
Reconstruction of the therm odilution curve using only the secondary part of this curve 
(omitting the grey area in the upper curve of Figure 1) resulted in an estim ated cardiac 
index of 2.3 l /m in /m 2. The hem odynam ic status im proved after adm inistration of fluids. 
Post-operatively another therm odilution m easurem ent, using the same arterial and venous 
catheter, was perform ed. This tim e a completely different curve (Figure 1, lower curve) was
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Figure 1
Two separate transpulmonary thermodilution measurements in the same patient using the same arterial and 
venous catheters.
The upper curve was registered in a low cardiac output state; the lower curve was registered in a normal output state. 
The grey area in the upper curve shows the cross-talk “area”. Note thefaster appearance o f the temperature change after 
injection o f the ice-cold solution in the upper curve compared to the lower curve (time intervalfrom injection to A  in the 
upper curve compared to time interval from injection to B  in right curve).
Tblood = blood temperature registered using the PiCCO catheter inserted in the femoral artery; Tinj = injectate 
temperature registered in the central venous catheter inserted in the femoral vein; A  = cross-talk temperature peak; B  = 
normal thermodilution peak
produced also using 3 m l of ice-cold saline. Now the cross-talk phenom enon could not be 
observed. H eart rate at that tim e was 159 bpm , M AP was 70 m m H g, blood tem perature 
was 37.6 C, cardiac index was 4.2 l /m in /m 2 and the child was clinically in  a  good hem o­
dynam ic state with w arm  extremities. T he interval tim e between injection and lowest blood 
tem perature in  this series of m easurem ents was 7.6 sec.
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C a se  2
D uring an anim al experim ent investigating hem odynam ic stabilization after experim ental 
surgery, we used the T P T D  technology to m easure cardiac output. A 7-cm-3 French arte­
rial Pulsiocath catheter in the fem oral artery was used in conjunction with a  single-lumen 
venous catheter. The venous catheter was surgically advanced through the fem oral vein. 
U sing the same P iC C O plus device and storage facility described in  case 1, we m easured 
cardiac output in  a  rhesus m onkey of 12 kg weight and 100 cm  height using an ice-cold
Figure 2
Exam ple o f  two separate transpulmonary thermodilution measurements in a monkey
The upper curve was registered with the venous injection point in the inferior caval vein position while the lower curve was 
registered in the same hemodynamic situation but with the injection point in the right atrial position.
Tblood = blood temperature registered using the PiCCO catheter inserted in the femoral artery; Tinj = injectate temperature 
registered with a central venous catheter inserted in the inferior caval position (upper) or right atrial position (lower curve); 
A = cross- talk temperature peak; B  = normal thermodilution peak
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Figure 3
Schematic view o f  the two mechanisms o f  the cross-talk phenomenon
A = normal flow state with thermal indicator injection in iliac vein
B  = low flow state with thermal indicator injection in iliac vein, the indicator diffuses to the iliac artery 
C = low flow state with thermal indicator injection in inferior caval vein, the indicator diffuses to the aorta 
CVC = central venous catheter; A C  = Arterial catheter; Ao = aorta; IC V  = Inferior caval vein
infusion of 3 ml norm al saline. T he anim al was in a clinical state of profound hem odynam ic 
shock. A t the tim e of the first T P T D  m easurem ent the heart rate was 110 bpm  and blood 
pressure 4 2 /2 9 /2 4  m m H g (SAP, M AP and DAP respectively). An abnorm al therm odilution 
curve was recorded (Figure 2 upper curve). Again the tim e interval between injection and 
first reaction of blood tem perature was short (5.6 sec).
A radiographic study was perform ed to verify the position of the venous catheter as it was 
suspected tha t it was positioned close to the therm istor-tipped arterial catheter. T he tip 
however was located in  the inferior caval vein ju st cranial o f the bifurcation. T he arterial 
catheter was positioned in  the iliac artery, not adjacent to the venous catheter. Subsequently 
the venous catheter was advanced under radiographic guidance until it reached the level 
o f the right atrium. W ithin 20 m inutes a  second T P T D  m easurem ent was perform ed. This 
tim e a norm al T P T D  curve was observed (Figure 2 lower curve). Blood pressure and heart 
rate were similar and cardiac index was 0.74 l /m in /m 2. The tim e interval between injection 
and lowest blood tem perature was prolonged to 14.4 seconds as m ight be expected with a 
very low cardiac output.
D isc u ss io n
In  adjunct to  the experiences of M ichard and colleagues, we propose that the venous injec­
tion of ice-cold saline close to the therm istor-tipped arterial line produces a  local change in 
tem perature, which influences the reading of the arterial therm istor (7). This was dem on­
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strated in  Case 1 (Figure 1 upper curve). N ot only the therm odilution curve was biphasic 
but also the interval between injection and detection of a tem perature change was very 
short reflecting a diffusion of tem perature from  venous to arterial site. This is schematically 
reflected in  Figure 3B. However, the second m easurem ent (Figure 1 lower curve) proves that 
when blood flow in the fem oral or iliac vein is m uch higher, the injectate is quickly trans­
ported  away from  the therm istor and the “cross- talk phenom enon” will not be seen in  the 
therm odilution curve. This (normal) situation is draw n in Figure 3A.
The second case dem onstrates that in  instances of a very low cardiac output, the cross-talk 
phenom enon can occur even if the two invasive catheters are not in  close proximity. In this 
case, as a result o f the extremely low blood flow in the inferior caval vein the injectate was 
able to diffuse to the aortic blood and in this way “cool dow n” the arterial therm istor. This 
is shown in Figure 3C. W hen the catheter was advanced to the right atrial position this 
phenom enon disappeared.
In order for the transpulm onary therm odilution technique to m easure cardiac output reli­
ably, all o f the following assumptions have to be met: 1) constant blood flow, 2) no or minimal 
loss o f indicator, 3) com plete m ixing of the indicator with blood, and 4) the indicator may 
only pass the therm istor once (8). Since in  bo th  of the described cases assumption 4 was not 
m et, the m easurem ents had  to be discarded. Furtherm ore, it is debatable w hether assump­
tion 1 was met. These cases dem onstrate that essential knowledge of the therm odilution 
technology is required for correct interpretation of the m easurem ents (9-11).
These situations m ay occur m ore often than  suspected. In a recent study we evaluated 115 
m easurem ents o f transpulm onary therm odilution in  27 children. After careful analysis of 
the stored dilution curves, at least four instances of the cross-talk phenom enon were ob­
served (> 3%). It is therefore advisable for the m anufacturer to im plem ent an algorithm  that 
analyses the therm odilution curve and produces a w arning if the cross- talk phenom enon 
is suspected. This algorithm  m ight be based upon a biphasic dilution curve together with a 
short tim e interval between injection and first appearance of a tem perature change by the 
arterial thermistor.
The reliable use of the T P T D  technique with a fem oral central venous catheter has been 
described in adults and children (12,13). In  order to prevent the occurrence of the cross-talk 
phenom enon in this situation, it has been advised to use longer central venous catheters for 
the fem oral route (14). However, this does not completely prevent this problem  in situations 
of very low blood flow as was shown in case 2. Therefore a central venous line in  the upper 
part of the body is preferred.
We conclude that when carrying out T p TD  m easurem ents with arterial and venous cathe­
ters both  positioned in  the lower body, the therm odilution curve should always be closely 
m onitored for a  biphasic shape, especially when the cardiac output is low and when the 
catheters are in  close proximity. It is recom m ended that the m anufacturer should develop 
an algorithm  tha t produces a w arning in these instances.
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A b stra c t
Objective
M easurem ent of extravascular lung water (EVLW) m ay be useful in the treatm ent o f critically 
ill children and can be perform ed at the bedside using the transpulm onary therm odilution 
technique (TPTD). There are currently no data  to verify the accuracy of these measurements 
in (small) children. We com pared the results of T PT D  m easurem ent with the clinical gold 
standard transpulm onary double indicator dilution (TPDD) m easurem ent in  young children.
Design
Prospective clinical study in children.
Setting
Catheterization laboratory of a university hospital.
Patients and Methods
Twelve children (<2 years or <12 kg) under general anesthesia.
Interventions
None.
M easurements and m ain results
M easurements were perform ed using injections of ice-cold indicator (saline or dye) through 
a central venous catheter. M ean cardiac index was 3.91 l /m in /m 2, m ean intrathoracic blood 
volume index (ITBVItpDD) was 614.9 m l/m 2, and m ean extravascular lung water index 
(EVLWItpDD) was 11.7 ml/kg. The correlation coefficient between EVLW ItpDD and 
EVLW ITpTD was 0.96 (95% confidence interval: 0.87 -  0.99; p < 0.0001). Bland Altman anal­
ysis for EVLW  measurem ents showed a m ean bias of 2.34 m l/k g  (18.13%) and limits of 
agreement ±2.97 m l/kg  (19.78%). The difference between measurem ents via the right atrium 
com pared with the femoral vein was 2.8%  for cardiac output, 8.2%  for global end diastolic 
volume, and 0.1%  for EVLW.
Conclusion
Clinical m easurem ent o f EVLW  in young children can be perform ed using the T P T D  with 
the injection catheter inserted in the femoral vein. Further studies are needed to clarify the 
clinical value of these measurements.
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In tro d u ctio n
Severe illness in  children, like sepsis, traum a, or hem odynam ic shock, is characterized by a 
concom itant increase in  capillary perm eability (1,2). In  this situation, excessive fluid resus­
citation m ay result in m ore deaths (3). M easurem ent o f extravascular lung w ater (EVLW) 
gives the opportunity to quantify the am ount of edema. EVLW  can easily be m easured at 
the bedside using the transpulm onary therm odilution technique (TPTD) (4,5). At present, 
this technique requires a therm istor-tipped 3-French fem oral artery catheter and the injec­
tion of ice-cold saline through a central venous catheter. It also requires a special device 
(PiCCO, Pulsion, M unich, Germany) for m easurem ents and calculations.
A part from  lung water, this technique also m easures cardiac ou tpu t (CO) and  global end- 
diastolic volume (GEDV). G ED V  is a  static volum etric param eter th a t reflects preload 
and has been shown to predict fluid responsiveness in  critically ill adult patients (6,7). 
F urtherm ore, the ratio  of EVLW  and GEDV  could differentiate betw een pu lm onary  ede­
m a  caused by increased hydrostatic pressure or acute parenchym al lung injury (8).
In  adult patients, the T P T D  technique has been  validated (9). In  a pediatric population, 
the C O  m easurem ents are accurate and applicable but, in contrast to adults, m easure­
m en t of lung w ater using the T P T D  technique results in  h igher values even in  children 
w ithout overt clinical signs of pu lm onary  edem a (4,6). Subsequently, G ED V  is m uch 
lower com pared  w ith adult values (4,10,11). T here are doubts w hether the calculation 
m ethod  is suitable for these patients (12).
A lthough the postm ortem  gravim etric technique is considered the gold standard  m ea­
surem ent of EVLW, the transpulm onary  double indicator dilution technique (TPDD) 
using injections o f ice-cold indocyanine green (ICG) is considered the clinical standard 
for EV LW  m easurem ent (13,14). However, the injection of IC G  im poses additional work, 
expenses, and  the risk of po ten tia l side effects. F urtherm ore, the special T PD D  arterial 
catheter requires a relatively large in troducing  sheath (minim al 4 French) in  the fem oral 
artery. Therefore, in  small children, the T P D D  technique is hardly  ever used.
Also central venous catheters in  children are regularly inserted in  the fem oral vein, 
w hereas in  adults the subclavian or in te rnal ju g u la r vein is preferred. In jection of the 
therm al indicator in  the fem oral vein could influence T P T D  m easurem ents because of 
the greater distance to the heart.
We m easured EVLW  in young children and com pared the results of the T P T D  m easure­
m ents with the T PD D  technique. We also com pared T P T D  m easurem ents perform ed with 
injections through a central venous catheter inserted in  the fem oral vein with injections 
through a catheter positioned close to the right atrium . This is, to our knowledge, the first 
study tha t validates EVLW  m easurem ent using the T P T D  technique in young children.
M eth o d s
This study was conducted in accordance with the D utch national legislation concerning 
biom edical studies in children and was approved by the national and local ethic com mittees 
concerning m edical research in  hum ans. All m easurem ents were perform ed after oral and 
w ritten inform ed consent from  both  parents.
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Patient Selection and Management
We included 12 children under general anesthesia with age <2 years or bodyweight <12 
kg. All children underw ent elective cardiac catheterization necessitating arterial and venous 
access. Exclusion criteria were the presence of a  cardiac or extracardiac shunt at the time 
of m easurem ent, severe valvular insufficiency, severe renal insufficiency, severe liver insuf­
ficiency, or a known allergy for iodine. Patients were prem edicated with the oral or rectal 
adm inistration of 0.3— 0.5 m g /k g  m idazolam  when judged  necessary. G eneral anesthesia 
was induced and m aintained with sevoflurane 1%—3%, fentanyl citrate 2—5 |^g/kg if indi­
cated and rocuronium  brom ide 0.5—1 m g /k g  before endotracheal intubation. T he trachea 
was in tubated  using a 3.5—4.5 m m  (inner diameter) cuffed endotracheal tube (Mallinck­
rodt, Hazelwood, M O), and the lungs were mechanically ventilated in a volume controlled 
m ode using tidal volumes of approxim ately 10 m l/k g  (Cicero EM , Drager, Germany). N or­
m ocapnia, guided by capnography, was achieved by adjusting the respiratory frequency to 
m aintain an end-tidal C O 2 tension between 30 and 38 to rr (4—5 kPa). S tandard  m onitoring 
consisted of electrocardiogram , heart rate, noninvasive blood pressure, transcutaneous oxy­
gen saturation, tem perature, and respiratory param eters. Fluid m anagem ent consisted of 
the adm inistration of 10 m l/k g /h r  glucose 2 .5 % /N aC l 0.45%. Im m ediately after cardiac 
catheterization, all children were extubated and transferred to the recovery room.
Catheterization Procedure
All cardiac catheterization procedures were perform ed by an experienced pediatric cardiol­
ogist. In  all cases, sheath introducers (Cordis C orporation, M iam i Lakes, FL) were inserted 
in both  the fem oral artery and vein for intravascular access. Size varied between 4 and 7 
French depending on the required diam eter for the interventional or diagnostic procedure. 
At the end of the procedure, the in troducer sheaths were w ithdraw n and pressure was ap­
plied for approxim ately 15 mins. All children received a special pressure bandage for further 
hemostasis. Afterward the catheterization sites were regularly checked for signs of bleeding. 
Also the lower extremities were checked for local circulatory disturbances.
Instrum entation
Through the arterial sheath, a special Oxim etry Therm o-D ye Dilution Catheter was intro­
duced (PV2023, Pulsion). This catheter is equipped with a therm istor for detection of changes 
in blood tem perature and also incorporates a  fiber optic. The fiber optic enables the detection 
of IC G  levels in the blood. The catheter was connected to the C O LD  com puter (Pulsion). 
Through the venous sheath, a 65 cm, 4 French multipurpose catheter (Arrow, Reading, PA) 
was introduced for injections of therm o or dye indicator. An injectate tem perature sensor 
(PV4045, Pulsion) was connected to this catheter and also to the C O LD  computer.
Transpulm onary Thermo- and Dye Dilution M easurements
Residual shunts were excluded by means of angiography. In two patients with valvular aortic 
stenosis scheduled for balloon valvuloplasty, the study was perform ed before the interventional 
procedure to prevent measurem ents in the presence of a large valvular insufficiency (Table 
1). In  all other patients, measurem ents were perform ed after the interventional or diagnostic 
procedures were completed. The theoretical backgrounds of m easuring blood volumes and 
EVLW  are explained in the Appendix. Therm odilution measurem ents were perform ed using 
multiple rapid injections of 4 — 6 ml of ice-cold saline (0.9% NaCl) through the central venous
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Table 1
Patient characteristics
P a tie n t A ge (m onth) W eig h t (kg) D ia g n o s is P ro c e d u re  ty p e
1 2.5 5 AoS Valve dilatation
2 3 6.6 AoS Valve dilatation
3 4 9 PDA PDA closure
4 7 9.5 PDA PDA closure
5 13 13.1 Hurler syndrome Diagnostic
6 23 11.8 PDA PDA closure
7 13 9 PDA PDA closure
9 20 14.5 PDA PDA closure
10 6 5 PDA PDA closure
11 16 8.9 Cardiomyopathy Diagnostic
12 17 10.2 PDA PDA closure
mean 11.3 9.3
AoS — aortic stenosis, PDA — Patent ductus arteriosus.
catheter. For double indica­
tor dilution measurements,
4 -  6 m l of an  ice-cold IC G  
(Pulsion) solution (1 m g /m L  
in glucose 5%) was injected 
through the central venous 
catheter. All measurements 
were done in duplicate, and 
the dilution curves were di­
rectly verified for norm al 
shape, irregularities, or signs 
of a  cross-talk phenom enon 
(15). If the m easured varia­
bles differed >10% , a  third 
m easurem ent was done and 
the m ean value o f three 
measurem ents was taken.
No abnorm al dilution cur­
ves were identified. Addi­
tional photographs are shown in figures 1, 2 and 3.
T he C O L D  com puter stores all therm odilution and dye dilution m easurem ent data  on a 
floppy disk. Using special software (cold2wks.exe; Pulsion) these data can be extracted to a 
personal com puter for further analysis. T he C O L D  com puter enables the calculation of 
lung w ater and volum etric variables using the double indicator or the single indicator tech­
nique. W hen perform ing the double indicator technique, it is possible to calculate the same
Figure 1
Measurement at the catheterisation lab
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Figure 2
Connection to catheters
Figure 3
Screen shot o f  the COLD computer after a transpulmonary dye dilution 
measurement
variables using both  double 
indicator and single indica­
to r technique from one se­
ries of measurem ents.
For calculation o f intratho- 
racic blood volume (ITBV), 
the c o L D  com puter was 
set to ITB V  = GEDV x 
1.25 (default setting).
T he calculation o f EVLW  
and GEDV using the sin­
gle indicator technique by 
the c o L D  com puter is 
similar to the m uch m ore 
used bedside P iC C O  sys­
tem  (Pulsion). T he P iC C O  
system uses only the T PT D  
and calculates CO , EVLW, 
GEDV, and other derived 
variables. In  this way, the 
P iC C O  represents the 
therm odilution p art o f the 
C O L D  system.
Protocol
T he arterial oximetry ther­
m odye dilution catheter was 
positioned ju st proxim al to 
the ao rta  bifurcation. The 
venous catheter was po­
sitioned ju st proxim al to 
the tip o f the introducer 
sheath. This was usually at 
the location of the external 
iliac vein. Subsequently, the 
first transpulm onary ther­
m odilution m easurem ent 
was done. Hereafter, the 
venous catheter was advanced to a  position above the diaphragm . At this position, close 
to the right atrium , the first T PD D  m easurem ent was perform ed. T he last m easurem ent 
was repeated after an  intervention free period of 10 mins. Thereafter, the venous catheter 
was w ithdraw n to the form er external iliac vein position and  it positions were verified using 
fluoroscopy. In  this way, two T PT D  m easurem ents at the level of the fem oral vein and  two 
T PD D  m easurem ents at the level o f the right atrium  were perform ed. T he first m easure­
m ents were used to analyze absolute values, whereas the second m easurem ents were used 
to calculate repeatability.
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Statistical Analysis
SD of lung w ater m easurem ent in  children is unknown. Sample size was, therefore, calcu­
lated using an expected m inim al acceptable correlation of 0.7 — 0.9 and a power of 80%. 
Because of these assumptions, we choose a smaller p value of 0.01. In  this m anner, we cal­
culated a sample size between 8 and 18. The coefficient o f variation for absolute values was 
calculated by dividing the standard deviation by the m ean value (16). Com parison between 
the two techniques was perform ed using correlation statistics (Pearson correlation) after 
confirm ing norm al frequency distribution of the data. Limits o f agreem ent were calculated 
by m ultiplying the SD of the bias w ith 1.96 (16). T he percentage bias was calculated by di­
viding each bias by each m ean value. The percentage limit o f agreem ent (percentage error) 
was calculated by dividing the absolute limits o f agreem ent by the m ean values.
Statistical calculations were perform ed using M edCalc 9 (M edCalc Software, M ariakerke, 
Belgium).
R e su lts
We excluded one patient (no. 8) because of catheter malfunction. Table 1 presents the charac­
teristics of the rem aining 11 children. The coefficient of variance for repeated measurements
Table 2
Individual hemodynamic, ventilator and volumetric parameters
P atien t M AP
(mmHg)
SaO 2
(%)
PEEP
(cmH2O)
2" 
g
CTTPTD
( l/m in /m 2)
G E D V T t p t d
(m l/m 2)
T T B V T t p d d
(m l/m 2)
E V L W Tt p d d
(ml/kg)
1 45 99 0 31 3.1 376.1 523.5 22.1
2 44 97 5 50 2.9 308.8 411.2 11.9
3 48 98 5 50 3.6 453.6 619.3 10.1
4 40 94 5 36 3.5 441.4 630.6 8.0
5 53 98 3 60 4.2 535.7 696.1 14.9
6 45 96 5 41 5.2 538.5 710.8 9.1
7 50 100 5 40 5.2 504.2 671.4 7.6
9 52 98 5 43 4.0 457.1 582.9 7.8
10 50 96 5 43 4.0 342.0 519.8 15.9
11 42 100 5 42 3.7 576.6 782.4 12.1
12 43 96 4 40 4.1 476.5 616.0 8.4
M ean 11.3 97.5 4.3 43.3 3.9 455.5 614.9 11.6
M A P  — mean arterial pressure; SaO2 — arterial oxygen saturation; PEEP — positive end expiratory pressure; FiO2 
—inspired oxygen concentration; CITPTD — cardiac index measured with transpulmonary thermodilution; GEDVItptd
— global end diastolic volume index measured with transpulmonary thermodilution; IT B V ITpDD = intra thoracic blood 
volume index measured with transpulmonary double indicator dilution; E V L W I — extra vascular lung water index 
measured with transpulmonary double indicator dilution.
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was 2.1% for CO, 6.8%  for EVLW, 3.6% for ITBVTpDD, 4.2%  for EVLW TpTD, and 3.6% for 
GEDVTpTD. There were no differences in the coefficient of variation between measurements 
done with injection of therm al indicator in the femoral vein or in the right atrium. Table 2 
presents several individual hem odynamic, ventilator, and volumetric measurements.
Figure 4 shows the correlation between EV LW iTpDD and EVLW Itptd. T he correlation coef­
ficient is 0.96 (95% confidence interval: 0.87 -  0.99; p < 0.0001). Figure 5 shows the B land- 
A ltm an plot of EV LW ITpDD and EV LW iTpTD. T he m ean bias is 2.34 m l/k g  and limits of 
agreem ent are ±2.97 m l/kg. Expressed as a  percentage, the bias is 18.13% with limits of 
agreem ent (percentage error) o f ±19.78% . M ean value of in trathoracic blood volume index 
(ITBVITpTD + ITB V Itpdd) /  2 was 592.1 m l/m 2, m ean bias (ITBVITpDD - ITB V ITpTD) was
45.5 m l/m 2, and limits o f agreem ent were ±49.3 m l/m 2 (percentage: 7.99%  ±9.9%).
Figure 4
Correlation between extravascular lung water index measured w ith transpulmonary thermodilution 
('E V L W Ij t t and E V L W I  measured w ith transpulmonary double indicator dilution (E V L W Itpdd).
The solid line represents the regression line, whereas dotted line represents the line o f equality.
The relationship between global end diastolic blood volume index m easured with T pT D  
technique and ITB V TpDD is shown in Figure 6. T he correlation coefficient is 0.99 (95% con-
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Figure 5
B land  A ltm an p lo t o f  extravascular lung water index (E V L W I) measured with transpulmonary thermodilution 
technique (T P T D ) and transpulmonary double indicator dilution technique (T P D D ) technique.
15
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The straight line represents mean bias, and dotted lines represent limits o f agreement.
fidence interval: 0.98 -  1.0; p < 0.0001). Instead of the default calculation of ITB V  used 
by the C O L D  com puter (ITBV tptd = 1.25 x G ED V Itptd) in this study, IT B V tptd could be 
best calculated using the formula: IT B V tptd = 1.24 x G Ed V L^td + 21.24. Figure 7 shows 
the relation between the ratio o f IT B V tpdd/G E D V Itptd and bodyweight. T h e  correlation 
coefficient was 0.72 (95% confidence interval: 0.92 to 0.22; p = 0.011).
Table 3
Differences between transpulmonary thermodilution measurements with injection o f thermal indicator in the 
right atrium and in thefemoral vein.
M e a su r e d  v a r ia b le B la n d  A ltm a n  a n a ly s is
m ean  bias (%) LA (%)
C o r r e la t io n  s ta t is t ic s
r  (95% CI) p
C I ( l /m in /m 2) 0.1 (2.8%) 0.5 (10.6%) 0.95 (0.80 to  0.99) <0.0001
EVLW ItptD (ml/kg) 0.0 (0.1%) 2.3 (14.4%) 0.97 (0.90 to  0.99) <0.0001
G E D V I ^  (m l/m 2) 41.1 (8.2%) 77.7 (12.7%) 0.94 (0.77 to  0.98) <0.0001
C I =  cardiac index; E V L W Iri^ D = extra vascular lung water index measured with transpulmonary thermodilution 
GEDVITpTD = global end diastolic volume index measured with transpulmonary thermodilution; bias = difference 
between venous injection at right atrium and iliac vein; LA  =  limits o f agreement; r =  correlation coefficient; 95%  CI 
= 95%  confidence interval; p  =  statistical significance o f correlation statistics.
Bias was calculated by subtracting values measured via right atrium from measurements via the iliac route.
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Figure 6
Correlation between global end diastolic blood volume index measured by transpulmonary thermodilution 
(G E D V IJP7D) and intrathoracic blood volume index measured with transpulmonary double indicator dilution
(i t b v i tpdd).
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The solid line represents the regression line.
Table 3 presents the differences in cardiac index, G EDV ITpTD, and EVLW ITpTD with the 
injection of the therm al indicator via the fem oral vein com pared with injection in  the right 
atrium. The difference in  m ean  transit tim e (MTt) was 2.48%  ±7.9% , with an expected 
higher M T t when injection was in  the fem oral vein. T he difference in  the down slope time 
(DSt) was 0.04%  ±10.6% .
D isc u ss io n
th i s  study shows that EVLW  m easured using the T p T D  closely resembles m easurem ents 
using the double indicator technique in  young children. Also these m easurem ents can be 
perform ed using a central venous catheter inserted in  the fem oral vein.
The m ild overestimation of EVLW Itptd com pared with EVLW Itpdd (18% in the p re­
sent study) has also been found by others in  anim al studies (10,17). T he overestimation of
63
CHAPTER IV
Figure 7
Correlation between the ratio o f  intrathoracic blood volume measured with transpulmonary double indicator 
dilution ( IT B V ttdd) and global end-diastolic blood volume measured with transpulmonary thermodilution 
( G E D V ^ D  and body weight.
The solid line represents the regression line.
EVLW TpTD and the concom itant underestim ation of ITB V TpTD were also shown in adult 
patients (9,18). Overestim ation can be explained by the calculation of ITB V tptd . This cal­
culation is based on the assumption that ITB V TpTD equals 1.25 x GEDVTpTD in all subjects 
(19). It presum es tha t pulm onary blood volume has a linear and constant relationship with 
the end-diastolic volume of the heart. However, this relation is not equal in  different patient 
groups or animals (7,10,18-20). In  our study population, this relationship was reflected by 
the form ula ITB V TpTD = 1.24 x GEDVTpTD + 21.24 (Figure 6). However, the inverse re­
lationship between ITB V tptd/G E D V tpdd and weight shows tha t in younger children this 
ratio presum ably increases (Figure 7). A pparently in  younger children the pulm onary blood 
volume is relatively larger com pared with older children or adults.
There are several considerations in using the T P T D  and TPD D  techniques. They require 
a norm al and even distribution of blood flow through the pulm onary vascular bed. Also 
when the indicator is injected in a vein close to the arterial catheter it could disturb the 
arterial tem perature detection because of local diffusion of tem perature. This effect is m ore 
pronounced w hen the C O  is low (15). D uring the transport of the indicator from  injection 
to detection point, there could be loss o f indicator, which mainly concerns tem perature.
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W hen small am ounts o f indicator are used in com bination with a large volume of tubing 
connected to  the central venous catheter, a part o f the indicator could rem ain in  the tubing. 
This is o f im portance in  small children when only 2—3 ml of indicator is used to prevent 
fluid overloading. Finally, although rare, extravasation of indicator at the injection point 
would influence the T P T D  or T PD D  m easurem ents. In this study, all the above m entioned 
factors were addressed carefully. Therefore and because of the physical properties of the 
TPD D  technique, we consider EVLW Itpdd to be the clinical gold standard for EVLW  m ea­
surem ent in our study.
Although EVLW Itptd and EVLW Itpdd were closely related, all the m easured values of 
EVLW I were m uch higher com pared with adult patients. T he range in  the present study 
was between 7.6 and 22.1 m l/kg, whereas in  adults the norm al range is 3—7 m l/kg. In  con­
trast, the GEDVTpTD was lower com pared with adults (norm al 650 — 800 m l/m 2) as can be 
seen in Table 2 (21). Furtherm ore, the m easured values of EVLW  showed an unexpected 
wide range tha t cannot be explained by the clinical situation. M any procedures were per­
form ed for closure of a patent ductus arteriosus. It could be anticipated that these children 
had higher lung w ater because of a left to right shunt that was closed just before the EVLW  
measurem ents. However, these children showed no clinical signs of pulm onary edem a. An 
inadequate mixing o f indicator through the pulm onary vascular tree will influence the m ea­
surement. It is unknow n to w hat am ount small, no t clinically detectible, perfusion irregu­
larities influence the T PD D  m easurem ent. Although a subclinical increase in lung water 
cannot be ruled out, these children could all be successfully extubated right after the proce­
dure and were sent to the ward w ithout supplem ental oxygen or clinical signs of increased 
work of breathing. O thers have reported  high (> 29 m l/kg) lung w ater values in young and 
critically ill children (4). At the same time, a recent study in critically ill adults showed that 
EVLW I > 16 m l/k g  was strongly associated with a very high m ortality ratio (22). Therefore, 
we believe this study supports the possibility that lung w ater values in children are higher 
com pared with adults.
These possible higher EVLW  values in children are difficult to  explain. Total w ater content 
in children is higher com pared with adults. T he total body water decreases during child­
hood from  approxim ately 64%  to 48%  (23). However, this decrease provides only a  partial 
explanation for the m easured high values of EVLW I. The relationship between weight 
and body surface area (BSA) provides a  partial explanation of the high EVLW  in children. 
D uring the first year of life, weight increases m ore than  three-fold (approximately from  3 to 
10 kg), whereas BSA increases approxim ately two-fold (approximately from  0.22 to 0.5 m 2). 
BSA in young children is relatively large com pared with older children or adults. Therefore, 
specifically in children under 1 year o f age, a com parison based on weight could be less 
reliable. O n  the other hand, GEDV and ITB V  are indexed to BSA and values in young 
children still differ from  adults.
The difference in  T P T D  m easurem ents using injections close to the right atrium  and via 
a central venous catheter in the fem oral vein has been studied in  adult patients (23). Their 
results closely resemble ours (Table 3). T he small difference in  C O  can be explained by 
increased loss of the tem perature indicator because of the longer route from  injection to 
detection site (24). Like others our results also show that the difference in GEDV is caused by
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a longer M Tt. This can be explained because M T ttem p x C O  reflects the volume of blood 
between injection and detection point. The m ean volume of the inferior caval vein (includ­
ing a p art o f the iliac vein) in our population was estim ated at 20 m l (length 25 cm, radius
0.5 cm) (25). This provides a good explanation for the larger GEDV w hen m easurem ents 
are perform ed through the fem oral vein. Therefore, we believe that the T P T D  technique 
in small children can be reliably perform ed using injections via a central venous catheter 
inserted in the fem oral vein. For m easurem ent o f C O  and EVLW, the results will re­
semble those perform ed via the right atrium. However, a small overestimation of GEDV 
(< 10%) will occur. EVLW  m easurem ents are influenced in a  lesser am ount because changes 
in GEDV are only reflected by a 25%  change in the calculation of EVLW  (Appendix 1).
The present study is lim ited by a relative small sample size although all children showed 
consistent m easurem ents with acceptable repeatability. Also we only included children w ith­
out clinically increased lung water. Anim al studies have shown that the T P T D  technique 
is reliable in experimentally induced high lung water, the question rem ains w hether these 
results are applicable to critically ill children with clinically increased lung water. In adults, 
the results were different in cases of severe pulm onary edem a, whereas others found com ­
parable results (9,19). A lthough gravim etric determ ination of lung tissue is considered to be 
the laboratory gold standard, it is difficult to  perform  and can only be done postm ortem ; 
therefore, it is impossible to use this technique clinically in children. T he double indicator 
technique is considered the clinical gold standard in  adults (13,14). As m entioned above, it 
can also be considered the clinical gold standard in  children. But studies using the double 
indicator m easurem ents in critically ill children are unethical because of the risk of ischemia 
to the leg as a result of the 4-French introducer sheath in the fem oral artery. Therefore, we 
believe the therm odilution technique is the only clinically available technique to m easure 
lung w ater in critically ill children. However, the results o f the present study cannot autom a­
tically be applied to the pediatric critically ill population. Clinical studies using the T PT D  
technique in the pediatric intensive care unit m ust be perform ed before recom m endations 
can be done regarding norm al values or clinical decisions based on EVLW  m easurem ents.
This is the first study that establishes the accuracy of lung water m easurem ents in  young 
children using the T P T D  during cardiac catheterization. This technique could provide 
the clinician with a powerful tool to guide fluid therapy and distinguish between capillary 
leakage or hydrostatic edem a (8,26-28). Also the simultaneously m easured G EDV  is pos­
sibly a better reflection of preload than  central venous pressure (6). A lthough the T PT D  
technique seems to  be useful for hem odynam ic m easurem ents in  children, it still requires a 
central venous catheter, an arterial catheter, and several injections of saline. Also in several 
congenital cardiac defects, predom inately with left to right shunt, these m easurem ents are 
inaccurate. Its successful use, however, has been reported  after single cardiac ventricle phy­
siology (29). U ntil further studies are perform ed clinicians should be careful when using and 
interpreting these m easurem ents in children at the pediatric intensive care unit. In  any case, 
the norm al values provided by the m anufacturer m ust be used with great care and should 
probably be adapted for this population.
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C o n clu sio n
EVLW  m easurem ent in  young children can be perform ed using the TPTD . T he results are 
com parable with m easurem ents using the double indicator technique. Also indicator injec­
tions in a central venous catheter inserted in  the fem oral vein are feasible. It is suggested 
that young children have higher values of EVLW  com pared with older children or adults. 
Further studies are needed to clarify the clinical value of these m easurem ents.
A ck n o w led gm en ts
We thank  our colleges of the anesthesiology and pediatric cardiology departm ent and the 
personnel o f the cardiac catheterization laboratory for their cooperation in conducting this 
study.
67
CHAPTER IV
R eferen ces
1. H azelzet JA , de G root R , v an  M ierlo G, Joosten  KF, v an  der V oort E, E erenberg  A , et al. C om plem ent 
activation in relation to capillary leakage in children w ith septic shock and p u rp u ra . Infect Im m un  1998;
66: 5350-5356.
2. N eu h o f C, W alter O , D ap p e r F, B auer J , Z ickm ann B, F ink E, T illm anns H , N eu h o f H . B radykinin and 
histam ine generation  with generalized enhancem en t o f m icrovascular perm eability  in neonates, infants, 
and children undergoing card iopu lm onary  bypass surgery. Pediatr C rit C are  M ed 2003; 4: 299-304.
3. G oldstein SL, Som ers MJ, B aum  M A, Sym ons J M , B rophy PD, Blowey D, et al. Pediatric patien ts w ith 
m ulti-organ dysfunction syndrom e receiving continuous renal rep lacem ent therapy. K idney In t 2005; 
67: 653-658.
4. Schiffm ann H , E rd lenbruch  B, S inger D, S inger S, H ertin g  E, H oeft A, B uhre W. Assessm ent o f cardiac 
output, in travascular volum e status, and  extravascular lung w ater by transpu lm onary  ind icato r dilution 
in critically ill neonates and  infants. J  C ard io tho rac  Vasc A nesth  2002; 16: 592-597.
5. T ibby  SM , H atherill M , M arsh  MJ, M orrison  G, A nderson  D, M urdoch  IA. C linical va lidation  of 
cardiac ou tpu t m easurem ents using fem oral artery  therm odilu tion  w ith direct fick in ventilated  children 
and infants. Intensive C are M ed 1997; 23: 987-991.
6. Lem son J ,  de Boode WP, H o p m an  JC W , Singh SK , van  der H oeven JG . V alidation o f transpu lm onary  
therm odilu tion  cardiac ou tpu t m easurem ent in a  pediatric anim al m odel. Ped iatr C rit C are  M ed 2008; 
9: 313-319.
7. M ichard  F, S chachtrupp A , Toens C. Factors influencing the  estim ation o f extravascular lung w ater by 
transpu lm onary  therm od ilu tion  in critically ill patients. C rit C are  M ed 2005; 33: 1243-1247.
8. M onnet X , A nguel N, O sm an  D, H am zaou i O, R ichard  C , Teboul JL . Assessing pu lm onary  p erm ea­
bility by transpu lm onary  therm od ilu tion  allows differentiation o f hydrostatic pu lm onary  edem a from  
A L I/A R D S . Intensive C are  M ed  2007; 33: 448-453.
9. M ichard  F, A laya S, Z arka  V  B ahloul M , R ichard  C, Teboul JL . G lobal end-diastolic volum e as an 
ind icato r o f cardiac preload  in patients w ith septic shock. C hest 2003; 124: 1900-1908.
10. K irov MY, K uzkov V V  K uklin V N, W aerhaug  K , B jertnaes LJ. Extravascular lung w ater assessed by 
transpu lm onary  single therm odilu tion  and postm ortem  gravim etry in sheep. C rit C are  2004; 8: R 451- 
R 458.
11. F ernandez-M ondejar E, G uerrero-Lopez F, C olm enero  M . H ow  im p o rtan t is the m easu rem en t o f ex­
travascular lung w ater? C u rr.O p in .C rit C are  2007; 13: 79-83.
12. C id JL , R uperez M , Sanchez C , C arrillo  A. L im itations o f extravascular lung w ater assessm ent by dilu­
tion  m ethods in children. C rit C are  M ed 2007; 35: 2001-2002.
13. Lewis FR , Elings VB, S tu rm  JA . Bedside m easu rem en t o f lung water. J  Surg Res 1979; 27: 250-261.
14. S tu rm  JA . In: D evelopm ent and significance o f lungw ater m easurem ent in clinical and  experim ental 
practice. Berlin: Springer-Verlag; 1990.
15. Lem son J , Eijk R JR , v an  der H oeven JG . T h e  “cross-talk phen o m en o n ” in transpu lm onary  therm o d i­
lution is flow dependent. Intensive C are  M ed 2006; 32: 1092.
16. Bland JM , A ltm an  D G . A pplying the right statistics: Analyses o f m easu rem en t studies. U ltrasound 
O bste t G ynecol 2003; 22: 85-93.
17. K atzenelson R , Perel A , B erkenstadt H , P re ism an S, K ogan  S, S tern ik  L, Segal E. A ccuracy of trans­
pu lm onary  therm odilu tion  versus gravim etric m easurem ent o f extravascular lung water. C rit C are  M ed 
2004; 32: 1550-1554.
18. R eu te r DA, Felbinger TW , M oersted t K , Weis F, Schm idt C , K ilger E, G oetz A E. In tra tho racic  blood 
volum e index m easured  by therm od ilu tion  for preload  m onito ring  after cardiac surgery. J  C ard io thorac  
Vasc A nesth  2002; 16: 191-195.
19. Sakka SG, R uhl C C , Pfeiffer UJ, Beale R , M cLuckie A, R e in h a rt K , M eier-H ellm ann  A. Assessm ent of 
cardiac preload  and extravascular lung w ater by single transpu lm onary  therm odilu tion . Intensive C are 
M ed 2000; 26: 180-187.
20. M ichard  F. Bedside assessm ent of extravascular lung w ater by dilution m ethods: T em ptations and pit­
falls. C rit C are  M ed  2007; 35: 1186-1192.
68
CHAPTER IV
21. K h a n  S, T ro f RJ, G roeneveld AB. T ranspu lm onary  dilution-derived extravascular lung w ater as a  m ea­
sure o f lung edem a. C u rr  O p in  C rit C are  2007; 13: 303-307.
22. Phillips C R , C hesnutt M S, Sm ith SM . Extravascular lung w ater in sepsis-associated acute respiratory 
distress syndrom e: Index ing  w ith p redicted  body weight im proves correlation  w ith severity of illness and 
survival. C rit C are  M ed 2008; 36: 69-73.
23. Schm idt S, W esthoff T H , H ofm ann  C , Schaefer J H , Z idek W, C om pton  F, van  der G iet M . Effect o f the 
venous ca theter site on transpu lm onary  therm odilu tion  m easurem ent variables. C rit C are M ed 2007; 
35: 783-786.
24. Wessel H U, Paul M H , Ja m es GW, G rah n  A R . L im itations of th erm al dilution curves for cardiac output 
determ inations. J A pp l Physiol 1971; 30: 643-652.
25. Sanjeev S, K arpaw ich  PP. Superio r ven a  cava and innom inate  vein dim ensions in grow ing children: A n 
aid fo r in terventional devices and  transvenous leads. Ped iatr C ard io l 2006; 27: 414-419.
26. M itchell JP, Schuller D, C a landrino  FS, Schuster DP. Im proved outcom e based on fluid m anagem ent 
in critically ill patients requ iring  pu lm onary  artery  catheterization . A m  Rev R espir Dis 1992; 145: 990­
998.
27. E isenberg P R , H ansb rough  J R , A nderson  D, Schuster DP. A  prospective study of lung w ater m easure­
m ents during  patien t m anagem en t in an intensive care unit. A m  Rev R espir D is 1987; 136: 662-668.
28. N ational H eart, Lung, and  Blood Institu te A cute R espiratory  Distress Syndrom e (ARDS) C linical Trials 
Netw ork, W iedem ann  HP, W heeler AP, B ernard  G R , T hom p so n  BT, H ayden  D, et al. C om parison  of 
two flu id -m anagem ent strategies in acute lung injury. N  Engl J  M ed 2006; 354: 2564-2575.
29. C herqaoui I, R a u x  O, D eh o u r L, R ochette A , D adure  C, C apdevila  X . T ranspu lm onary  th erm od ilu ­
tion  hem odynam ic m onito ring  for pheochrom ocytom a surgery in a child w ith com plex congenital heart 
disease. P aed ia tr A naesth  2006; 16: 1277-1280.
69
CHAPTER IV
A p p en d ix  1
Volumetric measurements using the transpulmonary double and single indicator dilution technique 
This technique is based upon the analysis o f a dilution curve detected by a special arterial 
catheter positioned in the distal aorta or iliac artery. T he dilution curve is the result o f an 
injection of an ice-cold solution (with or w ithout dye) with a known quantity and tem pera­
ture into a central vein.
Measurement o f  transpulmonary thermodilution cardiac output
By detecting a change in blood tem perature using a therm istor tipped arterial catheter the 
cardiac output (CO) is calculated using the Stewart H am ilton equation:
C O  = ((Tb - T ) x V  x K) /  (1 A T b . dt) (l/mm ) [1]
where T t = blood tem perature; T  = injectate tem perature; V. = injectate volume; J A T t . dt = 
area u nder the therm o dilution curve; K  = correction constant (specific weight and specific 
heat o f blood and injectate).
Volumetric measurements using the transpulmonary double indicator dilution technique.
The volumetric calculations are a reflection of the physical properties o f indocyanine green 
(ICG) and tem perature. Tem perature diffuses from  the intravascular volume to the extra 
vascular space. Because IC G  binds to album in it stays within the vascular volume, the ex- 
travascular lungwater is therefore reflected by the difference between the dilution of tem ­
perature and dye.
The tim e span between injection of the indicator and the tim e point where half o f the indi­
cator has passed the detection point is known as the m ean transit tim e (MTt). T he product 
o f M T t and C O  reflects the volume between the injection and detection point.
By multiplying the M T t of tem perature (M M ttemp) with the cardiac output (using form ula 
[1]) the In tra  Thoracic T herm al Volume is calculated (ITTV):
IT T V -—,-, = C O  x M M t x 1000 /  60 (ml) [2]1F1D temp v 1 L -1
This volume comprises of the intravascular space plus the extra vascular lung water. H ow ­
ever, by m ultiplying the M T t of dye (M M tdye) with the cardiac output the ITB V  as follows:
ITBV™__ = C O  x M M t x 1000 /  60 (ml) [3]1FDD dye v 1 L -1
Because IC G  stays within the vascular space this volume comprises only of the intravascular 
volume in the thoracic cavity and can therefore be considered to reflect cardiac preload. 
Subsequently by subtracting the ITB V  from  the IT T V  the EVLW  is calculated:
EVLW tpDD = IT T V  -  ITB V  (ml) [4]
By dividing EVLW  by body weight the EVLW I is calculated:
EVLW Itpdd = EVLW tpdd /  Weight (ml/kg) [5]
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By dividing ITB V  by body surface area (BSA) the In tra  Thoracic Blood Volume Index 
(ITBVI) is calculated:
ITB V ITPdd = ITB V TPdd /  BSA (m l/m 2) [6]
Volumetric blood measurements using the transpulmonary thermo dilution technique
This technique is solely based upon  the shape of the therm o dilution curve. Because a 
therm al indicator does not stay within the intravascular space but diffuses in intravascular 
and extra vascular space this technique uses a different way of calculating extra vascular 
lung water. T he pulm onary blood and ex tra vascular lung volume comprises the largest 
part o f the in trathoracic therm al volume. Therefore it can be considered to be the mixing 
cham ber of this volume and it m ainly influences the rate of decline in the dilution curve. 
The exponential down slope tim e (DSt) o f the therm odilution curve represents the largest 
mixing chamber.
By multiplying the down slope tim e of tem perature (DSttemp) with cardiac output (measured 
using form ula [1]) the Pulm onary T herm al Volume (PTV) is calculated as follows:
P T V -—,-, = C O  x D St x 1000 /  60 (ml) [7]1P1D temp v 1 L -1
By subtracting the P T V  from the IT T V  (using form ula [2]) it is possible to calculate GEDV:
GEDV tptd = IT T V tptd -  P T V tptd (ml) [8]
GEDV represents the blood volume of the heart and great vessels w ithin the thoracic space. 
By dividing GEDV by B sA  the GEDVI is calculated by:
GEDVITPTd = GEDVTPTd /  BSA (m l/m 2) [9]
The GEDV reflects, like the ITBV, cardiac preload. T he difference between ITB V  and 
GEDV being the lung blood volume. The relationship between ITB V  and GEVD  has been 
studied in adult patients and appears to be linear (20). Based upon this hypothesis ITB V  is 
by default calculated by the C O L D  com puter (and by the P iC C O  system) with:
ITB V tptd = GEDV tptd x  1,25 (ml) [10]
Subsequently ITB V I, EVLW  and EVLW I are calculated in  the same m anner as in the dou­
ble indicator technique using form ula’s [6], [4] and [5].
It is o f im portance to  recognize that ITB V  and G EDV  appear to have a fixed relation and 
are therefore interchangeable as a reflection of cardiac preload. ITB V  is directly m easured 
by the double indicator technique. GEDV is directly m easured by the therm odilution tech­
nique. T he therm odilution technique subsequently calculates ITB V  by m ultiplying GEDV 
with 1.25. The last calculation is necessary in  the process of calculating EVLW
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CHAPTER V
A b stra c t
Introduction
Extravascular lung w ater index (EVLWI) can be m easured at the bedside using the trans- 
pulm onary  therm odilu tion  technique (TPTD). T he goal o f this study was to com pare 
EVLW I values w ith a chest x-ray score of pulm onary  edem a and  m arkers of oxygenation 
in  critically ill children.
Methods
This was a prospective observational study in  a pediatric intensive care un it o f a university 
hospital. We included 27 critically ill children w ith an indication for advanced invasive 
hem odynam ic m onitoring. No specific interventions for the purpose of the study were 
carried  out. M easurem ents included EVLW I and other relevant hem odynam ic variables. 
Blood gas analysis, ventilator param eters, chest x-ray and  T P T D  m easurem ents were 
ob ta ined  w ithin a th ree-hour tim e fram e. Two radiologists assessed the chest x-ray and 
determ ined  a score for pulm onary  edem a.
Results
A to tal o f 103 m easurem ents from  24 patients were eligible for final analysis. M ean age 
was two years (range: two m onths to eight years). M edian cardiac index was 4.00 (range:
1.65 to  10.85) l /m in /m 2. M edian EVLW I was 16 (range: 6 to 31) m l/kg. T he w eighted 
kappa betw een the chest x-ray scores o f the two radiologists was 0.53. T here  was no signi­
ficant correlation  betw een EVLW I or chest x-ray score and the num ber of ventilator days, 
severity o f illness or m arkers o f oxygenation. T here was no  correlation  betw een EVLW I 
and the chest x-ray score. EVLW I was significantly correlated  w ith age and  length (r2 of
0.47 and  0.67 respectively).
Conclusions
T he extravascular lung w ater index in  critically ill children does not correlate w ith a chest 
x-ray score of pu lm onary edem a, no r w ith m arkers o f oxygenation.
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In tro d u ctio n
Extravascular lung w ater index (EVLWI) can be m easured at the bedside using the trans- 
pulm onary therm odilution technique (TPTD) incorporated  in the P iC C O  device (Pulsion, 
M unich, Germany). Besides EVLW I, the T P T D  technique also m easures cardiac output 
(CO) and global end diastolic volume index (GEDVI). EVLW I reflects the am ount o f fluid 
present in  the pulm onary interstitium  and probably also in the alveolar space while GEDVI 
is a reflection of the blood volume of the heart and in trathoracic great vessels. Consequent­
ly, GEDVI is used as an index for cardiac preload (1, 2).
In adults, EVLW I m easurem ent using the T P T D  technology reflects pulm onary edem a and 
correlates with severity o f illness or outcom e (3-10). A n EVLW I between 3 and 7 m l/k g  is 
considered norm al in  adults. Levels above 10 m l/k g  are associated with clinical pulm onary 
edem a (7). EVLW I divided by GEDVI m ay distinguish between pulm onary edem a due to 
increased capillary perm eability or increased hydrostatic pressure (11, 12). Furtherm ore 
therapy driven by EVLW I m easurem ents m ay improve outcom e (13-15).
We previously showed that the T P T D  technique is reliable in  children when com pared to 
the clinical gold standard, the double indicator dilution technique using injections of ice- 
cold indocyanine green (16). However, m easured EVLW I values are higher com pared to 
adults, especially in  younger children (16-18). Since fluid overload is also related to poor 
outcom e in children it could be advantageous to use the EVLW I m easurem ent for quantifi­
cation of (pulmonary) edem a (19, 20) and as a guide for directing therapy (13-15).
The presence and quantity o f pulm onary edem a in children are usually determ ined with 
the bedside chest x-ray. Also, oxygenation param eters like P aO 2/ F i o 2 (P /F  ratio) and A-a 
gradient reflect the severity o f pulm onary edem a and thus EVLW I. U p to date EVLW I 
m easurem ents in critically ill children in relation to  param eters of oxygenation have not 
been studied.
The goal o f this study was to com pare the EVLW I with a chest x-ray score of pulm onary 
edem a in a general critically ill pediatric population. Furtherm ore, we com pared both  the 
EVLW I and the chest x-ray score with collected m arkers of oxygenation and severity of 
illness scores.
M a te r ia ls  a n d  m e th o d s  
Patients
We included 27 m echanically ventilated critically children <10 years adm itted  to  our 
pediatric intensive care unit w ith an indication  for advanced hem odynam ic m onitoring. 
Fluid loading or vasoactive support was used according to  the ju d g m en t of the treating 
physician. M echanical ventilation was perform ed using an oral or nasal, cuffed or 
uncuffed endotracheal tube w ith a Servo 300 ventilator (M aquet, Sweden). Patients were 
m onitored  w ith a 3 French 7 cm  arterial Pulsiocath (Pulsion, M unich, G erm ay) catheter 
in  the fem oral position. C en tral venous access was accom plished using standard  venous 
catheters in  fem oral, subclavian or ju g u la r position w ithout echo guidance. N o extra 
catheters were inserted for study purposes only. P IC U  trea tm en t was no t influenced by 
the d a ta  ob ta ined  from  this study. Because of the observational natu re  the local ethics
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com m ittee responsible for m edical research in  hum ans approved the study and  waived 
the need  for in form ed consent.
Data collection
We collected patien t dem ographics, adm ission diagnosis, length o f P IC U  stay, num ber of 
ventilation days and  severity of illness scores (PIM and P R ISM  II). W hen a chest x-ray 
was ordered  we m easured EVLW I and  other hem odynam ic param eters using the T P T D  
technique. A rterial b lood gas analysis was perform ed and ventilation param eters were 
collected all w ithin a th ree-hour tim e fram e. M easurem ents were no t perform ed if a  rap id  
change in  b lood pressure, cardiac ou tpu t or h eart rate occurred. V entilator settings and 
the dose o f vasoactive drugs were no t changed during this period.
T P T D  m easurem ents were perform ed using the P iC C O plus or P iC C O 2 device and in ­
cluded CO , EV LW I, G ED V I and the ratio  of EVLW I to GEDV  O th er recorded  hem o­
dynam ic param eters were h ea rt rate  (HR), systolic, diastolic, m ean  invasive blood pres­
sure (SAP, DAP and MAP) and  central venous pressure (CVP). Ventilator d a ta  included 
the type of ventilation, inspiratory oxygen fraction (FiO 2), positive end expiratory p res­
sure (PEEP). level and peak pressure. A rterial b lood gases were draw n in a standard  way 
and sent to the laboratory  for routine evaluation. We calculated the P /F  ratio  and  the 
alveolar arterial oxygen gradient (A-a gradient) using standard  form ula and a respiratory 
quotient (RQ) of 0.8.
TPTD m easurem ents
T he T P T D  technology has been described in  detail elsewhere (7, 16, 21, 22). T he m easure­
m en t o f CO , EVLW I and  G ED V I is based upon  the properties of the transpulm onary  
therm odilu tion  curve. T he area  under the dilution curve represents CO. T he tim e in te r­
val betw een injection and  passage of the indicator (M ean T ransit time) represents intra- 
thoracic b lood volume and  the rate  o f decline of the dilution curve (Down Slope time) the 
am ount o f extravascular lung water. T he calculation of EVLW I is shown in A ppendix  1. 
T he cu rren t algorithm  calculates in tra thoracic blood volume (ITBV) from  G EDV  x 1.25. 
This assum ption however, is debatable in  bo th  children and adults (16, 23).
P iC C O  m easurem ents were perform ed by the attending critical care physician or experi­
enced P IC U  nurses. A m easurem ent was done by the subsequent injection of four boluses 
of ice-cold saline (3 to  5 m l, dependen t on patient weight) th rough  the central venous 
catheter. T he P iC C O  device was connected  to a  lap top  PC for storage of d a ta  using the 
special P iC C O w in  software (Pulsion, M unich, G erm any). In  this way all therm odilu tion  
curves and  hem odynam ic data  were stored autom atically for analysis afterwards. The 
software also stores the basic m easurem ents tha t are needed  for calculating EV LW I and 
GEDV I (mean transit tim e and  down slope time) (Appendix 1).
E rroneous m easurem ents detected by clearly abnorm al therm odilu tion  curves including 
the cross-talk phenom enon  were deleted afterw ards (24). A m easurem ent was only ac­
cepted w ith a m inim um  of th ree reliable injections. EVLW I was calculated afterwards 
according to the calculations shown in A ppendix  1 and  indexed to actual body weight. 
C ard iac ou tpu t is expressed in  liters per m inute and  indexed to  body surface area  ( l/m in /m 2). 
G lobal end diastolic volum e is expressed in  milliliters and  indexed to  body surface area 
(m l/m 2). Extravascular lung w ater is also expressed in  m illiliters and  indexed to body 
weight (ml/kg).
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Chest x-ray
T he chest x-rays were ob ta ined  in  anteroposterior d irection w ith the patien t in  supine 
position using a digital im aging system. T he requ ired  energy (kV) was dependent on body 
weight and age and  the actual x-ray was taken during  m axim al inspiration. T he chest 
x-rays were analyzed on a dedicated  digital radiology w orkstation w ith which, am ong 
others, brightness and contrast can be modified. Two radiologists w ith special pediatric 
expertise used the scoring system designed by H alperin  et al (Table 1) (25). This scoring 
technique divides the lungs into six regions. R ight upper lobar, right perihilar, right lower,
Table 1
Chest x-ray scoring system fo r  quantification o f  pulmonary edema
S co re  (po in ts) E d e m a  se v e rity  sc o r in g
0 norm al
10 mild pulmonary vascular congestion
20 m oderate pulm onary vascular congestion
30 severe pulm onary vascular congestion
40 interstitial edem a without septal lines
45 interstitial edem a with septal lines
50 mixed interstitial and alveolar edem a with some sparing of pulm onary region
55 mixed interstitial and alveolar edem a involving entire region
60 alveolar edem a with sparing of pulm onary region
65 alveolar edem a involving entire pulmonary region
Based upon Halperin et al (25).
left upper, left perih ilar and  left lower lobar. T he pulm onary  regions are each scored using 
a sem i-continuous scoring system consisting o f 0 to  65 points. A score of 0 points indicates 
no signs of edem a w hereas a value of 65 represents severe edem a. T he points for the six 
regions are sum m ed to construct the to tal score. In  this way the to tal score ranges between 
0 and  390 points. W hen a lung region could no t be assessed because of atelectasis it was 
ra ted  the m ean  value o f the o ther two regions on the same side.
T he radiologists were unaw are of o ther patien t characteristics but also unaw are of the 
score of the o ther radiologist. A fterwards the inter-observer variability was calculated 
using concordance correlation  and  w eighted kappa. T he m ean  to tal scoring of the two 
radiologists was used to com pare the chest x-ray score w ith the o ther recorded  variables.
Statistics
T he correlation  betw een EV LW I, chest x-ray score and surrogate m arkers o f lung edem a 
is unknow n in children. We considered a correlation  coefficient >0.6  as clinically relevant. 
W ith an a lpha erro r o f 0.05 and  a pow er of 80% , a sample size o f 19 would be necessary 
This would require m easurem ents from  at least 19 individual patients. Because the corre­
lation coefficient was essentially unknow n we aim ed for m ore th an  20 children, including 
m ultiple m easurem ents per patient.
78
CHAPTER V
Table 2
Patient characteristics per patient
Patient
(number)
G ender
(male/
female)
Age
(months)
W eight
fe)
D iagnosis Length
of
PICU
stay
(days)
Ven­
ti­
la to r
days
(days)
P roba­
bility of 
death  
PRISM  II
(%)
Proba­
bility  o f 
death  
PIM
(%)
O ut­
com e
1 F 24 14 Near Drowning 19 17 85 60 survived
2 F 83 18 Reconstruction of 
pulmonary artery
18 16 7 6 survived
3 F 23 14 Abdominal surgery 5 3 78 17 survived
4 F 9 8.5 RSV 16 15 4 11 survived
5 F 31 16 Meningococcal
disease
6 5 22 19 survived
6 F 2 4.8 Arterial switch 
operation
13 10 39 3 survived
7 F 5 7.1 Tetrology of Fallot 
repair
16 14 18 3 survived
8 F 8 6.5 Reconstruction of 
pulmonary artery
2 1 2 1 survived
9 M 4 4.4 VSD repair 13 5 26 1 survived
10 M 36 15 Meningococcal
disease
5 4 8 7 survived
11 M 6 9 Meningococcal
disease
5 4 9 8 survived
12 F 14 10 Meningococcal
disease
4 3 28 9
13 M 7 9 Inborn error of 
metabolism
12 5 88 3 survived
14 F 4 5.4 Post cardiac 
surgery
3 20 29 5 survived
15 M 17 12 Meningococcal
disease
13 9 37 53 survived
16 M 24 13 Cardiac shock 20 9 31 28 survived
17 M 8 9 Pneumonia 20 15 5 4 survived
18 F 8 8.4 Status epilepticus 8 4 2 7 survived
19 F 28 10 Post CPR 4 3 70 46 survived
20 M 27 16 Meningococcal
disease
6 5 61 63 survived
21 F 7 8 Shock/coma 12 7 54 24 survived
22 M 43 16 Septic shock 4 4 86 63 died
23 F 33 12 Septic shock 5 3 3 23 survived
24 M 32 15.2 Post CPR 18 16 40 2 died
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All d a ta  were tested for norm ality  using the d ’Agostino Pearson test. T he Pearson correla­
tion coefficient was used for d a ta  w ith norm al d istribution and  the S pearm an correlation 
coefficient for d a ta  w here norm ality  was rejected. Variables are presented  w ith m edian 
(interquartile range) except w hen specifically m entioned  otherwise. C orrelation  and scat­
terplots were calculated and constructed  using all separate m easurem ents. For com pari­
son of EVLW I and  chest x-ray scores w ith patien t characteristics, the m ean  values per 
patien t were taken unless m entioned  otherwise.
D ata  were stored in  Excel software (Microsoft, R edm ond WA, USA). Statistical calcula­
tions were perform ed using M edC alc 10 (M edC alc Software, M ariakerke, Belgium).
Table 3
Values o f  several measurements
V a ria b le V alue
MAP (mmHg) 65 (57 - 76)
H eart rate (bpm) 139 (118 - 153)
Cardiac index (l/m in /m 2) 4.00 (3.17 - 5.19)
GEDVI (m l/m 2) 432 (369 - 528)
EVLWI (ml/kg) 16 (13 - 21)
Chest x-ray score 133 (90 - 204)
A-a gradient (mmHg) 119 (74 - 168)
Pa02 /  Fi02 (mmHg) 283 (226 - 374)
PEEP (cmH2O) 6 (5 - 8)
median (interquartile range)
R e su lts
A total of 124 com bined m easurem ents from  27 patients were collected. After prim ary ana­
lysis four m easurem ents were rejected because data  were missing due to a  storage failure, 
five m easurem ents were excluded because the tim e interval between various param eters 
was m ore than  three hours, twelve m easurem ents were excluded because of an abnorm al 
therm odilution curve. Consequently 103 m easurem ents from  24 patients were eligible for 
final analysis o f which 22 patients h ad  serial m easurem ents. Two patients died (8%). Twelve 
registrations started on Day 0, four on Day 1, five on Day 2 and three after Day 2.
The num ber of m easurem ents per patient was 1 to 14 with a m ean of 4.3 m easurem ents 
per patient. O nly five patients did not receive vasoactive support (24 measurements). All 
other patients were treated  with dobutam ine, m ilrinone or nor-epinephrine.
Individual patient characteristics are shown in Table 2. All children had  norm al body pro­
portions. Table 3 shows the m edian values per variable. O f a  total of 618 pulm onary re ­
gions (three per side in  103 patients) for the chest x-ray scoring m ethod, the first radiologist 
could not score 20 regions (3.2%) and the second 17 regions (2.8%) because of atelectasis. 
The chest x-ray score ranged from  30 to 360 points with a m edian value of 133. T he m ean 
difference between left and right lung scoring was 1.7 (SD 4.8) for radiologist 1 and 6 (SD
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9.5) for radiologist 2. T he m ean  difference between the scoring of the two radiologists was
11.2 points with a range of -180 to +240 and an SD of 63.4. T he concordance correlation 
between the two radiologists showed an r  o f 0.73 with 95%  confidence interval o f 0.63 to
0.81. The weighted kappa was 0.53 with standard error o f 0.05.
Figure 1
Exam ple o f  chest x-rays and related variables in fo u r children with the lowest and highest chest x-ray score
P a tie n t A B C D
M ean chest x-ray 
score (points)
360 45 350 30
Weight (kg) 9 10 16 7.1
Diagnosis Meningococcal Post Meningococcal Post Fallot
disease resuscitation disease correction
FiO 2 0.4 0.35 0.6 0.35
PEEP (cmH2O) 6 5 5 5
PaO , (mmHg) 72.9 105 76.5 89.3
PaO 2/F iO 2 (mmHg) 182.3 300 127.5 255
A-a gradient (mmHg) 171.8 85.5 309 111.8
CI (l/m in /m 2) 5.3 3.9 4.8 3
GEDVI (m l/m 2) 435 618 566 404
EVLWI (ml/kg) 13 18 12 19.5
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Figure 2
Correlation between E V L W I  and chest x-ray score
Table 4
Correlation between E V L W I, chest x-ray score and several relevant parameters
EV LW I C h e s t x -ra y  sc o re
Age -0.67 (<0.001) -0.04 (0.724)
Body height -0.80 (< 0.001) 0.02 (0.4)
Ventilator days -0.009 (0.965) -0.038 (0.86)
PIM  score -0.384 (0.064) 0.056 (0.795)
PRISM  II score -0.169 (0.429) 0.262 (0.216)
GEDVI 0.015 (0.946) 0.299 (0.156)
A-a gradient -0.035 (0.866) 0.053 (0.799)
P a 0 2/ F i 0 2 0.194 (0.364) -0.087 (0.685)
EVLWI -0.222 (0.296)
correlation coefficient with p  value
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Figure 1 shows four examples of the two lowest and the two highest chest x-ray scores and 
concom itant collected variables. Figure 2 shows the scatterplot of the chest x-ray score and 
EVLW I. There was no significant correlation between chest x-ray score and EVLW I. Also 
there was no significant correlation between EVLW I and the individual chest x-ray score 
by the radiologists.
M edian PEEP level was 6 cm H ?O (range 3 to 15). T he PEEP level did not correlate with 
EVLW I, chest x-ray score, P a 0 2/ F i 0 2 ratio or the A-a gradient.
There was no correlation between the m ean  chest x-ray score or EVLW I and severity of 
illness, length of stay, ventilator days, use of vasoactive m edication, P /F  ratio and A-a gra­
dient (Table 4). Subsequently we determ ined these param eters per admission day. For the
Figure 3
Correlation between age and body height and E V L W I
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day of admission, the day of admission and the first day com bined or the first three days, 
this did not change the results.
We also analyzed serial m easurem ents per patient and found no correlation between changes 
in EVLW I on the one hand  and changes in  chest x-ray score, P /F  ratio or A-a gradient on 
the other.
The correlation between EVLW I and age or height is shown in Figure 3. T he correlation 
coefficient between age and EVLW I was -0.67 (95% CI -0.85 to -0.36; P <0.001) and 
between EVLW I and height -0.80 (95% CI -0.91 to -0.59; P <0.0001). T he chest x-ray 
score was no t correlated with age or height.
D isc u ss io n
This study shows tha t the m easurem ent o f extravascular lung  w ater index does no t cor­
relate w ith a  chest x-ray scoring system for quantification of pulm onary  edem a in criti­
cally ill children. N either EV LW I no r the chest x-ray score correlated  w ith m arkers of 
oxygenation.
The laboratory gold standard for the m easurem ent o f lung water is the postm ortem  gravi­
metric technique (26, 27). The clinical gold standard is the transpulm onary double indicator 
technique (TPDD) using injections of ice-cold indocyanine green (ICG) through a central 
venous catheter and an arterial catheter capable of detecting tem perature and IC G  concen­
tration. Its accuracy has been dem onstrated in animal studies (23, 28). However since the 
TPD D  technology requires a rather large introducer sheath and several injections of IC G  it 
has been replaced by the easier to apply T PT D  technique. Validation of the T PT D  techni­
que has been perform ed in various animal experiments against the gravimetric technique. In 
general an acceptable accuracy was found although T PT D  overestimates true EVLW I and is 
less reliable com pared to TPD D  (23, 28-32). In a recent study in adults a very close relation 
between EVLW I m easured with T P T D  with postm ortem  lung-weight (r2 = 0.91) was dem on­
strated (33).
The calculation of EVLW I requires two variables: intrathoracic therm al volume (ITTV) and 
intrathoracic blood volume (ITBV) (Appendix 1). IT T V  is directly m easured using the T PT D  
technique and is not considered to be a factor for erroneous measurements. ITBV is directly 
m easured using the TPD D  technology but cannot be m easured using the T PT D  technique. 
Instead, GEDV is measured. Based upon a study by Sakka et al the relation between ITBV 
and GEDV in adults is reflected by the factor 1.25 (34). The constant relationship between 
the two suggests that blood volume of the lung is linearly related to blood volume in the heart 
and great vessels. However it has been shown in adult patients that the relation between the 
two can vary (23).
Validation of EVLW I in children is m ore complicated. Clinically, the T P T D  technique can 
only be com pared to TPDD. We have previously shown in a small subset o f patients that 
T P T D  is generally reliable in children (16). However, our study also showed that, like in 
adults, the relation between GEDV  and ITB V  is not always reflected by the factor o f 1.25.
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We have shown that this factor is negatively correlated to body weight (r2 = 0.52). Therefore 
it is possible tha t in children of different ages a different factor for the relation between 
ITB V  and GEDV should be used. From a physiological viewpoint this looks attractive since, 
similar to the developm ent of the lung, the relative blood volumes in  the lung, heart and 
great vessels m ay change during growth. Also in  this small group of relatively healthy p a ­
tients the values of EVLW I were m uch higher than  general adult values. O ther studies have 
confirm ed the higher values of EVLW I in younger children (17, 18). T he present study 
shows that EVLW I values were m uch higher com pared to adult values. Again we found 
a significant correlation between age (or height) and EVLW I. This shows tha t lung water 
index is an age dependent variable and that current adult norm al values are not applicable 
to children. As only EVLW I was related to age this could explain the lack of correlation 
between EVLW I and the other variables.
The reason for the apparent higher values of EVLW I in younger children is not clear. Several 
explanations should be mentioned. First, EVLW I values could be falsely high but this is un ­
likely regarding our previous study (16). Second, the total body water content is higher. Total 
body water decreases approximately by 15% during childhood (35). Third, younger children 
may require a  higher conversion factor when calculating ITBV from  GEDV. Fourth, the rela­
tion between lung tissue mass and lung air volume is different in younger children (more tissue 
mass com pared to air volume).
Contrary to the results in adults, there was no significant correlation between the P aO 2/ F i 0 2 
ratio or A-a gradient and EVLW I (4, 36). Remarkably there was also no correlation between 
the chest x-ray score and the P a 0 2/ F i 0 2 ratio or A-a gradient.
Several studies in adults also tried to correlate EVLW I, m easured with the TPD D  technique, 
with different types o f chest x-ray score. In critically ill adults the results showed an r2 between
0.2 and 0.7 or no correlation at all (13, 25, 37-39). We found only one study that com pared 
lung water in children with a chest x-ray score. In this small study using a different EVLW  
technique also no correlation between EVLW I and the chest x-ray was observed (40).
The radiographic determ ination of pulm onary edem a may have several advantages over 
the dilution technique. It may detect edem a in non-perfused regions while the dilution tech­
nique is dependent on an equal perfusion of all lung parts (41). It is questionable whether 
the radiographic images reflect the same fluid collections that are m easured with T PT D  or 
TPDD. O ne m ay also argue that the fluid visible on the chest x-ray m ay not be m easured with 
EVLW I because the indicator is unable to reach these collections (for example, alveolar or 
pleural fluids). No chest x-ray scoring system has been validated up till now. Finally, this study 
showed that even if chest x-rays are assessed by two experienced pediatric radiologists, the 
inter-observer agreement is still moderate. Finally it is also possible that changes in the chest 
x-ray appearance of pulm onary edem a develop slowly com pared to the EVLW I lung water 
m easurem ent. Thereby the two estimates are not always synchronized.
Based upon this study it is questionable if a routine chest x-ray in critically ill children is ju s­
tified to quantify the am ount of pulm onary edema. This is in accordance with other studies 
considering the clinical value of routine chest x-rays in adults and children (42-46). W ith re­
gard to EVLW I measurem ents we believe, at present, that EVLW I in children should be stu­
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died further before it can be coupled to clinical decisions. Possible studies include the collection 
of norm al values in relatively healthy children and pediatric animal studies validating EVLW I 
to gravimetry. The lack of age-related norm al values makes com paring subgroups with nor­
m al or increased EVLW I difficult. Therefore it seems attractive to study other m easurem ent 
m ethods for the determ ination of lung water. U ltrasound could be a reasonable alternative to 
chest x-ray for the determ ination of lung water although there are currently no available data 
in children (47-49).
Several limitations of our study should be noticed. We collected all relevant data within a 
relatively small time frame, but especially in small children, oxygenation m ay change rapidly. 
However, we assume that the EVLW I and the chest x-ray score do not vary significantly within 
a three-hour time frame since all data  were collected under stable conditions. The chest x-ray 
score was not specifically designed for children but there is no reason why this is essentially 
different between adults and children. Also, the inter-rater agreem ent between the two radio­
logists was only m oderate and individual scores were also not correlated with EVLW I. The 
reliability of EVLW I measurem ents decreases with pulm onary vascular obstruction including 
hypoxic pulm onary vasoconstriction and focal lung injury (41). Also, high PEEP levels may 
obstruct small pulm onary vessels (50), although in our study the m ean PEEP level was only 
6.7 (SD 2.8) cm H 2O. Pulm onary ventilation/perfusion mismatch m ay have been present in 
some children but there were no clinical signs of severe pulm onary perfusion abnormalities 
(like pulm onary emboli). The lack of correlation between EVLW I and chest x-ray score could 
also be explained by the diverse nature of the underlying pulm onary conditions. However, this 
study was deliberately perform ed in a general and mixed population of critically ill children to 
study the usefulness in every day practice. A m ore uniform  patient group could have changed 
the results although in individuals there was also no correlation between m easured variables 
over time. Not all measurem ents were started on the day of admission to the PICU. If  possible, 
future studies should include measurem ents relative to the development o f the disease. 
Another concern is the use of femoral venous catheters in some children. Because in these 
situations the route of the indicator is prolonged com pared to catheters inserted in the up ­
per body this may influence the m ean transit time and thereby the m easurem ent o f EVLWI. 
However, we have shown earlier that EVLW I m easurem ent was not different when com par­
ing injection of the indictor in the right atrium  com pared to the femoral vein (16).
The fact that EVLW I in children is higher com pared to adults and most importantly that this 
effect is age- or length-related makes this value difficult to interpret
C o n c lu sio n s
We conclude that extravascular lung w ater index m easurem ents in  a general population of 
critically ill children using the transpulm onary therm odilution technique do not correlate 
with a chest x-ray score of pulm onary edem a. N either lung water index nor the chest x-ray 
score of pulm onary edem a correlates with m arkers of oxygenation, severity o f illness or 
P IC U  length of stay
86
CHAPTER V
K ey  m e s s a g e s
• Extravascular lung w ater index m easured in critically ill children using the transpulm o- 
nary  therm odilution technique does not correlate with a  chest x-ray score of pulm onary 
edema.
• Extravascular lung water in  critically ill children does not correlate with param eters of 
oxygenation.
• A chest x-ray score of pulm onary edem a in critically ill children does not correlate with 
param eters of oxygenation.
• In  children extravascular lung w ater is inversely related to age (or body height).
• Further studies are needed before lung water can be used in pediatric clinical guidelines.
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A p p en d ix  1.
Calculation of lung w ater index
General
The required param eters for calculating lung water index are:
1. C ardiac output (CO) in  l/m in
2. M ean transit tim e (MTt) in sec
3. M ean downslope tim e (DSt) in sec
4. Body weight (kg)
Calculations
- Intrathoracic therm al volume (ITTV) = C O  x M T t x 1000/60
- Pulm onary therm al volume (PTV) = C O  x D St x 1000/60
- Global end diastolic volume (GEDV) = IT T V  - PTV
- Intrathoracic blood volume (ITBV) = GEDV x 1.25
- EVLW  = IT T V  - ITB V
- EVLW I = EVLW  /  body weight
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CHAPTER VI
A b stra c t
Objective
The aim  of the present study was to explain why extravascular lungwater index (EVLWI) 
is higher and global end diastolic blood volume index (GEDVI) is lower in young children 
when m easured with the P iC C O  system. We searched for a correction factor in  order to 
enable the use of norm al values also for critically ill young children.
Methods
We pooled available data  from  children concerning organ weight derived from  autopsy 
studies and C T  lung m easurem ents. These data  include age, height, body weight, body 
surface area, lung weight and heart weight. For standard ideal age dependent weight and 
height we used published data  from  the W H O . From  the available data  we calculated the 
lung weight to body weight ratio, the heart weight to body surface area ratio and the end 
diastolic volume to body surface area ratio. We com pared these ra tio ’s to  body growth and 
development.
Results
L ung weight develops m ore slowly and with less m agnitude than  body weight. Also the 
(relatively) greater lung weight in  younger children results in  a higher am ount o f pulm onary 
blood volume. This explains the higher EVLW I in young children. E nd diastolic blood 
volume and heart weight increase faster and m ore pronounced com pared to BSA. This 
explains the lower GEDVI in  young children. We propose correction factors for com paring 
EVLW I and GEDVI to adult reference values.
Conclusion
EVLW I is higher and GEDVI is lower in  young children due to changing organ to body 
weight relationships during growth.
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In tro d u ctio n
Extravascular lungwater (EVLW) is the am ount of fluid present in the extravascular lung 
space (1,2). EVLW  can be m easured at the bedside using the single indicator transpulm o­
nary  therm odilution (TPTD) technique and quantifies the am ount of pulm onary edem a 
(3-5). M easurem ent o f EVLW  requires a fem oral artery catheter equipped with a  therm is­
tor, the injection of ice-cold saline through a central venous catheter and a special m onito­
ring device (PiCCO, Pulsion, M unich, Germany). Besides EVLW, the T P T D  technique also 
m easures global end diastolic volume (GEDV) and cardiac ou tput (CO) (6-8). GEDV reflects 
cardiac preload in adults and children (6,9).
To com pare subjects o f different size, variables like lung w ater or cardiac output are indexed 
to body dimensions. This is based upon the assumption tha t the relation between the vari­
able and the body dim ension used for indexing is linear. Traditionally EVLW  is indexed to 
actual body weight (EVLWI). In  contrast to its predecessors the recently introduced P iC C O 2 
device uses predicted body weight (PBW) instead of actual body weight to index EVLW. 
The resultant value is called “corrected EV LW I” . T he m ain reason for this adjustm ent is 
the otherwise falsely low value of EVLW I in obese patients. T he use of corrected EVLW I 
improves the reliability o f outcom e prediction in adults with sepsis-associated acute respira­
tory distress syndrome (10-12). GEDV and C O  are indexed using body surface area (BSA), 
calculated from  body height and weight (GEDVI and CI respectively).
The P iC C 0 2 device m easures C O  reliably in  children (8,13,14). However EVLW I in young 
children seems to be m uch higher com pared to adult values (7,9,15-17). As the reasons for 
this discrepancy are unknown, its validity and use in children is questioned (17). In contrast 
to EVLW I, GEDVI is lower in  young children (7,9). U p to now no explanation for for these 
deviant values in young children has been given. As a result there are still no reference values 
available for infants and preschool children.
We studied existing data  available in  the literature concerning lung development, lung 
weight, lung growth and the dimensional developm ent o f heart and body in children and 
adults. By com bining these available data  we offer an explanation, based upon physiology, 
why young children have a higher extravascular lung w ater index and a lower global end di­
astolic volume index. Subsequently we propose age-dependent pediatric correction factors 
for use in  children.
M eth o d s
Basic age-weight and age-height relations were collected from  a dataset provided by the 
W H O  (18,19). These data  were derived from  children raised in  different continents in  an 
environm ent that m inim ized constraints to growth such as a  poor diet, passive smoking 
and repeated  infections. Therefore these standards may depict the global average norm al 
hum an growth and reflect average ideal pediatric body proportions. We averaged the W H O  
data  for boys and girls and considered weight for age provided by the W H O  as ideal and
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equal to  predicted body weight (PBW). We calculated body surface area (BSA) from  weight 
and height using the algorithm  described by Haycock (20).
Next, we pooled available data  concerning lung weight in  relation to age derived from  auto­
psy studies and C T  lung m easurem ents in  children (21-24). Lung w ater m easurem ent using 
the P iC C O  system requires the use of a 3 French arterial fem oral catheter. Since this is only 
used in children above 3.5 kg we excluded data  from  smaller or p re te rm  children. We divid­
ed lung weight by body weight to calculate the lung weight to body weight ratio using the 
body weight presented in the available data. In  two studies body weight was not provided. 
In  these cases we used the W H O  data  to determ ine body weight from  age. Subsequently we 
pooled data  from  several adult autopsy studies to  gain insight into the relation between lung 
weight and body weight in  adults (25-31).
We also pooled available data  concerning h eart weight in relation to age derived from  au­
topsy studies in children (21,22,24,32). For calculating the heart weight to BSA ratio we 
determ ined BSA using weight and height provided by the W H O  data  set for the given age. 
Finally, correction factors were designed as follows: for correcting the factor relating GEDV 
and ITB V  (appendix 1) we based the algorithm  upon data  from  our earlier study (15). The 
starting value is 1.55 at one m onth  and ends with a value of 1.25 at a body weight o f 25 
kg. T he fastest decrease occurs during the first two years of life. Because the correlation 
between this factor and body weight appeared to be the strongest we used body weight 
instead of age (15).
The correction factor for the change in lung weight to  body weight ratio is based upon  the 
logarithm ic best-fit curve shown in figure 2. A ratio of 12 g ram /k g  lung weight to body 
weight serves as the “end” value at the age of 18 year and a ratio o f 23 as a  starting value. 
Furtherm ore the elbow in the curve is positioned at the age of 2.
The correction factor for adapting the relation between cardiac dimensions and BSA was 
developed as follows: the algorithm  is based upon the best-fit curve shown in figure 3. The 
correction factor is 1 at the age of 18 and 2 at the age of one m onth. Again the elbow in the 
curve is positioned at the age of two years. It corrects the calculated GEDVI.
Best-fit analyses were perform ed using Excel 2008 for M ac (Microsoft, Redm ond, WA, 
USA).
R e su lts
The relation of age with body weight and height is presented in figure 1. The pooled data 
from  lung weight in children are also plotted in figure 1 together with a best-fit curve. The 
best-fit function is reflected by: lung weight (gram) = -0.031 1x4 + 1.1257x3 - 12.857x2 + 
83.453x + 98.605 (x = age in  years). T he r 2 = 0.99.
Figure 2 presents the relation between age and the ratio of lung weight to body weight. The 
best-fit function was reflected by: ratio of lung weight to  body weight = -1.982ln(x) + 18.728 
(x = age in years). The r2 = 0.78. T he ratio is between 16 and 28 g ram /k g  at 1 m onth  and 
reaches 11 to  13 g ram /k g  at 18 years of age.
Figure 3 shows the relation of BSA to age together with the pooled data  o f heart weight. 
H eart weight is related to age by: heart weight (gram) = -0.0135x4 + 0.4711x3 - 4.8579x2 +
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27.426x + 23.485. T he r2 = 0.99 and x = age in years. The ratio of heart weight to  BSA is 
also depicted in  figure 3. T he relation between this ratio and age is reflected by -0.0918x2 + 
5.3222x + 94,381. T he r2 = 0.86 with x = age in  years.
We designed two pediatric correction factors for calculating EVLW I and one for GEDVI 
(table 1).
Figure 1
The relation between body weight, height and lung weight w ith age
Body weight and height in relation to age are based upon W H O  data (18). Height and weight are mean valuesfor boys 
and girls.
Lung weight represents pooled data from four studies (21-24).
The dotted line represents the best f it  curve. Lung weight (gram) = -0.0311x4 + 1.1257x3 - 12.857x2 + 83.453x + 
98.605. The r2 = 0.99 with x = age in years.
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Figure 2
The lung weight to body weight ratio related to age
The dotted line reflects the best f it  curve. Lung weight /  body weight (gram/kg) = -1.982ln(x) + 18.728. r2 = 0.78 
with x = age in years.
Lung weight represents pooled data from four studies (21-24). Lung weight is divided by body weight provided by the same 
study (21,22). From two studies we divided lung weight by predicted body weight based upon provided age (23,24).
D isc u s s io n
We show, based upon existing data, that the lung weight to body weight ratio declines with 
age (figure 2). T he fastest decline occurs within the first years of life. Since lung w ater is 
strongly related to  lung weight and is, at the same time, indexed to body weight these results 
offer an explanation why EVLW I is higher in young children com pared to older children 
or adults.
N orm al EVLW I in adults is 3 to 7 m l/k g  body weight according to  the m anufacturer 
(PiCCO, Pulsion, M unich, Germany). These data  are confirm ed by older and m ore re ­
cent publications (33,34). There are no clinical studies o f EVLW I m easurem ents in heal­
thy children, therefore (age related) norm al values are unknown. Clinically, higher EVLW I 
values have been shown in younger children but also in pediatric anim al experiments 
(7-9,15,17,35,36).
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Figure 3
The relation between B SA , heart weight and the heart w eigh t/B SA  ratio w ith age
Body surface area (BSA) in relation to age is based upon W H O  data (18). BSA represent mean valuesfor boys and girls. 
Heart weight represents pooled data from four studies (21,22,24) (32).
The best f it  fo r heart weight to age: heart weight (gram) = -0.0135x4 + 0.4711x3 - 4.8579x2 + 27.426x + 23.485. 
The r2 = 0.995 with x = age in years.
The best fitfo r heart weight/BSA: ratio (gram/m2) = -0.0918x2 + 5.3222x + 94,381. The r2 = 0.86 with x = 
age in years.
Extravascular lungwater (EVLW) is the am ount of fluid that is present in the extravascular 
space of the lung (1,2). T he quantity o f extravascular fluid is dependent on the net driving 
force over the vessel wall and will be proportional to tissue mass. Therefore, when perfusion 
is equally distributed an increase in  organ tissue mass will lead to a similar increase in the 
quantity o f extravascular fluid. A higher absolute value of extravascular lung w ater in  young 
children is not in  conjunction with these physiologic rules.
At present there is one anim al study com paring data of healthy new born lam bs to adult 
sheep (37). In  this study, lung w ater was determ ined using the gravim etric technology. The 
study shows tha t the lung weight to body weight ratio is 24.3 g ram /k g  in new born lambs
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and 12.9 in adult sheep. This seems to be similar to hum ans since lung weight to body 
weight ratio in  adults is roughly between 12 and 17 g ram /k g  with a m ean around 14 (25,27­
31). However, the am ount o f extravascular lung w ater indexed to body weight was 13.3 
m l/k g  in lam b and 6.1 m l/k g  in sheep. M ost im portantly the lung w ater to dry lung weight 
ratio was 4.0 m l/g ra m  in bo th  lam bs and sheep. Snapper et al m easured lung water in sheep 
while decreasing the lung weight by tying off parts o f the lung (38). Their results show that 
there was a linear relation between dry lung weight and lung w ater w ith an r2 of 0.95. From 
these studies it can be concluded that lung water is indeed a proportional fraction of the 
tissue mass.
The total weight o f new born hum an  lungs is approxim ately 100 gram s at one m onth  while 
the weight of adult lungs is approxim ately 1000 gram  (28). T he relation between lung 
weight and age is expressed in a polynom ial function to the fourth power com parable to  the 
developm ent o f body weight (figure 1). H addad  et al found the same type of m athem atical 
relation (22). U ntil the age of eight, there is m ore tissue to air com pared to  older children 
and adults and the fastest change occurs in the first 2 years (39,40). There is, approximately, 
a  2.5 fold increase in  the tissue to air ratio from  the new born to children at the age of six. 
U p to  the age of two the growth of lung volume is probably related to bo th  an increase in 
the num ber and size of alveoli (23,39,41). T he developm ent of height and especially body 
weight is rapid  in  the first years of life (figure 1). However body weight increases m ore rapid 
and with greater m agnitude than  height. Since body surface area (BSA) is calculated from 
body weight and height there is a concom itant rap id  increase in  BSA.
Although body weight and lung weight develop rapidly in young children, body weight 
increases even faster and thus the lung weight to body weight ratio decreases by a factor of 
approxim ately 0.5 during childhood and adolescence hum an  developm ent (figure 2) (21,42). 
This implies tha t young children have relatively m ore lung tissue mass in  relation to body 
weight com pared to older children or adults. Because a higher lung tissue m ass is related to  a 
larger extravascular lung water volume this is the first explanation why young children have 
a higher EVLW I com pared to older children or adults.
A ppendix  1 shows the calculation of lung  w ater and concom itan t variables using the 
transpu lm onary  the rm odilu tion  technique. Since m easurem ents o f CO , m ean  transit 
tim e (M Tt) and  downslope tim e (DSt) are based upon  physical properties they are p ro b ­
ably reliable in  all subjects. As a result G ED V  m ust be reliable in  all subjects (appendix 
1). H ow ever for the calculation of EV LW  a factor o f 1.25 betw een G ED V  and  IT B V  is 
used (43). This factor represents the rela tion  betw een pu lm onary  b lood volum e (PBV) 
and G ED V  and assumes a constan t and linear relation. H ow ever it has been  shown tha t 
this factor is no t equal in  all subjects (3). We showed in  a pediatric  study th a t this factor 
is w eight (and age) dependen t and  varies betw een approxim ately 1.5 in  young and  1.2 
in  older children  (15). This phenom enon  is in  accordance w ith the relatively larger lung 
w eight in  young children. A larger lung w eight will be accom panied by a larger PBV. 
T hus w hen a falsely low factor is used, IT B V  will be too low and  as a result EV LW  will 
be too high (appendix 1). This is the second explanation  why EV LW I is h igher in  youn­
ger children.
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Table 1
Pediatric correction o f  E V L W I  and G E D V I
P a r a m e te r s F o rm u la s
EVLW I
1. corrected ITBV (ITBVp) calculation 
(correction for relatively higher PBV)
ITBV p = -0.099 * ln(x) + 1.6128 
(x = body weight in kg)
1. Index EVLW  to PBW (to prevent obese 
children from having a  false low EVLWI)
PBW can be calculated from W H O  data. Also the 
current p i c c o 2 algorithm could be used
1. Calculation of a  pediatric corrected EVLWI 
(EVLWIp)
Correction for changing body weight to lung 
weight ratio)
EVLWIP = EVLWI * (-1.982 * ln(x) + 18.728)
(x = age in years)
GEDV
1. index GEDV to GEDVI using BSA based upon 
PBW (to prevent obese children from having a
false low GEDVI)
PBW can be calculated from W H O  data. Also the 
current p i c c o 2 algorithm could be  used
2. Pediatric correction of GEDVI (GEDVIp) GEDVIp = GEDVI * 1,4188x"0125 
(x = age in years)
Lung w ater m ust be indexed to m ake a com parison between individuals o f different size 
and to use norm al values. Lung w ater has been indexed to body weight for a long tim e and 
m any studies have presented these results (1,12,44,45). Because of the non-linear relation 
between de absolute am ount of lung w ater and body weight it could be argued that lung wa­
ter should be indexed to a other body dimensions (like height). Actually, lung w ater should 
be indexed to lung weight but this seems impossible since lung weight can not be m easured 
in vivo and no body variable develops linearly with lung weight (37). Therefore we propose 
to continue to index lung w ater to body weight. In  doing so one m ay choose betw een accep­
ting higher values of EVLW I in young children and develop age dependent norm al values 
or im plem ent a  correction factor for correcting or “norm alizing” values of children.
We propose to  develop correction factors in  order to acquire com parable EVLW I values in 
all ages. The necessary steps are m entioned below.
1. First the calculation of ITB V  should be adapted to  the different relation between PBV 
and GEDV in young children. Since the relation between lung weight and body weight 
is logarithm ic (figure 2) an similar algorithm  should be used. T he proposed form ula is 
based upon the only available data  and presum es tha t the factor is approxim ately 1.55 at
3.5 kg body weight and declines to  1.25 at a body weight o f 25 kg (15). This procedure 
results in a m ore correct calculation of ITB V  in children (ITBVp) (table1).
2. The second issue concerns the use of actual or predicted body weight (PBW). In  adults 
indexing to PBW  seems m ore useful (10-12). T here are no data  available for children. 
However to prevent obese children from  having a false low EVLW I it seems practical to 
use PBW  also in children. Predicted body weight m ight best be calculated from  height. 
In  children the variation in  height and weight for a given age is very large. For example 
in boys 2 years o f age body weight varies between 9 and 15 kg (5 and 95 percentile) and
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in girls 10 years of age between 24 and 35 kg. However, weight is m ore closely related to 
height (18). It should be no ted  that the weight to height relation is significantly different 
in girls com pared to boys. Therefore when calculating PBW  in children there should be 
a gender related algorithm  that is based upon height.
3. The last correction should compensate for the changing lung weight to body weight ratio. 
As explained earlier this algorithm is also logarithmic. An example is depicted in table 1.
Global end diastolic volume (GEDV) is a virtual volume including, theoretically, the end 
diastolic volumes of left and right atria and ventricles plus the volume of central veins and 
aorta between the point o f injection and the point o f detection of the indicator. Therefore 
GEDV has no  anatom ical counterpart that can be used for indexing. A part from  heart 
weight (figure 3) the developm ent of end diastolic blood volume (EDV) m easured using an ­
giography or echocardiography will closely resemble GEDV D uring growth EDV m easured 
using angiography, increased from  25 ml with a BSA of 0.5 m 2 to 125 m l at 1.5m2 (46). So 
EDV increased with a factor 5 and BSA with a factor 3. T here was an exponential relation 
between developm ent o f EDV and BSA (46). This exponential relation was confirm ed by 
Buechel et al using cardiac M R I data  (47). U sing 3D echocardiography Poutanen et al 
showed that left ventricular mass to BSA ratio increased from  50 g ram /m 2  at three years 
o f age to 80 g ra m /m 2 at 17 years (48). D uring hum an  developm ent left ventricular mass 
increased with a factor 4 (from 35 to 130 gram) while BSA increased with a factor 2.5 (from
0.7 to 1.7) in  healthy hum ans ranging from  2 to  27 years (48).
We believe tha t the available data, shown in figure 3, and the above m entioned data  from 
EDV in relation to age, offer an explanation why younger children have a lower GEDVI 
com pared to older children or adults. Since the calculation of GEDV  requires no assum p­
tion and is entirely based upon  physical properties, the absolute GEDV value is likely to be 
reliable in young children.
C om parable to EVLW I we propose to correct the lower GEDVI values in children. N orm al 
values for GEDVI are 680 - 800 m l/m 2 according to the m anufacturer. The proposed cor­
rection is shown in table 1.
The results of this study apply to  all children m onitored using the P iC C O  system. However 
there are some limitations. All data are based upon existing studies that were not designed 
to specifically study higher EVLW I and lower GEDVI values in young children. Also the 
data m ight not always refer to healthy lung or heart samples and m ight therefore not alway 
reflect standard values. This m ight be an explanation for the scatter of data o f the lung 
weight to  body weight ratio resulting in a less optim al r2 of 0.78. Also age m ight be less 
suitable for a correction of lung w ater and GEDV. H eight could be m ore suitable. Indeed 
lung weight correlated better w ith lung volume com pared to age (23). O n  the other hand  
autopsy data on lung weight are almost all related to  body weight or age and height is often 
not provided.
The proposed correcting algorithms appear useful to norm alize EVLW I and GEDVI values 
in young children to adult reference values. T he advantage is that, for the first time, these 
m easurem ents can be interpreted  in  relation to known norm al values. O n  the other hand  
every calculation or “correction factor” adds a source of error. Therefore the proposed al­
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gorithms are only a proposal for further research and definitely need further clinical studies. 
Caution m ust still be applied w hen in terpreting  EVLW I and GEDVI (corrected or not) in 
the clinical setting in  small children.
In summ ary we offer, for the first time, an explanation for higher values of EVLW I and 
lower values of GEDVI in young children. They are caused by age related changes in the 
ratio of lung weight to body weight and in  the ratio o f end diastolic blood volume to  body 
surface area during growth. Also, in young children, the pulm onary blood volume seems 
large com pared to global end diastolic volume. We propose several correction algorithms 
for adjusting EVLW I and GEDVI to  adult reference values. Clinical validation of these 
algorithms is mandatory.
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A p p en d ix ; Calculation of extra vascular lung w ater and global end diastolic 
volume
The transpulmonary thermodilution technique delivers three basic measurements:
1. C ardiac output (CO) in  l/m in
2. M ean transit tim e (MTt) in sec
1. M ean downslope tim e (DSt) in sec
Secondary required parameters include:
1. Body weight (kg)
2. H eight (cm)
3. Body surface area (BSA) based upon weight and height is calculated by a specific for­
m ula (20)
Calculations by the P iC C O  device:
A - In trathoracic therm al volume (ITTV) = C O  x M T t x 1000 /  60 (ml)
B - Pulm onary therm al volume (PTV) = C O  x D St x 1000 /  60 (ml)
C - G lobal end diastolic volume (GEDV) = IT T V  - P T V  (ml)
D - In trathoracic blood volume (ITBV) = G EDV  x 1.25
E - EVLW  = IT T V  - ITB V  (ml)
F - EVLW I = EVLW  /  body weight (ml/kg)
G - GEDVI = G EDV  /  BSA (m l/m 2)
Important issues
The calculation of ITB V  using the assumed factor o f 1.25 (calculation D) is based upon one 
study in adult subjects (43). The factor can be different between individuals but can also be 
different related to  age (3,15).
The premises that P T V  can be calculated from  the D St is tha t this must be the largest 
“m ixing cham ber” of blood and indicator. The pulm onary blood volume must therefore be 
larger than  GEDV.
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Non-invasive blood pressure measurement in children
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CHAPTER VII
A b strac t
Introduction
Continuous noninvasive arterial blood pressure can be m easured in finger arteries using an 
inflatable finger cuff (FAP) with a special device and has proven to be feasible and reliable 
in adults. We studied prototype pediatric finger cuffs and pediatric software to com pare this 
blood pressure m easurem ent with intra-arterially m easured blood pressure (IAP) in critically 
ill children.
Methods
We included sedated and mechanically ventilated children adm itted to our pediatric intensive 
care unit. We perform ed simultaneous arterial blood pressure measurem ents during a rela­
tively stable hem odynamic period and com pared FAP, IAP, and the noninvasive blood pres­
sure oscillometric technique. We also com pared IAP to a reconstruction of brachial pressure 
from finger pressure.
Results
Thirty-five children between 2 and 22 kg body weight were included. In  total, 152 attempts to 
record a FAP pressure were perform ed of which 4.6%  were unsuccessful. W hen com paring 
FAP to IAP, bias was -16.2, -7.7, and -10.2 m m  H g for systolic arterial blood pressure, diastolic 
arterial blood pressure, and m ean arterial blood pressure. Limits of agreem ent (LOA) were 
respectively 26.1%, 30.1%, and 22.6%. W hen reconstruction of brachial pressure from finger 
pressure was com pared to IAP, these results were -11.8, 0.6, and -0.9 m m  H g for bias and 
21.7%, 8.9%, and 8.9%  for LOA. W hen noninvasive blood pressure oscillometric technique 
was com pared to IAP, the results were: -6.8, -0.9, and -3.8 m m  H g for bias and 18.2%, 38.6%, 
and 22.1%  for LOA.
Conclusion
Beta type continuous noninvasive arterial blood pressure m onitoring using a finger cuff with 
brachial arterial waveform reconstruction seems reliable in hemodynamically stable critically 
ill children.
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In trodu ction
Continuous arterial blood pressure monitoring is of great importance in m any clinical situa­
tions, including emergency and critical care medicine but also during anesthesia. In this respect, 
intra-arterial blood pressure measurem ent (IAP) is considered the clinical “gold standard.” In 
clinical practice, however, blood pressure is frequently m easured using the noninvasive blood 
pressure oscillometric technique (NIBP) with a cuff around the upper arm. Unfortunately, this 
provides only intermittent measurements, and several studies have suggested that NIBP and 
IAP may differ significantly (1,2). In small children, an intra-arterial catheter may be difficult 
to insert and requires specific medical skills. As in adults, NIBP measurements in children only 
provide intermittent data and may also be less reliable (3). Therefore, a  beat-to-beat, noninvasive 
and reliable technique for tracking arterial blood pressure in small children is highly desirable. 
Continuous noninvasive blood pressure can be m easured in finger arteries (FAP). It requires a 
small finger cuff and a special device (Nexfin, BMEYE, Amsterdam, The Netherlands). FAP 
thus provides a noninvasive finger arterial pressure curve and has proven to be feasible and 
reliable in adults (4-6).
Recently, prototype small finger cuffs especially designed for the pediatric population were 
developed by BMEYE, and a pilot study has shown promising results (7). In the current study, 
we used these prototype pediatric finger cuffs (four different sizes) and pediatric software to 
com pare this new noninvasive continuous blood pressure m easurem ent with intra-arterially 
measured blood pressure in critically ill children. In a subgroup, we also com pared IAP m ea­
surements with the standard NIBP technique.
M eth o d s
The local ethics com m ittee responsible for m edical research in hum ans approved the study 
and waived the need for inform ed consent. Inclusion criteria were body weight <60 kg, need 
for sedation, m echanical ventilation and continuous m onitoring of in tra-arterial blood pres­
sure. Exclusion criteria were fast changes in  blood pressure or heart rate, clinically detecta­
ble ischem ia of the fingers and kinking or partial obstruction of the intra-arterial catheter. 
All m easurem ents were perform ed by one of the authors (CH).
Patients were routinely sedated at the discretion of the treating physician using several seda­
tives in com bination with m orphine and acetaminophen. All children’s lungs were m echani­
cally ventilated using a Servo 300 ventilator (Maquet,Getinge, Sweden) with a positive end-ex­
piratory pressure level set as judged clinically necessary. Besides IAP, children were monitored 
with electrocardiogram, transcutaneous arterial oxygen saturation, end tidal C O 2 and, occa­
sionally, central venous pressure. H em odynam ic and respiratory m onitoring was perform ed 
using a H P  Merlin type central nervous system m onitoring system (original a product of HP, 
Irvine; at present: Philips, Eindhoven, The Netherlands). H em odynam ic support included the 
administration of additional fluids or vasoactive drugs when judged necessary. Furtherm ore, 
central and peripheral hand  tem perature, urine production, lactate level, capillary refill time, 
and base excess were collected. The severity of illness was calculated using the Pediatric Index 
of M ortality and Pediatric Risk o f Mortality Version II score (8,9).
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Figure 1 T he sites of insertion of
Example o f  a beta type finger blood pressure c u ff  in use. the intra-arterial catheter
were the femoral, radial or 
brachial artery. T he arterial 
catheters (either 20, 22 or 
24-gauge) were connected 
to standard low compliant 
tubing and  a pressure trans­
ducer (Edwards Lifescien- 
ces, Irvine, USA). T he pres­
sure transducer was zeroed 
to am bient air pressure and 
positioned at the level of the 
midaxillary position. Air 
bubbles were flushed from 
the system before data col­
lection. T he pressure trans­
ducer was connected to a 
type 78353B m onitor (HP, Irvine, USA). This m onitor device has an analog output channel, 
which was connected to the prototype pediatric noninvasive finger pressure device (BMEYE, 
Amsterdam, T he Netherlands). This device recorded these blood pressure signals with 200 Hz 
sampling rate digitally. T he prototype pediatric finger pressure device used in this study uses 
the basic FAP principles as originally developed for the form er Finapres™  device, with several 
specific new pediatric components, including pediatric finger cuffs, modified servo hardware 
and  software and  a special pediatric version of the Physiocal expert system (5,10). T he FAP 
technique is based on the volume clamp principle of Penaz and  was further developed by 
Wesseling et al (10,11). T he m ethod uses an inflatable finger cuff that contains an infrared 
photoplethysm ograph on the inside. Figure 1 shows a picture of a prototype finger cuff in a 
child. T he plethysmograph and the air pressure in the cuff are linked by a fast reacting servo 
system. W hen pressure in the finger artery increases, m ore blood enters the finger and subse­
quently m ore light is absorbed. As a consequence, the output of the plethysmograph decreases. 
This output is com pared with a set point, which reflects the diam eter of the artery at near-zero 
transm ural pressure. Consequently, m ore air is passed into the cuff to increase cuff pressure 
and  oppose the initial increase in artery blood volume. Vice versa the cuff deflates with decrea­
sing finger blood pressures. Finger arterial pressure is m easured indirectly by recording cuff 
pressure. T he fast reacting servo system is driven by an expert system (Physiocal, BMEYE, 
Amsterdam) designed to determ ine and track the correct unloaded diam eter at which the fin­
ger artery is clamped (12). T he Physiocal algorithm will keep cuff pressure constant at regular 
intervals. As a consequence, the m easurem ent of blood pressure is tem porarily (for 2-3  beats) 
interrupted. Figure 2 depicts an example of a simultaneous registration of IAP and FAP.
FAP m easurem ents were, w ithout preference, perform ed at the left or right hand  depending 
on the possibility to measure on a particular side. For instance, bandages or splints to fixate 
a radial artery prevented m easurem ents on this hand. T he inflatable finger cuff was applied 
to the middle phalanx of the finger tha t gave the best signal, preferably the middle or index 
finger.
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Figure 2
Exam ple o f  a simultaneous recording o f  intra-arterial and finger arterial blood pressure (without waveform 
reconstruction).
Registration in a boy o f 6  kg with status epilepticus. The intra-arterial catheter was inserted in the right radial artery. 
Finger blood pressure was obtainedfrom the middle finger o f the left hand. The intra-arterial blood pressure (IAP) curve 
is lagging behind because o f a build-in delay o f about 0.25 s o f the monitor system.
The NIBP, based u pon  the oscillometric technique with an inflatable cuff around the upper 
arm , was m easured using the M erlin type central nervous system m onitor (HP, Irvine, USA). 
Because of the arousal reaction with subsequent changes in  blood pressure as a  consequence 
o f NIBP cuff inflation, m easurem ents were only perform ed when clinically feasible and in 
m ore deeply sedated children. We selected an upper arm  cuff o f the correct size according 
to the instructions of the m anufacturer. M easurem ents were perform ed on the same arm  
as the FAP was m easured. Because FAP is not m easurable during the NIBP m easurem ent 
at the ispilateral hand, we took the FAP value a few seconds prior to the start o f the NIBP 
m easurem ent.
The finger arterial pressure is physiologically somewhat lower com pared to the blood pres­
sure m easured at the brachial level. A software algorithm  can be used that converts FAP 
to a  reconstructed brachial artery pressure waveform (reBAP) (13). The reconstruction of 
brachial pressure from  finger pressure corrects both  waveform (affecting pulse pressure) and 
offset (shifting the curve up or down). T he cause of the different m ean pressure is the resis­
tance to flow, causing peripheral m ean pressures to be lower than  central m ean pressures. 
This shift (and other effects) is corrected according to Bos et al (14). T he waveform is affec­
114
CHAPTER VII
ted by viscoelastic properties and reflections of the arterial tree. In  adults, the pulse pressure 
is (on average) greater in the finger than  in the brachial artery or the aorta. In m athem atical 
term s, this can be described as an amplification of the high frequencies if one goes from 
central to periphery. To correct this, the inverse operation (filtering of high frequencies) is 
applied. In  this study, we used the version of the algorithm  as im plem ented in  the Beats- 
cope 1.1 software (TN O  Biomedical Instrum entation, Am sterdam , T he Netherlands). In 
this way, the FAP signal was afterwards processed into the reBAP signal using this algorithm, 
although this is designed for adults (14). A version for a pediatric population is currently not 
available.
In  this study, the IAP data  from  the three different m easurem ent sites (radial, brachial, fe­
moral) were pooled and all blood pressure data were analyzed off-line. For each recording, a 
com parison was m ade by taking an average over a 20—30 s control period taken im m ediately 
after onset o f a recording session as soon as a proper finger blood pressure was obtained. 
W henever possible, the registrations were repeated over days with a  m axim um  of 10 regis­
trations per patient. T he FAP signal was recorded simultaneously with the IAP signal.
D ata  from  FAP, reBAP, and IAP were analyzed using Beatscope 1.1 software. We com pared 
systolic (SAP), diastolic (DAP), and m ean arterial blood pressure (MAP) values of IAP, FAP, 
reBAP, and NIBP for determ ination of bias and limits o f agreem ent in assessing absolute 
blood pressure levels using the Bland A ltm an analysis (15). Bias was calculated by subtracting 
IAP from  FAP, IAP from  reBAP and IAP from  NIBP. Limits o f agreem ent were calculated 
by m ultiplying the standard deviation of the bias with 1.96. In  the Bland A ltm an plot, the 
bias was plotted against the m ean value (16). C orrelation was calculated using the Pearson 
product m om ent correlation coefficient in  case of a norm al frequency distribution of data. 
O therwise, the Spearm an correlation coefficient was used. Possible differences between two 
variables concerning blood pressure values or bias were analyzed using the t-test for paired 
m easurem ents after confirm ing norm al frequency distribution of data. Possible differences 
between m ore than  two variables concerning blood pressure values or bias were analyzed 
using analysis of variance. If  the analysis o f variance test was positive (P < 0.05), then  a 
Student-Newm an-Keuls test for pairwise com parison of subgroups was perform ed. Pos­
sible differences between standard deviations were calculated using the F-test. Calculations 
and data  m anagem ent were perform ed using Excel for windows (Office 2007, Microsoft, 
Seattle, USA). Statistical calculations were perform ed with M edCalc 9 (M edCalc Software, 
M ariakerke, Belgium).
R e su lts
Thirty-five sedated and mechanically ventilated children between 2 and 22 kg body weight 
were included in  the study. F urther patient details are depicted in  Table 1. Table 2 shows 
concom itant variables recorded during the tim e of blood pressure m easurem ents. D uring 
blood pressure recording, some children received therapy with (a com bination of) vasoactive 
drugs. There were 13 episodes with milrinone, 50 episodes with dobutam ine, 15 episodes 
with epinephrine, and 25 episodes with norepinephrine.
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Table 1
Patient characteristics (n = 3 5 )
M e a n  (range)
Weight (kg) 7.4 (2 - 22)
Length (cm) 68.8 (40 - 130)
Age (months) 20.2 (0.1 -  125.5)
Length of P IC U  stay (days) 14 (0.7 - 101.8)
survival 93%
M ean probability of death using PIM 12% (1 -  65%)
M ean probability of death using PRISM  II 28% (3 - 90%)
Diagnosis
22 x congenital cardiac surgery 
3 x traum a 
4 x respiratory insufficiency 
3 x status epilepticus 
2 x abdominal surgery 
1 x cardiac failure
PICU — pediatric intensive care unit; P IM  — pediatric index of mortality; P R ISM II — pediatric risk of mortality version II.
Table 2
Patient variables during blood pressure measurements (n — 145)
M e a n  (range)
PEEP (cmH2O) 6.2 (3 -  24)
Body tem perature (°C) 37.1 (35.0 -  40.7)
H and tem perature (°C) 32.5 (26.3 -  36.7)
delta temp %  (central — hand temp.) 12.2 (-2.8 -  31.7)
Lactate level (mmol/l) 1.9 (0.8 -  5.2)
U rine production in last 2 hours (m l/kg/hour) 3.9 (0.0 -  11.0)
Base excess -0.7 (-8.9 -  9.4)
Capillary refill time finger (sec) 2.1 (1 -  12)
Capillary refill time central (sec) 1.9 (1 -  5)
Cuff size FAP 57 x cuff-1 
37 x cuff-2 
20 x cuff-3 
31 x cuff-xs
Arterial catheter position 26 x brachial artery 
51 x radial artery 
68 x femoral artery
Attempts to achieve FINAp pressure 2.5 (1 -  12)
PEEP = positive end expiratory pressure; FAP = finger arterial pressure.
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Table 3
M ean blood pressure values with (range)
IAP FAP reB A P
SAP (mmHg) 89.2 (55.8 -  160.0)a,b’ 73.1 (44.4 -  154.3)c 77.8 (51.4 -  144.4)c
DAP (mmHg) 49.9 (31.2 -  90.0)a 42.3 -  (18.9 -  91.7)b’c 50.5 (32.6 -  92.6)a
MAP (mmHg) 63.8 (42.1 -  115.0)a 53.7 (28.7 -  113.6)b,c 62.9 (42.4 -  115.4)a
ANOVA (p < 0.05)
SAP — systolic arterial pressure; DAP — diastolic arterial pressure; M A P  — mean arterial pressure; IAP — intra arterial 
pressure; FAP — finger arterial pressure; reBAP — Reconstructed brachial arterial pressure 
a — Different from FAP 
b — Different from reBAP 
c — Different from IAP
In  total, we perform ed 152 attem pts in these 35 children to  record a FAP pressure. In  4.6%, 
these attem pts were unsuccessful. O n  average, 2.5 attem pts (range, 1-22) were required to 
obtain a signal o f acceptable quality, in which each attem pt takes about 1-2 min. The num ­
ber o f attem pts to achieve a proper FAP recording, by reapplying the finger cuff, was higher 
w hen cuff-1 (the smallest cuff) was used (P < 0.05). A m ean num ber of 3.7 attem pts was 
needed for cuff-1, 2.1 for cuff-2, 2.0 for cuff-3, and 1.4 for cuff-xs. Table 3 shows the blood 
pressure averages obtained during the first recording for IAP, FAP, and reBAP.
Figure 3 shows the Bland A ltm an plot for SAP, DAP, and M AP com paring FAP-IAP and 
reB A P- IAP. The correlation coefficient between FAP and IAP was 0.89, 0.90, and 0.94 for 
SAP, DAP, and MAP, respectively. These values were 0.89, 0.91, and 0.95 for the correlation 
coefficient o f SAP, DAP, and MAP between reBAP and IAP. The bias between reBAP-IAP 
was significantly smaller for SAP, DAP and MAP com pared to the bias between FAP-IAP 
(P < 0.0001). Also the limits o f agreem ent (LOA) between reBAP-IAP were significantly 
smaller than  those of FAP-IAP for DAP and MAP (P = 0.01 and P = 0.045, respectively) but 
not for SAP (P = 0.28).
There were no significant differences in  bias between FAP-IAP and reBAP-IAP for SAP, 
DAP, and MAP when IAP was m easured using femoral, radial or brachial catheters.
Table 4 shows a comparison between patient subgroups for bias and LOA of FAP-IAP for SAP, 
DAP, and MAP. The correlation coefficient between the central (rectal) and peripheral (hand) 
tem perature difference and the bias between FAP-IAP for the MAP was -0.17 (P = 0.05). The 
cuff type used had  no effect on the bias between FAP and IAP for SAP and M AP Only for DAP 
was a significant difference in bias between cuff-2 and cuff-1 was present (P = 0.04).
In a subgroup of 13 children, we com pared the bias between reBAP-IAP and NIBP-IAP. 
Fifty-two m easurem ent pairs were collected. All NIBP m easurem ents were successful. The 
subgroup with NIBP m easurem ents was com parable to the total group for tem perature, lac­
tate level, base excess, urine production, and the use of vasoactive drugs. However, body 
weight was lower (P = 0.009), capillary refill time of the finger lesser (p = 0.003) and num ber 
of attem pts increased (P = 0.002). Because of these differences, we did not com pare blood 
pressure data from  the NIBP group with the whole group.
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Figure 3
Bland  A ltm an plo t fo r  systolic,  diastolic and mean arterial blood pressure
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Comparison between IAP, FAP, and reBAP. The printed numbers reflect percentage values for bias and limits of agreement. 
IAP = intra-arterial pressure; FAP = finger arterial pressure; reBAP = reconstructed brachial arterial pressure; SAP = 
systolic arterial pressure; DAP = diastolic arterial pressure; M A P  = mean arterial pressure.
Figure 4 shows the Bland A ltm an plots of this subgroup for the two m ethods (reBAP and 
NIBP) when com pared to IAP. For DAP, the bias between reBA P-IA P and N IB P-IA P was 
not significantly different (P = 0.33). However, there was a significant difference for the bias in 
SAP (P = 0.0001) and M AP (P = 0.012). The LOA were com parable for SAP (P = 0.59) but 
significantly smaller for M AP and DAP (both P < 0.001) when we com pared NIBP to IAP
To exclude the possibility tha t the repeated  m easurem ents in  a few patients influenced 
the total result, the bias between FAP-IAP for only the first m easurem ent in each patient
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Table 4
Comparison between finger arterial pressure (FAP) and intra-arterial pressure (IAP), differences in bias and 
limits o f  agreement (LOA) fo r  S A P  DAIP and M A P  among several subgroups
SAP
(mmHg) 
bias (LOA)
p  value
bias
(LOA)
DAP
(mmHg) 
bias (LOA)
p  value
bias
(LOA)
M A P
(mmHg) 
bias (LOA)
p  va lu e
bias
(LOA)
Body weight
< 5 kg (n = 68) 17.0 (17.1) 0.31 (0.03) 7.3 (10.3) 0.59 (0.26) 9.9 (10.6) 0.6 (0.94)
> =  5 kg (n = 77) 15.3 (22.2) 7.9 (11.8) 10.4 (10.7)
lactate level
> 2 m m ol/l (n = 65) 14.2 (20.7) 0.40 (0.61) 7.2 (10.2) 0.85 (0.39) 9.7 (9.7) 0.78 (0.19)
< =  2 m m ol/l (n = 37) 16.1 (21.2) 7.7 (11.5) 9.3 (11.7)
Urine production 
in last 2 hours
< 2 m l/kg/hour (n = 32) 15.7 (19.1) 0.80 (0.85) 7.0 (13.9) 0.6 (0.1) 9.8 (13.4) 0.78 (0.83)
>=2 m l/kg/hour (n = 109) 16.2 (19.8) 7.8 (10.5) 10.2 (9.9)
capillary refill time finger
> 2 sec (n = 35) 17.2 (22.6) 0.47 (0.22) 5.4 (10.4) 0.54 (0.35) 8.7 (9.3) 0.07 (0.5)
< =  2 sec (n = 110) 15.8 (19.1) 4.4 (12.1) 10.6 (10.9)
Base Excess
< -2 m m ol/l (n = 60) 15.7 (19.7) 0.69 (0.85) 8.1 (11.7) 0.38 (0.45) 10.5 (11.2) 0.46 (0.43)
> =  -2 m m ol/l (n = 85) 16.4 (20.2) 7.3 (10.70) 9.9(10.3)
delta temperature 
(central - peripheral)
> 5 °C (n = 49) 15.7 (22.7) 0.78 (0.06) 6.7 (12.4) 0.23 (0.27) 9.3 (10.7) 0.25 (0.79)
< =  5 °C (n = 86) 16.2 (18.1) 8.1 (10.8) 10.4 (11.0)
Treatment with all vasoactive 
drugs *
with (n = 56) 20.1 (19.2) 0.0002
(0.88)
7.8 (12.3) 0.72 (0.54) 10.9 (12.2) 0.22
(0.036)
without (n = 89) 13.7 (18.9) 7.5 (10.4) 9.7 (9.5)
Treatment with 
nor-epinephrine
with (n = 25) 13.6 (15.6) 0.17 (0.1) 8.1 (12.5) 0.62 (0.34) 9.2 (12.4) 0.35 (0.18)
without (n = 120) 16.7 (20.7) 7.5 (10.9) 10.3 (10.2)
SAP — systolic arterial pressure; DAP — diastolic arterial pressure; M A P  — mean arterial pressure; SD — standard 
deviation
* — dobutamine or epinephrine or nor-epinephrine or milrinone or enoximone or a combination o f these drugs
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Figure 4
Bland  A ltm an plots fo r  arterial pressure, comparison between IA P  reBAP and N IB P
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The printed numbers reflect percentage values fo r  bias and limits o f agreement LAP — intra-arterial pressure; FAP 
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diastolic arterial pressure; M A P  — mean arterial pressure.
(n — 35) was com pared to  the other (repeated) m easurem ents (n — 110). There were no dif­
ferences in bias or LOA for SAP, DAP, and MAP.
In order to analyze sensitivity and specificity o f FAP in detecting hypotension, we calculated 
the 5th and 50th percentile o f the norm al MAP value based upon recent literature (17). 
Because no patient had  an IAP value below the 5 th  percentile, we took the 50th percentile 
as reference. In  doing so, the sensitivity for detecting a MAP level below or above this value 
was 98% , 86% , and 86% , respectively, for FAP, reBAP, and NIBP. T he specificity was 52%, 
79%, and 81% , respectively.
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D isc u ss io n
This study shows that a continuous noninvasive finger arterial pressure m easurem ent can be 
accurate for continuously m easuring MAP in stable critically ill children.
In  4.6%  of attem pts, a FAP signal was not obtainable. Also m ore than  one attem pt was often 
necessary to obtain a reliable FAP signal. This was significantly m ore frequent when using 
the smallest finger cuff, thus in smaller children. Im provem ent in cuff design (cuff-1) and or 
start-up process o f the software in order to shorten the interval tim e for obtaining a proper 
FAP value seems w arranted.
The overall results show a considerable bias between FAP and IAP. T he largest difference 
being -21.1%  (SAP). T he bias for MAP and DAP was lower (-18.6% and -18.8% , respective­
ly) and in  concordance with results in adults (18, 19). Interestingly, Andriessen et al. using 
similar prototype equipm ent, observed a smaller bias in new borns (7). They observed that 
the (not reconstructed) m ean  finger pressure was on average about 5 m m  H g lower than  the 
invasive m ean  pressure. In  the current study, the bias of the m ean finger pressure is about 
-10 m m  Hg. Both studies confirm  the expected lower peripheral m ean pressure. Both studies 
also indicate tha t the pulse pressure attenuation w hen reconstructing central pressures is not 
applicable in children. In  the current study, the MAP and DAP are properly corrected by 
the reconstruction of the blood pressure, but the SAP is 10 m m  H g  too low. Also in the latter 
study, the pulse pressure of the FAP is smaller than  the pulse pressure of the invasive pres­
sure. It m ight be m ore appropriate to amplify pulse pressure in the process o f reconstructing 
central blood pressures from  peripheral pressures in children.
Application of a commercially available device (Finapres) has been described earlier in  neo ­
nates. In  this study, the cuffs were put around the baby’s wrist. Results showed a small bias 
and LOA (20). However, when m easuring on the finger, venous congestive blood pooling 
is lim ited to the finger tip, whereas m easurem ents on the wrist cause blood pooling in the 
whole hand , which is painful and not the intended use of the m ethod and device.
Brachial waveform reconstruction (reBAP) in adults leads to a m ore central blood pressure 
m easurem ent with narrow er LOA (14,21,22). In  the present study, the perform ance im prov­
ed significantly when this adult reBAP algorithm  was used: for MAP, the bias decreased 
from  -10 to -1 m m  H g but also the LOA im proved from  ±22.6%  to ±14% . Considering 
that this algorithm  was designed for adults and that arm  arterial properties and pulse wave 
propagation in children are different, further im provem ent seems possible. Although, in our 
study, reBAP was com puted afterwards, this is also possible in a real-time mode.
Several studies have com pared NIBP with IAP and results were com parable to our findings 
in the present study (2,23). However, when NIBP was com pared to  reBAP, the latter had  a 
significantly lower bias for SAP and MAP and also significantly lower LOA for MAP and 
DAP. This dem onstrates tha t m easurem ent o f MAP in these pediatric patients could be 
m ore reliable with reBAP than  with NIBP
The study is lim ited by several factors. First, we used different arterial catheter sites. This 
makes a com parison m ore difficult, although we could no t dem onstrate a difference between
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m easurem ents using different arterial catheter sites. Second, the cuffs and software used are 
still b type and must be adjusted for com m ercial use. Third , different interventions and 
m edications can influence the arterial pressure curve on various locations (24,25). Finger 
artery pressure m easurem ent is another way of m easuring blood pressure at a site tha t was 
n o t used before in  children. It therefore has the same lim itations as pressures m easured at 
the radial, fem oral or brachial level in tha t it does no t always reflect the aortic pressure. 
Fourth, although we could no t find an effect o f a com prom ised peripheral perfusion on 
the m easured pressure difference, this m ay be explained by the relatively stable hem ody­
nam ic situation. Therefore, these results should not be extrapolated easily to children with 
severe shock or a rapidly changing blood pressure. Fifth, this study was designed to analyze 
absolute blood pressure values. It remains to  be studied how accurate this technique is in 
reflecting (rapid) changes in blood pressure. Sixth, we tested the FAP m ethod for a relatively 
short period. It remains to  be studied if it can be used in our patients for a longer time.
The finger cuffs can be unpleasant for children. Therefore, clinical use in  awake children 
m ight be limited. If  the start-up tim e of the FAP technique is improved, it could provide a 
fast and continuous signal that m ight be useful in  em ergency cases but also during proce­
dures when an arterial catheter is difficult or impossible to insert. T he possibility to  estimate 
and track cardiac output using the same technology makes it even m ore interesting (26). 
Further studies are w arran ted  to prove its clinical value.
In summary, beta  type continuous noninvasive arterial blood pressure m onitoring using a 
finger cuff and brachial arterial waveform reconstruction seem reliable in critically ill chil­
dren. The accuracy for m easuring DAP and MAP seems at least equal to the noninvasive 
standard, upper arm  cuff oscillometric technique.
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A b stra c t
Background
Continuous non-invasive m easurem ent of finger arterial pressure (FAP) is a reliable techno­
logy in  adults. FAP is m easured w ith an inflatable cuff around the finger and simultaneously 
converted to a reconstructed brachial artery pressure waveform (reBAP) by the Nexfin™ 
device. We assessed the adequacy of a  prototype device (Nexfin-paediatric), designed for a 
paediatric population, for detecting rapid blood pressure changes in children during cardiac 
surgery.
Methods
T hirteen anaesthetised children with a m edian age of 11 m onths (2 m onths — 7 years) 
undergoing congenital cardiac surgery were included in the study. reBAP and IAP were 
recorded simultaneously during the surgical procedure. To assess the accuracy of reBAP in 
tracking blood pressure changes the 4 largest IAP variations w ithin a 5-m inute tim e interval 
were identified from  each procedure. These variations were com pared offline with reBAP 
during a 10s control period before and a 10s period after a blood pressure change had  oc­
curred.
Results
In  10 out of 13 children a non-invasive blood pressure recording could be obtained. T here­
fore recordings from  these 10 children were eligible for further analysis resulting in  40 data 
points. The correlation coefficient between reBAP and IAP in tracking blood pressure 
changes was 0.98. reBAP followed changes in IAP with a  m ean bias for systolic, diastolic and 
m ean arterial pressure of 0.0 m m H g (SD 5.8), 0.1 (SD 2.8) and 0.19 (SD 2.7) respectively.
Conclusion
The prototype device closely follows arterial blood pressure changes children. However, in 
a considerable num ber of attem pts obtaining a signal was tim e-consum ing or unsuccessful. 
This technique seems prom ising but requires further technical development.
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In tro d u ctio n
In children undergoing m ajor surgery, significant changes in  arterial blood pressure may 
result in  decreased organ perfusion and tissue dam age (1). Routinely, non-invasive blood 
pressure m easurem ent (NIBP) using the autom atic oscillometric technique with an upper 
arm  inflatable cuff is used during anaesthesia. Non-invasive blood pressure m easurem ent 
is an easy, relatively fast, non-invasive but in term ittent technique. Therefore NIBP is less 
suitable for m onitoring patients with (possible) rapid changes in blood pressure. Also NIBP 
m easurem ents m ay be less reliable com pared to  intra-arterial blood pressure (IAP) m easu­
rem ent (2-5).
IAP m easurem ent using an intra-arterial catheter is com m only used during m ajor surgery 
and in critically ill patients. IAP provides a reliable and continuous blood pressure m easure­
m ent and also allows for blood sampling. However arterial catheter p lacem ent in children is 
undesirable before induction of anaesthesia, can be tim e-consum ing and requires extensive 
experience. In  addition, the m ethod is associated w ith a small risk of bleeding, infection and 
distal limb ischem ia (6). For these reasons NIBP is still frequently used in  small children. 
Blood pressure can be continuously m onitored using an inflatable cuff around the finger 
using the Nexfin™  device (BMEYE, Am sterdam , The Netherlands). The Nexfin™  device is 
the improved successor of the form er Finapres™  device (Ohm eda, USA) and is based upon 
similar technology. This non-invasive finger blood pressure m easurem ent m ethod has been 
widely studied and has proven to be feasible and reliable in  adult subjects (7,8). Accuracy 
and precision of Nexfin™ in adult patients are com patible with the standards of the 
Association for the A dvancem ent o f M edical Instrum entation (AAMI) tha t allow a m axi­
m um  bias o f 5 m m H g and a m axim al standard deviation of 8 m m H g (9,10).
The form er Finapres device has previously been studied in children using cuffs originally 
designed for adults. In  these studies there was a significant m easurem ent bias com pared to 
IAP, but the Finapres accurately tracked short-term  blood pressure changes (11-13). 
Recently a research prototype with special adaptations for use in the paediatric population 
(Nexfin-paediatric) was developed by the com pany that developed the Nexfin™  device and, 
in the past, also developed the Finapres device (BMEYE, Am sterdam , T he Netherlands). 
In two recent studies, the accuracy of the new  prototype for m easuring arterial pressure 
in critically ill children under hem odynam ic stable conditions was shown to be acceptable 
com pared to IAP (14,15).
The goal of the present study was to assess the accuracy of Nexfin-pediatric in detecting 
rapid blood pressure changes in young children undergoing congenital cardiac surgery.
M eth o d s
Subjects
We included thirteen children scheduled for congenital cardiac surgery. In all children IAP 
m onitoring was p art o f their routine anaesthetic m anagem ent. Non-invasive finger blood 
pressure m easurem ents were only used for research purposes and not for clinical decision 
making. Because of the non-invasive and observational design of adding finger arterial pres­
sure m easurem ents the local ethics com m ittee approved the study protocol and waived the
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need for inform ed consent. We choose this patient group because of the availability of IAP 
in all children and the m agnitude of the expected blood pressure changes.
Anesthesia
Prem edication consisted of the rectal adm inistration of m idazolam  0.3 to 0.5 m g/kg. In­
duction of anaesthesia was perform ed using inhaled sevoflurane (3 — 8%). G eneral anaes­
thesia was instituted using continuous inhaled adm inistration of sevoflurane (approximately 
3%) and m idazolam  (range 0.2 — 0.3 m g/kg) in  com bination with fentanyl boluses (range 
1 — 5 m icrogram /kg) or continuous infusion (0.1 m ic rogram /kg /m in) at the discretion 
of the attending anaesthesiologist. Muscle relaxation was achieved using pancuronium  
0.2 m g/kg. The trachea was in tubated  using a 3.5 to 6 m m  cuffed endotracheal tube (Mal- 
linckrod, Hazelwood, USA) and the lungs were mechanically ventilated in  a volum e-con­
trolled m ode using tidal volumes of approxim ately 6-10 m l/k g  (Aestiva, D atex-O hm eda, 
M adison, USA).
N orm ocapnia, guided by capnography, was achieved by adjusting the respiratory frequency 
or tidal volume to  m aintain  an end tidal c o 2 tension between 4 — 5 kPa. At the end of the 
surgical procedure, all children were adm itted to the paediatric intensive care unit. Children 
were routinely m onitored using EKG, IAP, transcutaneous arterial oxygen saturation, cap- 
nography, core tem perature, skin tem perature and central venous pressure.
Non-invasive blood pressure m easurem ent
The Nexfin-pediatric is a research prototype that provides continuous, non-invasive finger 
blood pressure in  children. Both the form er Finapres device and the new prototype are 
based upon  the volume clam p principle o f Penaz. A part from  this Nexfin uses the Physiocal 
criteria of Wesseling (16-18). T he device uses an inflatable finger cuff w ith a built-in photo­
plethysm ograph (figure 1). The pressure in  the finger cuff is controlled by a  fast reacting servo 
system. T he setpoint o f the servo is determ ined by the Physiocal criteria and is dependent on 
the visco-elastic properties o f the wall o f the finger arteries. T he Physiocal criteria drive the 
calibrating procedure of the device. This calibrating procedure is perform ed automatically 
and is activated frequently at the start of the m easurem ent, its frequency declines when a 
m ore stable signal is detected. W ith this m ethod the finger cuff never occludes the finger ar­
teries, which m eans tha t the blood flow to the finger is m aintained under all circumstances. 
The pressure in  the inflatable cuff closely resembles the finger arterial pressure (FAP). FAP 
is physiologically lower than  blood pressure m easured at the brachial level which is the most 
com m on site o f blood pressure readings. Also the waveform characteristics are different 
(19,20). To solve this discrepancy, a software algorithm  can be used tha t converts the finger 
arterial pressure to a  reconstructed brachial artery pressure waveform (reBAP) (8,21,22). In 
adults, reBAP is used and displayed real tim e in  the Nexfin™  device. T he Nexfin-pediatric 
also has this capability. However, during this study, the reconstruction of reBAP from  the 
FAP was perform ed off-line solely for research purposes.
Nexfin-pediatric differs from  Nexfin as follows. Specially designed research prototype small 
paediatric finger cuffs in  four different sizes were used to acquire FAP. T he m easurem ent 
device was adjusted for this study and equipped with special paediatric software for servo 
control and physiological setpoint (Physiocal) determ ination. T he device allowed for storing 
FAP and IAP signals sim ultaneously w ith a 200 H z sample rate. Subsequently the stored
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Figure 1
Example o f  a prototype finger c u ff applied in a child o f  2 .5  year (11 kg)
Inflatable cuff Photoplethysmograph
data were processed offline w ith a special software package (Beatscope 1.1, T N O  biom e­
dical instrum entation , A m sterdam , the N etherlands). Beatscope incorporates a software 
algorithm  to convert FAP waveforms to reBAP waveforms. A fter application of the soft­
w are algorithm  for reconstructing the brachial arterial signal the resulting reBAP values 
were stored and  com pared w ith IA P values. T hus we collected the “raw ” finger arterial 
pressure signal (FAP) digitally. Subsequently, we used a software algorithm  offline to p ro ­
duce the reconstructed signal (reBAP). reBAP is considered the standard  and  m ost accu­
rate blood pressure signal from  this device.
Invasive arterial blood pressure m easurem ent
A fter induction  of anaesthesia a 22- o r 24-gauge in tra  arterial ca theter was inserted and 
connected, using standard  low com pliant tubing, to a disposable pressure transducer 
(Edwards Life-sciences, Irvine, CA, USA). T h e  attending paediatric cardiac anaesthetist 
chose the site o f insertion based upon  clinical judgm ent. T he radial and  fem oral arteries 
were the preferred sites. T he brachial arte ry  was only used w hen o ther routes were u n ­
successful. T he pressure transducer was zeroed to am bien t air pressure and  positioned at 
the level of the m id axillary line. A ir bubbles were flushed from  the system before data 
collection. T he in tra-arterial pressure m easurem ent was checked for quality by visually 
inspecting the waveform  and perform ing a square wave test. W ith this test underdam ped 
(extra oscillations) o r overdam ped (slowed upstroke and  loss o f oscillations) pressure sys­
tems can be identified. R outine m onitoring was instituted using the H P  M erlin CM S m o­
nitoring  system (originally a p roduct o f HP, Irvine, USA; Nowadays: Philips, Eindhoven,
130
CHAPTER VIII
the Netherlands). T he m onitor ou tpu t signal was connected  to the N exfin-pediatric pres­
sure m easurem ent device, w hich enabled the registration of the arterial curve w ith 200 
H z sam pling rate.
Recording of IAP and FAP
After IAP was obtained, an appropriate size finger cuff was p laced on the m iddle p h a ­
lanx  of the second or th ird  finger preferably according to the guidelines provided by the 
m anufacturer. In  the child w ith a b rach ial arterial ca theter the cuff was placed on the 
contra lateral hand . In  five children w ith a radial artery catheter the cuff was also placed 
on the contra lateral side in all but one. W hen a fem oral arterial catheter was used either 
h an d  could be taken for finger cuff placem ent. T he same observer (CM H) applied the 
finger cuff in  all experim ents.
An attem pt to  acquire FAP was defined as a p rocedure to apply or reapply the finger cuff 
and start the device until an acceptable finger arterial curve appeared  on the screen and 
the Physiocal calibrating  procedures were infrequent. T he quality o f the FAP curve was 
the p rim ary  consideration and  resem blance w ith the IAp curve was no t checked since 
reconstruction o f the FAP signal to reBAP was n o t perform ed at this stage.
T he h an d  was fixed at the m idaxillary level to  prevent any hydrostatic level errors. FAP 
and IA p  were sim ultaneously and continuously recorded  using the prototype device 
during the whole course of the surgical procedure, w ith exception o f the period on car­
diopulm onary bypass (CPB). A lthough m easurem ent o f FAP is possible during  CPB this 
was n o t the goal o f this study.
Core tem peratu re and  tem peratu re of the palm  of the h an d  to  which the finger cuff was 
attached were constantly m onitored. T he h an d  and fingers were checked regularly for 
signs o f tissue hypoxia or o ther side effects.
Data comparison
As no ted  above d a ta  were analysed off line. We com pared  IAP and reBAP m easurem ents 
o f absolute b lood pressure levels during  a 10 second control period after onset o f a re­
cording session. To determ ine the ability o f reBAP to track  blood pressure changes, we 
identified the 4 largest changes in  IAP during each surgical procedure. This was done 
by analysing the com plete IAP recording afterw ards for the whole procedure. For each 
patien t we searched for large changes in m ean  arterial pressure (MAP) regardless w hether 
these changes were an increase or a decrease in  b lood pressure. In  o rder to select only 
rapid  changes we also searched only for changes th a t occurred w ithin a five-minute tim e 
fram e. Eventually the four largest changes in  (MAP) th a t occurred  w ithin a five-minute 
tim e interval were eligible for fu rther analysis. A t last we com pared  the blood pressure 
values acquired w ith IAP w ith the values of reBAP during a 10 second period  ju s t before 
and after a b lood pressure change occurred.
Statistical analysis
To assess the adequacy of reBAP in determ in ing  absolute b lood pressure levels we com ­
pared  reBAP and  IAP and  calculated bias (reBAP — IAP) and limits o f agreem ent (1,96 
x SD) using the B land A ltm an m ethod  (23,24). O nly one m easurem ent per patien t was 
used for com paring absolute values. To determ ine the accuracy of tracking blood pressure 
changes we com pared the IA p changes to  the changes in  reBAp using the pearson cor­
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relation coefficient and the B land-A ltm an analysis for repeated  m easurem ents (25). D ata 
were checked for no rm al distribution using the K olm ogorov-Sm irnov test. T he influence 
of vasoactive drugs on the m ean  bias was checked using the studen t’s t-test.
T he prim ary  goal o f this study was to  com pare changes in  b lood pressure as m easured by 
reBAP and  IAP. Therefore we considered a correlation coefficient betw een changes in re- 
BAP and  IAP of 0.9 or greater significant. At the same tim e a value of 0.7 (or less) would 
be unacceptable. W hen using a significance level o f 0.05 and  pow er of 0.9 this would 
require a  sample size of 31.7. Since we p lanned  to analyse the four greatest changes in 
blood pressure per patien t this would result in  8 children. Because of uncertain ties w ith 
respect to  technical aspects we included 5 m ore children (total 13).
Calculations and  data m anagem ent were perform ed using Excel for windows (Office 
2007, M icrosoft, Seattle, USA). Statistical calculations were perform ed w ith M edC alc 11 
(M edCalc Software, M ariakerke, Belgium).
Table 1
Patient characteristics
P a ­
tie n t
Age
(month)
W eigh t
(kg)
V a so ac ­
tive
d ru g s
P ro c e ­
d u re
FAP m e a ­
s u r e m e n t  
su c c e ss fu l
T e m p e ra ­
tu r e  o f  th e  
h a n d  (C)
IA P m e a n
(range) (mmHg)
IA P ca ­
th e te r  
s i te
i 47 15 k PA recon­
struction
yes 35.6 42.5 (48.5 - 
110.2)
rad
2 33 12 Fallot yes 33.9 46.9 (33.2-63.5) fem
3 3 5 d VSD yes 37 67.2 (41.7 - 89.7) fem
4 90 31 Ross pro­
cedure
yes 36.4 63.7 (36.2 - 88.0) rad
5 44 13 ASD yes 32.9 64.6 (36.5-77.5) rad
6 3 4 m ,n,d VSD no 33 54.2 (43.2-68.2) fem
7 4 4 VSD no 35 54.8 (38.0-70.7) fem
8 23 15 m ,f Fontan yes 35.5 43.8 (35.0-54.0) fem
9 3 4 m VSD no 33 49.2 (30.8-64.2) fem
10 37 12 m ,f Fontan yes 34.7 53.3 (33.0-68.8) brach
11 2 4 m,n,d VSD yes 31.1 41.0 (19.7-87.2) rad
12 8 7 e Glenn yes 34.4 54.9 (35.0-67.0) fem
13 11 10 m Fallot yes 30.6 55.5 (36.7 - 67.0) rad
Data expressed as mean values (range)
k= ketanserin, d = dobutamine, m = milrinon, f  =fenylephrine, n = nor-epinephrine, e = epinephrine, VSD = ventricle 
septal defect, ASD  = atrial septal defect, Fallot = tetralogy o f fallot, Ross = Ross procedure fo r  aortic stenosis, Glenn 
= bidirectional glenn procedure in case of hypoplastic left heart syndrome, PA = pulmonary artery, rad = radial artery, 
fem  = femoral artery, brach = brachial artery.
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Figure 2
Exam ple o f  a 2 0  second simultaneous pressure recording o f  reBAP and IA P
In the reBAP signal tracing at 10 seconds, a calibration (physiocal) period can be identified 
R e su lts
Thirteen children (ASA class 2-4) with a m edian age of 11 m onths scheduled for congenital 
cardiac surgery were included in the study. All patients had  an adequate IAP signal. In three 
children no finger arterial blood pressure curve could be obtained even after multiple attempts 
with different sized cuffs on different fingers. These children were not different from  the other 
10 concerning type of surgery, baseline blood pressure, heart rate or hand  temperature. The 
overall success rate was therefore 76%. Patient characteristics are described in table 1.
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Figure 3
Changes in IA P  versus changes in reBAP fo r  mean arterial pressure
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The dotted line reflects the line o f equality. The solid line reflects the linear correlation
O n  average, we needed 5 attem pts for each patient (range 1 -  22) to obtain an acceptable 
FAP signal. A total of 1100 minutes of simultaneous blood pressure registration was record­
ed with a m ean of 106 minutes (range 50-180 minutes) per patient. Eventually data from 10 
patients were eligible for further analysis including the 4 largest blood pressure changes per 
patient this resulted in 40 data points for analysis.
D uring anaesthesia, the m ean M AP value m easured intra-arterially was 59.5 m m H g (range 
28.4 m m H g to 106.6 mmHg). An example of an individual tracing of reBAP and IAP is 
shown in figure 2.
C om pared to IAP, reBAP underestim ated SAP by 8.9 m m H g with limits of agreem ent 
(LOA) + / -  20, overestimated DAP with bias of 1.8 m m H g (LOA + / -  11) and overestimated 
M AP with a bias of 0.3 m m H g (LOA + / -  9.3).
T he bias between the two m easurem ent m ethods was not significantly correlated to body 
weight, hand  tem perature or core tem perature with a correlation of -0.53 (95% CI -0.86 -  
0.14), 0.08 (95% CI -0.74 -  0.66 and -0.24 (95% CI -0.84 -  0.62) respectively. T here was no
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Figure 4
B land  A ltm an p lo tfo r A  SAP, D A P  and M A P
A reBAP (the magnitude of the blood pressure change) is compared with A  IAP for systolic, diastolic and mean arterial 
pressure. Mean difference (bias) is indicated by the solid line, limits of agreement (1.96 x SD) by the dashed lines.
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difference in  bias between IAP m easured at the radial and reBAP or IAP m easured at the 
the fem oral artery and reBAP
ch an g es in blood pressure m easured with reBAp and IAp were highly correlated w ith an r2 
o f 0.96 for SAP, 0.97 for DAP and 0.98 for M AP T he changes in MAP are shown in Figure 
3. reBAP tracked changes in  IAP with a m ean bias for systolic, diastolic and m ean  arterial 
pressure of 0.0 m m H g (SD 5.8), 0.1 (SD 2.8) and 0.2 (SD 2.7) respectively (Figure 4).
D isc u ss io n
O u r study dem onstrates th a t reBAP m easured w ith the prototype N exfin-pediatric is ca­
pable of tracking blood pressure changes in  children undergoing congenital cardiac sur­
gery. A lthough several previous studies have been  perform ed in  children using the form er 
Finapres device, this is the first study to  use finger cuffs and  software especially designed 
for small children during  m ajor surgery. T he accuracy of reBAP in determ in ing  absolute 
blood pressure was com parable to  a previous study perform ed in critically ill children
(14).
Unfortunately in almost 25%  of patients a FAP signal was not obtainable after induction of 
anaesthesia. This is different from  previous studies perform ed in small children adm itted to 
an IC U  and from  studies in adult patients where reBAP shows a success rate o f 97%  (8,12­
15,26). Besides a lower success rate the absolute difference between reBAP and IAP was 
com parable with the previous study (14). T he lower success rate m ay be explained by the use 
o f volatile anaesthetics, the occurrence of core hypotherm ia and a decreased environm ental 
tem perature in  the operating theatre. Volatile anaesthetics m ay reduce peripheral blood 
flow (27). However, after induction, intra-arterial diastolic pressure dropped to  an average 
of 46 m m H g, which was only slightly lower than  the pressures m easured in previous studies. 
Core hypotherm ia, which com m only occurs during surgery, causes vasoconstriction in digi­
tal arteries, which reduces blood flow. T he use of sevoflurane im pairs this therm oregulatory 
response, lowering the threshold for peripheral vasoconstriction to 35.1° C (28). However, 
hand  tem perature was not significantly lower in those patients where a non-invasive signal 
was unobtainable.
W hen assessing the accuracy of a  new  m easuring device, one has to ensure an appropriate 
“gold standard” for com parison. W hen a gold standard does not exist, a  new m ethod has 
to be com pared to the next best m ethod. In  this particular study we used the intra-arterially 
m easured blood pressure. However, the adequacy of the IAP, systolic pressure in  particular, 
is affected by the quality of the pressure waveform (29). Therefore, m easurem ent discrepan­
cies between reBAP and IAP m ay also result from  m easurem ent errors in IAP, although an 
adequate IAP signal was obtainable in every patient.
A lim itation of this study is the use of different catheter insertion sites for the m easurem ent 
of IAP, although we were unable to detect significant differences in  bias between various 
arterial catheter insertion sites. Also, there was no relationship between bias on the one hand  
and core tem perature, h and  tem perature, and use of vasoactive drugs on the other.
136
CHAPTER VIII
Despite a  recording period of several hours we didn’t encounter any side effects. This is in 
agreem ent with previous studies in children (12-15).
The research prototype type and the paediatric finger cuffs need further developm ent for 
clinical use in a next version of this device. Also, this version of the software algorithm 
for reconstructing the brachial arterial signal is designed for adults. A lthough it perform ed 
acceptably in  an earlier paediatric study, a further im proved version for a paediatric po­
pulation is currently under construction (14). This further im provem ent is based upon  the 
different elastic properties o f arteries in  children com pared to  adults (19). Thereafter, more 
research is needed to  evaluate the accuracy of this new technique in children. W ith regard 
to the commercially less interesting paediatric m arket this developm ent poses a  challenge to 
every m anufacturer.
In  adults the Nexfin technology is capable of m easuring cardiac output using a reconstruct­
ed brachial arterial pressure curve. This m ay be a valuable adjunct to Nexfin-pediatric 
(30,31). Also the reBAP signal could be used for determ ining fluid status using arterial pres­
sure variations (32). In  certain  cases where a fast continuous technique is vital, such as em er­
gency medicine, anaesthesia and critical care medicine, a non-invasive finger sensor device 
could prove to be effective. Also, given the non-invasive nature of the m easurem ent, this 
continuous technique could be valuable for research purposes.
C o n clu sio n
Continuous non-invasive reconstructed brachial artery pressure from  finger blood pressure 
adequately reflects intra-arterial blood pressure changes in  children during cardiac surgery. 
However the m easurem ent in  the operating theatre using this prototype can, at the present 
state of development, still be tim e-consum ing and has a significant failure rate. W ith further 
development, this technology could be useful for m onitoring blood pressure in children in 
the clinical setting.
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CHAPTER IX
A b stra c t
Cardiac output (CO) m easurem ent is becom ing increasingly im portant in the field of pedi­
atric intensive care m edicine and pediatric anesthesia. In the past few decades, various new 
technologies have been developed for the m easurem ent of CO. Some of these m ethods are 
applicable to pediatric patients and some are already being used in children. The devices 
and m ethods have their advantages and lim itations and, therefore, it is difficult for the clini­
cian to decide which technique should be used. This article focuses on the currently available 
m inimally invasive and noninvasive m onitoring devices for C O  m easurem ent in children. A 
brief explanation of the technical aspects o f each m ethod and clinical use will be followed 
by the knowledge, gained from  infant anim al and clinical pediatric studies. The goal of this 
article is to give an update of the various C O  m easurem ent technologies in children.
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In tro d u ctio n
Cardiac output (CO) m easurem ent is the cornerstone of advanced hem odynam ic monitoring 
and provides invaluable inform ation for the circulatory m anagem ent of critically ill patients. 
M easurem ent of C O  at the bedside in adults started with the introduction of the pulm onary 
artery catheter (PAC) in 1967 (1). W ith the PAC, C O  can be m easured by employing the ther­
modilution technique, but it requires an invasive right-heart catheterization. The technical 
aspects and the risks involved make the PAC less applicable for children and unsuitable for 
neonates and young children. As a result, C O  m onitoring and concom itant hem odynamic 
m anagem ent evolved strongly in adults, while the development in children lagged behind.
D uring the last decade m ore technologies have becom e available for m easurem ent o f C O  
and additional hem odynam ic variables. Since the new er m ethods do not require the same 
degree of invasiveness as the PAC they are called less or minimally invasive. However, some 
o f these minimally invasive technologies still need arterial and central venous catheters, but 
by also using these catheters for standard treatm ent and pressure m easuring purposes, one 
has two birds with one stone. T he new  technologies have replaced the need for usage of the 
invasive PAC for almost all, except some specific, clinical indications, such as pulm onary 
hypertension. Examples of these new er technologies are several types o f transpulm onary di­
lution techniques, D oppler m easurem ents and arterial pressure curve-based C O  estimates. 
These new devices are in p art also suitable for m easuring C O  in young children, first studied 
a decade ago (9,3). As a  result, hem odynam ic m onitoring in  children is now slowly evolving 
in the pediatric critical care and anesthesia arena.
O ne of the problem s for the pediatric intensivist and anesthesiologist is to decide which 
technique should be used in pediatric patients (4,5). N ot all m ethods are properly validated 
in  children, and conclusions of studies, reviews and editorials concerning adult hem odynam ­
ic m onitoring cannot be extrapolated to pediatric patients (6—13).
This article gives an update on available technologies o f minimally invasive and noninvasive 
C O  m onitoring in pediatric patients.
C lin ica l im p o rta n c e  o f  m e a su r in g  C O
C ardiac output is the am ount o f blood pum ped by the heart every m inute, expressed in 
liters per m inute. It is the product o f cardiac stroke volume and heart rate. Stroke volume 
is determ ined by preload, contractility and afterload. Given that children vary widely in 
weight and height, C O  is norm ally indexed to body surface area ( l/m in /m 2), but can also 
be indexed to body weight (l/m in/kg). Indexing of C O  enables clinicians to  com pare m ea­
sured C O  values between individuals and to established norm al values.
A ccording to  O hm s law, b lood pressure is re la ted  to  C O  and  systemic vascular resistance. 
T herefore, a low b lood pressure is the result of a  low C O , a low periphera l resistance or 
both . Since b lood pressure is essential for the perfusion of organs and  tissues, it is m ain ­
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ta ined  by several regulating  systems in  the body, the m ost im p o rtan t being  the baroreflex. 
W hile b lood pressure is im p o rtan t as the driving perfusion pressure, C O  is im portan t for 
delivering oxygen to  the tissues. This oxygen delivery is reflected by the m ultiplication 
of CO , hem oglobin  level and oxygen saturation. W hen indicated , C O  can be increased 
by various m easures, for instance volum e therapy  to increase preload, vasoactive m ed­
ication to increase contractility  and  vasodilating agents to  decrease systemic vascular 
resistance.
Clinical estim ation of CO, although still frequently practiced, poorly correlates with the 
true value of C O  (14,15). M easurem ent o f C O  is, therefore, imperative to determ ine the 
hem odynam ic status o f the patient, to initiate the appropriate therapy, to follow the patien t’s 
response to therapy and, thereby, to  prevent organ dysfunction.
H ow  to  in te rp re t  s tu d ie s  c o m p a r in g  d iffe ren t C O  tech n iq u es
The num ber of studies validating C O  m easurem ent in  children is lim ited and almost all 
include small num bers o f patients or animals. Additionally, the m ethodology varies between 
several studies. To clarify the differences between these studies, we will briefly m ention two 
general aspects o f the m ethods used: which reference m ethod is used and how the results 
are analyzed.
W hen validating a C O  technique, the new  technology should be com pared  w ith a gold 
standard  reference technique. This reference technique should be accurate in  m easuring 
true  values, should have a small variability and  should provide reproducible results. Fi­
nally, the reference m ethod  itself should n o t influence the m ethod  being  tested. To our 
knowledge, the best in  vivo m ethod  o f m easuring  C O  is the use o f u ltrasound  transit 
tim e flow probes. These flow probes should preferably be positioned around  the pu lm o­
nary  artery, since positioning the p robe around  the ascending ao rta  will result in  a C O  
value no t including flow to the coronary  arteries (16). U ltrasound  flow probes have a 
docum ented  variability less th a n  10%, provide real-tim e continuous C O  values and  do 
n o t need  calibration. M easured  values closely resem ble true  C O  (17—19). Flow probes, 
being  highly invasive, are norm ally  only feasible in  anim al models. Therefore, w hen stu­
dying C O  m easurem ents in  hum ans, o ther less reliable m ethods are used for validation. 
C om paring  C O  m easuring  devices using a less reliable reference m ethod  can  therefore 
lead to  erroneous results.
The clinical standard in  adults for m easuring C O  is the pulm onary artery therm odilution 
(PATD) technique. In pediatric patients, m ethods such as the Fick technique and transpul- 
m onary therm odilution (TPTD) have been regarded as sufficiently precise and accurate to 
act as a clinical gold standard (3,20,21).
The appropriate statistical analysis for com paring two m easurem ent technologies is well 
described but not always sufficiently practiced. C orrelation coefficient and regression analy­
ses are inappropriate statistical techniques for com paring two m ethods m easuring the same 
physiological variable, such as CO. In 1986 Bland and A ltm an proposed a new  statistical
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m ethod (22). This m ethod delivers graphical inform ation in which the difference between 
the two m ethods is p lotted against the m ean values of the two methods. U sing this statistical 
analysis, the agreem ent by m ultiplying the standard deviation of the difference between the 
m ethods by 1.96. The limits of agreem ent reflect the boundaries between 95%  of all m ea­
surem ent values tha t are positioned in the plot.
Additionally, Critchley and Critchley recom m ended using the percentage error to com ­
pensate for the relationship between the m agnitude of C O  m easurem ents and the size of 
the error, especially im portant for pediatric patients, who have lower absolute C O  values 
com pared with adults (23).
The percentage error can be calculated by taking the percentage of the limits of agreem ent 
in relation to the m ean C O  m easurem ent value of the reference technique. T he percentage 
error can be used as cutoff value for accepting a new technique. The basis of this approach 
is that, in order to accept the new  technology, the level of accuracy and precision should 
be at least equal to  the reference technique. They suggest acceptance of a new  m ethod 
judged  against the ±20%  precision of the reference m ethod and consequently accept the 
percentage of error of agreem ent between the new  and the reference technique of up  to 
±30% . This shows that the precision of the reference technique is extremely im portant 
when assessing the com bined error of the two. Therefore, the precision of the reference 
m ethod should always be m entioned and any validation study should start with a definition 
of acceptable percentage error (using the error-gram  of Critchley and Critchley) prior to 
the data  analyses (23,24).
By using the m ethod  proposed by Critchley and Critchley in  ped iatric  studies there m ight 
be an im portan t drawback. T he percentage error is calculated by using the m ean  of a 
range of absolute C O  values. W hen the limits o f agreem ent (e.g., the errors in  m easure­
ment) are p roportional to  the m ean  C O  value, the percentage erro r will be com parable 
betw een high and low C O  samples. For instance, in  com paring a pediatric and an adult 
study validating the transpulm onary  therm odilu tion  technique, the m ean  C O  value was 
2.55 l /m in  in the ped iatric  study and 8.8 l /m in  in  the adult study. T he limits o f agree­
m en t were 0.49 l /m in  in  the pediatric and  2.2 l /m in  in the adult study (3,25). Thus, the 
percentage erro r was even smaller in  the pediatric study. However, due to technical rea ­
sons, errors in  the m easurem ent m ay also have an absolute character and m ay n o t solely 
be proportional to the m easured value. In  these cases, the limits o f agreem ent would be 
relatively larger com pared  w ith the m ean  value, resulting in  a larger percentage error in 
subjects w ith lesser weight or lesser size.
Besides analyzing the accuracy of a new  technique to reflect absolute values of CO, the 
ability to track directional changes should be carefully studied (26). This is becom ing more 
im portant since changes in  C O  as a result of therapeutic interventions are frequently 
considered m ore valuable than  single m easurem ents.
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In d ic a to r  d ilu tion  m e th o d s
Indicator dilution m ethods are based on m easuring the change of concentration over time 
of an indicator at a point dow nstream  following a venous injection. In  doing so, the flow is 
inversely proportional to the area under the concentration—tim e curve for the indicator as 
shown in the Stewart—H am ilton equation:
Flow = mass o f  indicator /  \C (t) x  dt
Indicator dilution methods, regardless o f w hat indicator is used, have to fulfill the follow­
ing conditions: constant blood flow, no or m inim al loss of indicator between injection and 
detection point, com plete m ixing of the indicator with blood and the indicator must pass 
the detection point only once (27). Almost all indicator dilution m ethods require a central 
venous catheter and an arterial catheter. Sequential injections of the indicator are per­
form ed as soon as the dilution curve is back to  baseline. This prevents recirculation bias 
between separate measurem ents. D uring a single therm odilution, the dilution curve is in ­
terrup ted  at the downslope p art based upon a specific algorithm  to prevent the effects of 
recirculation (28). Subsequently, the curve is extrapolated from  the in terrupted  point to the 
baseline in  order to  calculate the area under the curve (AUC) (29,30).
Transpulm onary therm odilution CO
The T P T D  technique uses therm al energy as an indicator. In  contrast to PATD, the trans- 
pulm onary approach uses a large (mostly femoral) systemic artery in  which the tem perature 
change is detected. Since T P T D  does not require the insertion of the pulm onary artery 
catheter, this m ethod is considered ‘less invasive’. Moreover, no extra catheters have to be 
inserted because this special therm istor-equipped arterial catheter can also be used as an 
arterial catheter for continuous blood pressure m easurem ent and blood sample drawing. 
A central venous catheter for the injection of an ice-cold indicator is needed, but is often 
already employed in patients where C O  m onitoring is indicated. T he m inim um  size of 
the therm istor tipped arterial catheter is 3-French, which makes it accessible for infants 
weighing as little as 3.5 kg (31,32). Furtherm ore, a special device is needed to com pute the 
m easured values pulse-contour C O  (pulse-induced contour C O ; PiCC O ™ ) (Table 1).
Several ped iatric  or juvenile anim al studies showed T P T D  to be a reliable technique for 
C O  m easurem ent. Lem son et al. validated T P T D  C O  m easurem ents, w ith ultrasound 
perivascular flow probes serving as the standard  reference, under various hem odynam ic 
conditions (20). T he study was perform ed in  new born  lam bs as a  surrogate for infants. 
C O  m easurem ent was also reliable in  a low C O  state w ith a percentage erro r o f ±14.7% . 
Besides m easuring absolute values, the T P T D  m ethod  was also reliably capable of track­
ing changes in  CO. Ruperez et al. com pared  T P T D  w ith PATD in juvenile anim als and 
dem onstrated  m oderate agreem ent (percentage erro r o f ±33% ) (33). C linical pediatric 
studies dem onstrated  the m ean  of a series o f th ree T P T D  m easurem ents, spread ran d ­
omly over the respiratory  cycle, to  be a reliable and validated m ethod  for estim ating C O  
in children (34). Pauli et al. used the direct Fick m ethod  as the clinical reference standard 
and found a percentage error of ±11% . O th er pediatric clinical studies used the indirect 
Fick m ethod  (indirect calorim etry) and  PATD as a reference m ethod  for C O  m easure-
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Technologies fo r  measuring cardiac output
R eference technology re fe ren ce
m e th o d
su b jec ts w e ig h t o f  
su b jec ts  (kg)
n u m b e r  o f  
su b jec ts
ra n g e  o f  C O  
(1/min)
b ia s
(1/min)
lim its  o f  a g re em e n t 
(1/min)
PE  (%) r 2
Lemson et al (20) TPTD UFP lambs 4 .2-12.5 11 0 .4 -3 .1 0.2 0.24 14.7 0.95
Riiperez et al. (33) TPTD PATD Hgs 9 -1 6 16 0 .9 -5 .6 0.28 0.63 30 0.86
Pauli et al. (34) TPTD 0 2  Fick humans 4 .3 -8 8 18 0 .4 -6 .2 0.06 0.38 10.7 0.99
Tibby et al. (3) TPTD 0 2  Fick humans 2 .5 -60 24 0 .24-8 .7 0.03 0.49 19 0.99
Mcluckie et al (2) TPTD PATD humans 9 .8 -23 .7 9 3 -5 .3 0.19 0.42 9.5 NA
Piehl et al. (66) TPTD PATD pigs 24-37 10 0 .8 -6 .0 0.14 0.47 11.6 0.96
Linton et al. (47) TPLD TPTD humans 2.6 - 34 17 0 .4 -6 .0 -0.10 0.62 31.8 0.96
Taguchi et al. (57) PDD, prototype UFP pigs 7.5 -14.0 15 NA 0,034 0,59 65& NA
de Boode et al. (59) TPUD UFP pigs 3 .5 -7 .0 9 0 .4 6 -1 .9 0.04 0.26 26,9 NA
Lopez-Herce et 
al. (65)
APGGO
(HGGO)
TPTD pigs 9-16 51 0.52-4.22 0.04 1.10 62.7 0.41
Piehl et al. (66) APGGO
(HGGO)
PATD pigs 24-37 10 0 .8 -6 .0 0.11 0.45 11 0.97
M ahajan et al. (67) APGGO
(HGGO)
TPTD humans >10 16 1.4-9.7 (indexed) 0.08 1.98 54 0.53
Fakler et al. (68) APGGO
(HGGO)
TPTD humans 10.6-35.6 24 1.86-7.04
(indexed)
0.05 0.8 20& 0.86
Kim et al. (69) APGGO
(IiDCO)
TPLD humans 13-77 20 1.9-5.9 (indexed) 0.19 0.28 8.8 0.88
Calamandrei et 
al. (76)
PRAM transthoracic 
echo doppler
humans 2 -4 5 48 0.89 -  7.48 0.12 0,6 20.3 0.98
Tibby et al. (85) Oesophageal
doppler
TPTD humans 3 -7 0 100 0 .3 2 -9 .1 9 NA NA NA 0.82
Schubert et al. (88) Oesophageal
doppler
transthoracic 
echo doppler
humans 2 .6 -4 7 26 2.3 (SD ±1.4) 0.36 1.67 77.7 0.72
C
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Continued Table 1
Technologies fo r  measuring cardiac output
R eference techno logy re fe ren ce
m e th o d
su b jec ts w e ig h t o f  
su b jec ts  (kg)
n u m b e r  o f  
su b jec ts
ra n g e  o f  C O  
(1/min)
b ia s
(1/min)
l im its  o f  a g re e m en t 
(1/min)
PE (%) r 2
Knirsch et al. (89) Oesophageal
doppler
PATD humans 3 .4 -59 .4 40 1 .2 -7 .1 0.66 1.79 54.3 0.65
Critchley et al. (95) TC D U  (US- 
GOM)
UFP dogs 11-22 6 0.9-5.6 -0.01 0.33 13 0.87
Knirsch et al. (91) TC D U  (US- 
GOM)
PATD humans 3 .4 -51 24 1.3 -  5.3 -0.13 1.34 36 NA
Botte et al. (99) GO, Fick transthoracic 
echo doppler
humans 15-60 21 1.82-9.96 -0.61 0.94 20 0.85
Levy et al. (100) GO, Fick PATD humans 9 .2 -4 7 .4 37 1 .2 -5 .4 -0.27 1.49 53& 0.69
de Boode et al.
(103)
modified GO, 
Fick
UFP lambs 2 .9 -6 .4 7 0 .2 -1 .4 0.08 0.25 35& 0.86
Osthaus et al. (106) EV TPTD pigs 11 .2 -13 .8 5 0 .2 9 -4 .5 -0.63 1.28 83 0.67
Tomaske et al.
(107)
EV PATD humans 0.5-16.5 50 0 .6 -7 .2 0.66 1.49 43.8 0.79
Tomaske et al.
(108)
EV transthoracic 
echo doppler
humans 3.4-59.4 36 0.62-6.27 0.31 1.92 67.7 0.56
Norozi et al. (109) EV 0 2  Fick humans 2 .7 -5 4 32 0 .4 -4 0.01 0.46 38& 0.94
Schubert et al. (88) EV transthoracic 
echo doppler
humans 2 .6 -47 13 2.3 (SD 1.4) 0.87 3.26 159& 0.77
Note: when interpreting validation data we advise to use mainly the Bland Altman method (looking at bias and limits of agreement) and the percentage error.
APCCO  =  arterial pressure based continuous cardiac output; TP TD  =  transpulmonarv thermodilution; TPLD  =  transpulmonarv lithium dilution; TPUD  =  transpulmonarv 
ultrasounddilution; PDD  =  pulse dve densitrometrv; P R A M  =  pressure recording analytical method; UFP =  ultrasound flow probe; E V  =  electrical velocimetry; TCD U  =  Trans- 
cutaneous continuous wave Doppler ultrasound.
NA  =  not available; PE  =  percentage error; & =  value not provided in article but deductedfrom graphical data.
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Table 2
Devices fo r  measuring cardiac output in children
N a m e
(M a n u fa c tu re r )
T ech n o lo g y In v a s i­
v e n e s s
E q u ip m e n t R e liab il ity  
in  c h ild re n
R e m a rk s
p i c c o
(Pulsion, M unich, 
Germany)
t p t d  +
A p c c o
+ + + special A c  + c V c + + + M ultiple hemodynamic 
param eters, continuous, 
gold standard in children
L id c o
(LidCO, London, 
UK)
t p l d  +
A p c c o
+ + A c  + c V c  or p v c + + + Continuous, requires 
injection of lithium, not 
for children < 40 kg
D D G  2001 
analyzer 
(Nihon Kohden, 
Tokyo, Japan)
p d d + / - p v c
Finger/nose clip
Non-invasive, interm it­
tent, no validation in 
children
c o s ta tu s  
(Transonic, 
Ithaca, USA)
t p u d + + + A c  + c V c Interm ittent, no valida­
tion in children
Flowtrac/Vigileo 
Edwards Lifes- 
ciences, Irvine,
USA)
A p c c o + A c Continuous, calibration 
not possible. No valida­
tion in  children
M ostcare  
(Vytech, Padova, 
Italy)
A p c c o + A c + /- Continuous, calibration 
not possible
C ardioQ P 
(Deltex, Chiches­
ter, U K  )
oesophageal
doppler
+ / - oesopagus probe + /- No intravascular cathe­
ters needed. difficult in 
small children
u s c o m
(Uscom, Sydney, 
Australia)
Transcutaneous
Doppler
- external doppler 
probe
+ /- Non-invasive, in term it­
tent, operator dependent
N ic o 2
(Respironics, 
Paris, France)
c o 2 fick  rebre­
athing
+ / - endotracheal tube Non-invasive, only in 
intubated patients with 
Tv > 300 ml
Aesculon 
(Osypka medical, 
Berlin, Germany)
Electrical
im pedance
cardiometry
- surface electrodes + /- Non-invasive, continuous
N ic o M
(Cheetah M e­
dical, Tel Aviv, 
Israel)
bioreactance surface electrodes Non-invasive, continuous
Nexfin
(BMEYE,
Amsterdam,
Netherlands)
A p c c o finger cuff Non-invasive, also m ea­
sures continuous blood 
pressure, no calibration 
incorporated, not for 
small children
+ and - symbols represent the degree o f invasiveness or reliability (e.g., + + +  =  reliable or invasive, - = not invasive or 
less reliable).
A C  = arterial catheter; APCCO = arterial pressure based continuous cardiac output; CVC = central venous catheter; 
PDD = pulse dye densitrometry; PVC = peripheral venous catheter; TPTD  = transpulmonary thermodilution; TPUD  
= transpulmonary ultrasounddilution.
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m ents (2,3). They dem onstrated  acceptable agreem ent (Table 2). In  addition, these studies 
confirm ed tha t T P T D  slightly overestimates CO. In  conclusion, the T P T D  appears to  be 
accurate and  can be considered as a reference standard  for C O  m easurem ent in  children 
(21). In  the presence of cardiac shunts, the P iC C O plus device is capable of detecting and 
quantifying right-to-left shunts (Pulsion Company. P iC C O  operational m anual, software 
version 7.0, p art 8.4.5. 2005). However, validation o f this m ethod  has no t been  published 
and the m ethod  has not been incorporated  in  the successor o f this device. Studies on the 
reliability o f therm odilu tion  C O  m easurem ent in  the presence of left-to-right shunts are 
n o t conclusive (35,36).
Besides C O  m easurem ent, the T P T D  technique also allows for assessment of global end 
diastolic volume and extravascular lung water. Global end diastolic volume is related to 
preload and extravascular lung w ater is a  quantification of pulm onary edem a (37,38). The 
results o f in trathoracic and intracardiac volumes and extravascular lung water volume in 
juvenile animals and children are different from  adult reference values (39,40). Further stud­
ies are needed to define norm al values in the pediatric range and clarify the clinical value 
of these m easurem ents (39—42). W hen using the P iC C O  device, additional continuous C O  
m easurem ent is possible using pulse contour analysis (see later).
W hen using the T P T D  technology some points are of im portance. A fem oral venous cathe­
ter can be used for indicator injection (27,40,43). However, the use of venous and arterial 
fem oral catheters on the same side of the body and of the same length should be avoided. 
Local extravascular distribution of the therm al indicator can reach the arterial therm istor 
before the tem perature change by blood does. This phenom enon is called ‘crosstalk’ and 
is blood-flow dependent (44,45). Finally, the absolute values of C O  are always slightly, but 
consistently, overestimated because of tem perature loss.
Lithium dilution CO
The transpulm onary lithium  dilution C O  m ethod (TPLD) uses an isotonic solution of li­
th ium  chloride (LiCl) as the indicator and requires a venous and arterial catheter, usually 
already in place, and a specially developed lithium  sensor (46). After venous injection of 
LiCl, arterial blood is w ithdraw n by m eans of a m echanical device through a lithium  sensor, 
and C O  is derived from  the lithium  concentration—tim e curve. Each m easurem ent requires 
approxim ately 3 m l of blood. The sensor consists of a lithium-selective electrode. W hen 
the lithium-selective m em brane is in contact w ith blood, the voltage across it is related to 
plasm a lithium  concentration following the N ernst equation together with a correction for 
plasm a sodium concentration. The TPLD  technique is incorporated  in  the lithium  dilution 
C O  (LiDCO™ ) device (see Table 1).
There is currently one study in  pediatric patients validating TPLD  C O  m easurem ents. 
Using T P T D  as the reference technique, the results dem onstrate its safety and feasibility in 
patients who weigh as little as 2.6 kg. From the data  the percentage error could be recalcula­
ted, which was quite acceptable (±32%) with a percentage of the bias o f 5% (47).
The TPLD  m ethod does not require a special arterial or venous catheter. Like the PiCCO, 
the L iD C O  device offers the advantage of continuously m onitoring C O  using an arterial 
pressure-based C O  technique (see later). Several points should be considered. Each m easu­
rem ent takes approxim ately 3 m l of blood, which is a significant am ount for small infants.
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Since the m ean of two to three m easurem ents is needed, this would take up to 10 m l of 
blood loss for each C O  m easurem ent, which is not acceptable for small children. TPLD 
cannot be used in  the presence of some non-depolarizing neurom uscular blocking agents 
and the baseline lithium  level at the start of the m easurem ent should not exceed 0.2 m E q /l 
(48). The curren t intravenous LiCl dose recom m endation for adults is 0.15 m m ol for every 
single C O  m easurem ent, with a m axim um  cumulative dose of 3 mmol. T he dose used in 
children for a single C O  m easurem ent is 0.002—0.009 m m ol/kg, which has no known phar­
macological effect (48,49). In  some countries, the use of LiCl as an indicator is prohibited 
by law, and the device has not yet acquired a U S  FDA registration for children weighing less 
than  40 kg.
Pulse dye densitom etry
W ith pulsed dye densitometry, in term ittent C O  m easurem ents can be obtained at the bed­
side by using a finger or nose clip device and a dye densitogram  analyzer (DDG2001 anal­
yzer, see Table 1).
This technique is based on  a dye (indocyanine green) dilution technique w ith a transcuta- 
neous signal detection adapted  from  pulse oxim etry (50). In  contrast to the conventional 
dye dilution m ethod, this technique does not require b lood sam pling after the venous 
injection of indocyanine green. C O  and  circulating b lood volume can  be calculated by 
analyzing the pulsatile change in  indocyanine green concentra tion  in  the arterial blood 
by placing a probe over arterial vessels. A ppropriate signal detection is m andato ry  and 
high h eart rate , poor peripheral circulation, in terstitial edem a and m ovem ent artifacts 
negatively influence this.
Studies in adults are limited, and recent data  regarding reproducibility and validity of the 
pulsed dye densitom etry m ethod are conflicting (51—53). A lthough the first (experimental) 
studies in  pediatric animals and patients applying blood volume and c o  m easurem ents are 
published, the technique has not been validated (54—57). T he applicability in  clinical p rac­
tice is, therefore, as yet unknown.
Ultrasound dilution m ethod
The ultrasound dilution technology was first introduced in  adult patients during hem odi­
alysis and is still under development. T he m ethod uses an extracorporeal arterial-venous 
tubing loop, connected to  existing intravascular central venous and arterial catheters, in 
which the indicator is injected. A roller pum p provides a constant blood flow through the 
loop and the system needs to be prim ed once at the beginning of every series o f C O  m ea­
surements. N orm al isotonic saline, heated  to body tem perature, is used as the indicator. The 
difference of velocity of ultrasound between blood and isotonic saline induces a decrease in 
ultrasound velocity, which is used to obtain a dilution curve (58). The average of two to  three 
consecutive injections spread random ly over the respiratory cycle is advised for obtaining an 
accurate value of C O  (59). T he volume of the injectate is 0.5 m l/kg, w ith a m axim um  of 30 
ml. O perato r errors are reduced because flow sensors m easure exactly the injectate volume, 
whereas dilution sensors in  the arterial part m easure ultrasound velocity.
The technique was accurate and precise in  the C O  range of less than  1.5 l/m in  in a piglet 
study (59). T he first data  o f pediatric use are available, but m ore hum an  studies are needed 
to further assess the reliability of this m ethod in  various clinical situations for infants and 
children (60).
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The use of a nontoxic, low volume and w arm ed injectate makes it attractive for infants and 
children, as well as for patients who are at risk for fluid overload. As with the T P T D  techni­
que, this m ethod also provides static hem odynam ic variables, such as central blood volume, 
total end-diastolic volume and active circulation volume, for all o f which the clinical utility 
has yet to be evaluated.
A rte ria l p r e s su r e - b a se d  C O  m e a su re m e n t
Arterial pressure-based continuous C O  m easurem ent (APCCO) converts the arterial pres­
sure wave into CO. It is based upon  the principle that the stroke volume of one heartbeat 
generates a corresponding arterial pressure wave. U sing an A PC C O  m ethod, the pressure 
wave is converted back into stroke volume.
Several different algorithms for converting the pressure waveform to stroke volume exist; 
different m ethods are also employed for taking the m ean value of several heartbeats and 
for converting stroke volume to C O  (61). Several facts regarding the A PC C O  systems for 
use in  children are of im portance. First, the pressure waveform is largely dependent on 
the Windkessel function of the aorta. This function is influenced by the aortic compliance, 
which changes over tim e due to patient-related factors, but also by changes in blood pressure 
itself. Second, the arterial pressure waveform changes from  central (aorta) to peripheral (ra­
dial) positions. In  general, the systolic pressure increases and the diastolic pressure decreases 
going downstream , while the m ean  pressure rem ains the same as a result o f the reflection 
of the arterial waveform. This effect is also dependent on patient-related (static) factors, 
such as age and m edication (dynamic), by influencing vascular tone. Third, these systems 
have to rely on an optim al arterial pressure waveform. Therefore, an optim al arterial pres­
sure transducing system has to be used with low com pliant tubing, fast-reacting pressure 
heads and careful calibration. Especially in  small children, kinking of catheters, dam ped 
waveforms and m ovem ent artifacts often exist due to the small size of the arterial catheters 
in these patients. Fourth, cardiac rhythm  disturbances will influence these systems. Fifth, all 
algorithms used are designed for adults and do not address specific vascular properties that 
are applicable to  a growing and developing vascular system (62). O w ing to these variables, 
it is challenging to  m easure C O  reliably by only converting an arterial waveform to volume 
w ithout knowing the individual patient-related factors.
The available A PC C O  systems are P iC C O , PulseCO  (LiDCO), F loTrac/V igileo™  system, 
pressure recording analytical m ethod (PRAM; M ostCare® ) and Nexfin (formerly Model- 
flow) (Table 1). They all use their own specific algorithms and m ethods for converting the 
pressure wave to volume. Pulse-contour and pulse C O  use a second C O  technique for cali­
bration. The F loTrac/V igileo system uses a stored database of m any patients as reference 
for calibration. The other systems (PRAM, Nexfin) are independent of patient characteris­
tics or calibration. T he systems incorporating a second calibrating C O  m easuring technique 
have the advantage over other m ethods that they also provide volum etric data, which may 
be helpful in targeting fluid therapy. However, the techniques used for calibration have their 
own (technical) limitations.
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Pulse-contour
T he pulse-contour analysis o f the P iC C O  system requires an initial calibration using 
TPT D . Furtherm ore, periodic recalibration  is necessary on a regular basis, at least every 
8 h, or m ore frequently w hen patien t-related  factors change (63,64).
Lopez-H erce et al. studied the correlation  betw een C O  m easured by T P T D  and P iC C O  
in an infant anim al m odel (65). Based on the correlation coefficient, the au thors conclu­
ded th a t there was a good agreem ent, but on recalculating the percentage erro r (±63% ) 
the m ethod  should have been  rejected. Piehl et al. dem onstrated  in  a piglet hem orrhagic 
shock m odel a percentage erro r of 11% betw een P iC C O  and  PATD under stable hem o­
dynam ic conditions (66). O n  the o ther hand , P iC C O ’s utility in  the setting o f rapidly 
changing hem odynam ics was lim ited unless recalibration  w ith T P T D  was frequently p er­
form ed.
A study in  pediatric cardiac surgery patients showed no good agreem ent (percentage er­
ro r ±54% ) betw een C O  m easured by T P T D  com pared  w ith P iC C O  (67). Part o f the 
explanation is found in  the ir study population. Some patients h ad  in tracard iac shunts and 
valvular diseases, which m akes bo th  C O  m easurem ent techniques unreliable. However, 
the weak agreem ent persisted even after the congenital defects were corrected. From  an­
other pediatric study, the results for accuracy and precision cannot be reliably recalculated 
(68).
In  our opinion, the pulse-contour analysis algorithm  has to  been refined, especially for 
use in  ped iatric patients and  in changing hem odynam ic conditions. T he small patien t size 
w ith small absolute C O  values, very high heart rates, ab rup t changes in  b lood pressure 
and the greater com pliance of the child’s aorta, affects the accuracy and  precision of 
P iC C O  analysis. Therefore, using the P iC C O  system in children, the continuous pulse- 
contour system can be used as a rough estim ate of CO. However, im portan t therapeutic  
decisions should be based on the m ore reliable T P T D  C O  m easurem ents.
PulseCO
The PulseCO m ethod, incorporated  in  the L iD C O  device, converts the arterial waveform 
to a nom inal stroke volume using a pressure-volume transform ation (48). By using the entire 
pressure waveform rather than  ju st the systolic portion of the curve, the PulseC O  system in­
corporates the influence of peripheral resistance and the reflected wave from  the periphery. 
The C O  estimations are periodically calibrated by the TPLD  technique, com parable to the 
pulse-contour m ethod.
The m ethod has been validated in a pediatric study com paring pulse c o  against pATD 
under hem odynam ically stable conditions (69). This resulted in very precise (percentage er­
ror of 8.8%) and accurate (relative bias 6%) m easurem ents. T he m ethod seems promising, 
but further studies under various hem odynam ic conditions are w arranted. Like the PiC C O  
system, the accuracy and precision are dependent on the frequency of recalibration. Also 
with this m ethod, we would like to advise tha t im portant clinical decisions are based upon 
the m ore reliable TPLD  technique.
FloTrac/Vigileo system
The F loTrac/V igileo system is a  C O -m onitoring system based on analysis o f the systemic 
arterial pressure wave, which does not require calibration. T he stroke volume is derived by
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the application of a proprietary algorithm, using the patien t’s vascular resistance and arte­
rial com pliance based on sex, height, weight and age, and the pulse pressure waveform char­
acteristics (70). T he pulsatility is derived from  continuous analysis of the shape of the arte­
rial pressure waveform. T he technique involves determ ination of the area under the arterial 
pressure curve, thus quantifying the relationship between the am ount o f blood flow and 
the pressure wave associated with it. This relationship can vary widely from  one individual 
to another, but also in a single individual as clinical conditions change. By using the afore­
m entioned system, the second-generation operating F loTrac/V igileo system recalculates its 
calibration constant every 60 s and does not provide a beat-to-beat C O  result.
Contradictory results have been obtained in adult, hem odynam ically unstable patients (71 — 
73). However, the algorithm  has been modified, which m ay improve the reliability of the 
device (74). Arterial wave artifacts, aortic regurgitation and an irregular pulse influence the 
m easurem ents unfavorably. As far as we know, no pediatric or infant anim al studies have 
been published using this m ethod.
PRAM
The pressure recording analytical m ethod analyzes the systemic arterial pressure waveform 
m orphology (75). The results o f this beat-to-beat analysis allow for determ ination of the 
stroke volume, which provides C O  by multiplying stroke volume by heart rate. This recently 
developed m ethod has been studied in children by C alam andrei et al. (76). The PRAM  
C O  m easurem ents were com pared with transthoracic D oppler echocardiographic m ea­
surements. Recalculation of their data  shows a percentage error o f 20.3%. T he m ethod 
may be valuable in pediatric patients, but m ore clinical validation studies are warranted.
U ltra so u n d  tech n iq u e s 
Transthoracic echocardiography
Transthoracic echocardiographic assessment o f C O  can be divided into volum etric and 
D oppler-based m ethods (77,78). U sing volumetric m easurem ents of the left ventricular vol­
um e perform ed at the end systolic and end diastolic phase, the stroke volume (end-diastolic 
m inus end-systolic volume), and hence the stroke volume, can be estim ated (79).
The two m ain lim itations of this volumetric m ethod are resolution and geom etry (80). The 
resolution of echocardiography is approxim ately 1 m m  (77). But a variation of 1 m m  in the 
size of the ventricle radius of an infant heart can influence the stroke volume estim ation to 
an im portant extent. T he geom etric lim itations rely on the assumptions of circular or el­
liptical shape of the ventricles and on the uniform  contractions of the ventricles. In  clinical 
practice, this is often not the case.
D oppler-based m ethods require accurate m easurem ent of the pulm onary or aortic valve 
annulus and the velocity profile o f systolic flow through the valve (81). The velocity-time 
integral is known as stroke distance, which is the distance that a colum n of blood will travel 
along the ao rta  in one cardiac cycle. Stroke distance can be converted to stroke volume, and
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hence CO. T he m ajor difficulty is the m easurem ent of the aortic dimensions for the calcu­
lation of the cross-sectional area. This may cause large variations in C O  data  between the 
reference m ethod and D oppler echocardiography (82).
Both these techniques require train ing in echocardiography, which makes it less useful to 
m any intensive care unit practitioners. A nother problem  is the need for the constant re­
alignm ent o f handheld  probes. O n  the other hand, transthoracic echocardiography sup­
plies a vast am ount o f functional, m orphological and thus diagnostic inform ation, including 
indices of diastolic dysfunction, regional wall abnorm alities, valve regurgitation, pericardial 
effusion, cham ber dilatation, cardiac cham ber interdependence, systemic and pulm onary 
blood flow (Q p /Q s  ratio), superior caval vein flow (neonates) and organ flow.
Lu et al. evaluated the accuracy, reproducibility and efficacy of various m ethods of volu­
m etric echocardiographic assessment of left ventricular indices in  children. In  this study, 
M -mode, 2D and 3D echocardiographic algorithms were com pared with cardiac m agnetic 
resonance m easurem ents. T he 3D echocardiography was superior to the other m ethods in 
accuracy and reproducibility for quantification of the LV indices in children (80). Chew et 
al. published a 20-year literature review for D oppler C O  m easurem ent in children, focusing 
on its reliability, bias and precision in  com parison to standard reference m ethods such as 
therm odilution, dye dilution and Fick techniques (82). They concluded tha t D oppler CO  
m easurem ents are reasonably precise, w ith a percentage error o f ±30%  and a percentage 
bias of less than  10% (range: -37—16%) in the m ajority o f studies. However these results are 
operator and thus experience dependent.
Echocardiographic estim ation of C O  in the intensive care unit has several limitations, such 
as technical problems, exam iner variability and costs. Furtherm ore, transthoracic echocar­
diography is, by definition, a noncontinuous m easure of cardiac function and filling status, 
and not useful as a trend  m onitor over hours and days. As such, echocardiography cannot 
be considered to be a C O  m onitoring device. However, it is has becom e an indispensable 
diagnostic tool for critically ill adults and children in m any intensive care units.
Transesophageal Doppler ultrasound method
The transesophageal D oppler ultrasound technique (TED) m easures the descending aortic 
blood velocity. The D oppler probe is positioned in the esophagus at the m idthoracic level 
and placed in  the direction of flow in a blind fashion and is subsequently adjusted to obtain 
the optim al D oppler signal (83). M urdoch and Tibby derived blood flow velocity in  m echa­
nically ventilated children in  the descending ao rta  w ithout the need for direct aortic cross­
sectional area m easurem ent, which is a  m ajor source of error o f D oppler flow m easurem ent 
(84,85). They used signal m inute distance as a  surrogate for CO , which is a tim e—velocity 
integral multiplied by heart rate.
C om pared with the T P T D  technique, in bo th  studies the signal m inute distance was able 
to track changes in  C O  under various hem odynam ic conditions. This property makes TED 
a very useful m ethod for guiding fluid m anagem ent in children (86). However, percentage 
error could not be recalculated from  their data  for C O  m easurem ents. M ohan et al. studied 
tracking changes in C O  with suprasternal D oppler ultrasound and T E D  in children (87). 
Their data  support that TED  seems to be a clinically useful tool in  m onitoring trends in  CO.
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Chew et al. reviewed several pediatric studies o f ultrasound D oppler C O  m easurem ent, 
and concluded that transesophageal D oppler m easurem ents seem to be m ore reproducible 
than  transthoracic echocardiography, with an interobserver repeatability o f 2 .5 -8%  and 
an intraobserver repeatability of ±3%  (82). Schubert et al. com pared T E D  (CardioQP™ ; 
see Table 1) with transthoracic echocardiography for C O  m easurem ent in postcardiac sur­
gery infants and children (88). TED  seemed to underestim ate C O  and recalculation of the 
percentage error resulted in  an unacceptably high value of ±78% . T he Working G roup on 
Noninvasive H aem odynam ic M onitoring in Paediatrics com pared the C ardioQ P™  eso­
phageal D oppler technique in children during heart catheterization with the PATD m ethod 
(89). They conclude that C O  values cannot be reliable m easured with the CardioQ P™  
calculating a percentage error of ±54% .
Technical aspects, such as probe size, fixation and patient tolerance, are lim itations for the 
use of TED. W ith the provision of special pediatric probes, the technique seems safe for 
children and infants (88). O n  the other hand, in small children it is difficult to position the 
D oppler probe optim ally and, owing to its size, the probe cannot be left in place for a long 
period of tim e in  small children. Furtherm ore, the nasogastric tube can negatively influence 
the quality of the obtained signal. The absolute C O  m easurem ents should not be in ter­
preted, as they almost always underestim ate the true value. This can be explained by the 
assumption tha t the insonation angle (the angle between the ultrasound beam  and the aortic 
blood flow) is supposed to be approxim ately the same as the fixed angle between the probe 
and the transducer. Even small deviations of the actual from  the assumed angle will result 
in erroneous velocity calculations, because of the nonlinear character of the cosine function 
in the D oppler equation (90).
Continuous wave Doppler ultrasound
The ultrasonic C O  m onitor (USCOM ) (see Table 1) is a  new, easy to handle portable ap­
paratus for m easuring CO. It provides a transcutaneous C O  m easurem ent based upon con­
tinuous wave D oppler ultrasound. T he D oppler flow is m easured using a handheld  probe 
positioned on the thorax. A nom ogram , based on the subject’s height, incorporated  into the 
software, estimates the valve cross-sectional area, so tha t the C O  can be calculated from  the 
m easured flow across the aortic or pulm onary valve (91-94).
The reliability found in  anim al studies com pared with u ltrasound flow probes around the 
ascending ao rta  were acceptable, with a percentage error o f 13% (95). It has been used in 
adults, as well as in children and neonates, for assessment of serial C O  m easurem ents and 
changes in CO. T he only validation study in  children has been perform ed by K nirsch et al. 
against the PATD (91). W ith a percentage error o f ±36% , they concluded tha t the U S C O M  
does not reliably represent absolute C O  m easurem ents com pared with PATD. A pilot study 
in healthy new borns and p reterm  neonates showed a good inter-operator (rater) agreem ent 
(92). T he study of Phillips et al., com paring U S C O M  versus 2D echo D oppler in  37 p re­
te rm  neonates, showed good agreem ent between the two in term ittent C O  m easurem ent 
m ethods (96).
The U S C O M  C O  m easurem ents are rather dependent on the skills o f the operator and 
on the quality o f the D oppler flow signal. T he nom ogram -based estimates of the cross­
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sectional area of the ao rta  and pulm onary values are bound  to introduce some systematic 
error into the m easurem ent o f C O  in the clinical setting. T he validity of this technique 
requires further studie. Its clinical use seems especially beneficial in  settings of emergencies 
for a quick and global estim ation of CO.
F ic k  p r in c ip le  tech n iq u e
The direct oxygen Fick m ethod is a gold standard for the m easurem ent o f CO. T he Fick 
equation relates C O  to oxygen consum ption and the arterial-venous oxygen content dif­
ference (3,97,98):
C O  = V O 2/(C a O 2-C v O 2)
where V o 2 is oxygen consum ption; c a o 2 is arterial oxygen content; and c v o 2 is mixed 
venous oxygen content.
However, this m ethod requires the precise and simultaneous m easurem ent of V O 2 (using 
calorimetry), hem oglobin level and arterial and m ixed venous oxygen saturation. This ren ­
ders the m ethod not practical for bedside m easurem ent.
The equation m ay also be modified using carbon dioxide (C O 2) elim ination and the differ­
ence between the venous and arterial c o 2 blood content. The N IC O 2™  m onitor (see Table 
1), designed for C O  m easurem ent, utilizes the indirect Fick principle for C O 2, based on a 
partial rebreathing m ethod, which obviates the need to m easure C O 2 in the blood stream 
(99-101). However, this technique needs further adjustm ents for use in  younger children 
and is dependent on the assumed am ount of pulm onary shunt (99,102). O ne of the m ajor 
disadvantages of this Fick derived m ethod is tha t the m easurem ent of C O  requires a period 
o f steady state. Furtherm ore, its use is restricted because of the m any potential techni­
cal problems, such as sampling, air leak, high inspiratory oxygen concentrations and death 
space. Currently, it can only be used in  patients ventilated w ith tidal volumes m ore than  300 
ml. Consequently, the technique is often not applicable in  critically ill patients who require 
extreme ventilatory conditions, using high fractions of inspired oxygen. T he technique will 
also fail in conditions tha t affect the in tra  alveolar distribution of the gas, for instance in  the 
presence of severe interstitial or obstructive lung disease (12).
Besides the rebreath ing c o 2 Fick m ethod, a  m odified C O 2 Fick m ethod is also applicable 
in children. Like the oxygen Fick m ethod, it requires arterial and central venous blood 
sampling. Instead of determ ination of V O 2, V C O 2 m easurem ent is necessary. V C O 2 can be 
m easured using volum etric capnography. A lthough reliable, this technique is still com plicat­
ed and shares m any disadvantages with the oxygen Fick m ethod, but it has the advantage of 
being validated in  small subjects (103).
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B io im p e d a n ce  te ch n iq u e s
The noninvasive thoracic bioim pedance technique for m easuring C O  was introduced more 
than  40 years ago with im pedance cardiography (104). In  the last decades two successors of 
the im pedance cardiography technology have been developed: electrical velocimetry (EV) 
and bioreactance.
The first m ethod relates the m axim um  rate o f change of thoracic electrical im pedance to 
peak aortic blood acceleration, and derives the m ean  aortic blood velocity using a transfor­
m ation (105). This technique m easures changes in  the transthoracic im pedance during car­
diac ejection caused by volumetric changes of the ao rta  and by conductivity changes of the 
blood in the aorta. T he basic equation of the algorithm , in  contrast to form er approaches, 
focuses on the com partm ent with the greatest contributing factor to conductivity changes, 
being the blood in the aorta. M inor changes in  high-resistance low-conductivity com part­
m ents, such as the lung, gas and surrounding tissues, are neglected. This technique requires 
four disposable surface electrodes, two placed at the left side of the neck and two placed on 
the left lateral side of the thorax  at the level of the xiphoid process. T he device emits a small 
sinusoidal, low current (2 mA) with high frequency (50 kHz) through two electrodes on both 
sides. The other two electrodes record the thoracic electrical bioim pedance (Z). Changes 
of the basic im pedance are averaged over ten cardiac cycles. T he first study to validate EV 
in an infant-sim ulated m odel, was a  piglet study com paring C O  m easurem ents of EV with 
T P T D  under various hem odynam ic conditions (106). A lthough the EV  m ethod could track 
changes of m ore than  15% in CO, the percentage error was m arkedly higher (83%), which 
they attributed to the m orphology differences between hum ans and piglets. Four hum an 
studies have been published in pediatric patients since the com m ercial availability of the 
Aesculon® (see Table 1). Tomaske et al. com pared EV  with PATD in pediatric patients 
with congenital heart disease w ithout shunts, under hem odynam ic stable conditions (107). 
They could n o t assess reliable C O  m easurem ents with EV and found a  percentage error of 
±44% . Recently, the same group published a similar study, this tim e com paring C O  m ea­
surements o f EV  with transthoracic echocardiographic D oppler flow (108). Again, agree­
m ent between the two m ethods was low. Two other clinical studies also showed an unac­
ceptable percentage error (88,109).
Although the E V  m ethod is potentially attractive, being noninvasive, continuous and easily 
applicable, at this stage it cannot be used in  clinical practice for reliable m easurem ent of 
absolute C O  values in children. New approaches for optim izing electrode position on the 
patien t’s surface have been suggested for im provement.
Bioreactance, the second technique, is the analysis o f the variation in  the frequency spectra 
of a  delivered oscillating current that occurs when the current traverses the thoracic cavity. 
This is different from  the traditional bioim pedance technique tha t analyses only the changes 
in signal am plitude. A lthough prom ising results in adults have been published, there are cur­
rently no pediatric data  available (91,110—112).
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N on in vasive  co n tin u o u s fin ger a r te r ia l  p r e s su r e  & C O  m o n ito r in g
Blood pressure and C O  can be obtained using a continuous, noninvasive, finger arterial 
pressure m easurem ent technique. This m ethod requires an inflatable finger cuff tha t in­
corporates a photoplethysm ographic sensor, a rapid-reacting pneum atic servo system and a 
special device (Nexfin; see Table 1). This m ethod is based upon the vascular clam p principle 
o f Penaz and is the successor of the form er Finapres device (113—115).
In short, the plethysm ographic signal drives the servo system in a way that the finger arte­
rial wall is constantly kept unloaded. Thereby, the cuff pressure is a reflection of the finger 
arterial pressure. After application of a software algorithm, a brachial pressure curve is 
generated (116). T he blood pressure m easurem ent is reliable and complies with the Asso­
ciation for the A dvancem ent o f M edical Instrum entation standards in adults (117—119). In 
children, a beta-type device has been shown to be feasible and accurate in  m easuring blood 
pressure (120-122).
The Nexfin device incorporates an A PC C O  m ethod that can be applied to the arterial wave­
form  from  the finger artery. Patient param eters (weight, length, gender, age) are needed to 
track changes in  C O  m ore reliable. U sing a separate calibration m ethod is possible but is 
not required. This continuous noninvasive C O  m ethod has only been studied in adults so 
far, and has shown been to  be reasonably accurate (123-127). At present, only finger cuffs 
for children from  6 to 8 years o f age are commercially available. Application for younger 
children will be available in the future.
E x p e r t  c o m m e n ta ry
The ideal C O  m onitor should be accurate, reproducible, continuous, noninvasive, easy to 
apply, operator-independent, cost effective and should have a rapid  response tim e (beat-to- 
beat) (4). Unfortunately, no such technique exists for C O  m easurem ent in either pediatric 
or adult practice.
In  this article, we discussed the available C O  m onitoring  devices tha t are currently  avai­
lable and, in  part, applicable in  ped iatric  patients. T he choice is m ainly determ ined  by 
the clinical indication and situation. Thereafter, the balance betw een invasiveness, risks, 
instrum entation, user expertise and additional param eters th a t can be collected, together 
w ith cost, will finally be decisive. In  choosing a device the physician should consider the 
following three questions: is a reliable absolute m easurem ent o f C O  required  or is track­
ing changes m ore appropriate? In  the first case a m ore invasive approach  is required. In 
the latter, a continuous technique should be applied. Is an invasive m easurem ent feasible 
or does the clinical situation require noninvasiveness? W hen noninvasiveness is required, 
the physician should be aw are tha t the ob ta ined  results are often less reproducible. Are 
other hem odynam ic m easurem ents also required  (such as extravascular lung  w ater or 
arterial pressure variations)?
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In  clinical practice, invasive dilution techniques should be considered for hem odynam ic 
m onitoring of septic and other (postoperative) circulatory com prom ised pediatric patients 
during pediatric intensive care unit treatm ent. T he C O  value m ay help the clinician to 
guide inotropic, vasopressor or fluid therapy. In  the setting of perioperative hem odynam ic 
m onitoring, continuous C O  m easurem ent, such as an A PC C O  m ethod or TED, is p roba­
bly m ore convenient. Tracking changes in  these situations is particularly inform ative and in 
some systems there is no need for in term ittent recalibrations. Noninvasive m ethods, such as 
echocardiography and other ultrasound techniques, can be very useful in the first phase of 
treatm ent of an acute patient, because it can be available quickly and can guide the direc­
tion of treatm ent in the first phase. D epending on the severity o f the circulatory insufficien­
cy, continuous and m ore invasive m onitoring should be considered thereafter.
In  general, a  m ore invasive technique produces a m ore reliable absolute m easurem ent. Most 
importantly, the physician should have the knowledge of the technical background and p it­
falls that are associated with the use of the chosen technology.
Five-year view
D ata from  adult studies cannot be extrapolated to small children. M ore research is needed 
to further adapt algorithms and technologies for the pediatric population. Unfortunately, 
industrial interest is generally directed towards adult critical care m edicine and anesthe­
siology. Besides that, technical difficulties and ethical constraints to perform  clinical valida­
tion studies in children also play a role. We believe tha t the com bination of transthoracic 
echocardiography and a fast and continuous A PC C O  m onitoring technology (with or with­
out calibration) will be the most ideal com bination in  the near future.
W ith every new  device comes the need for validation and evaluation of its usefulness in the 
clinical setting. In  this regard  there is a growing need for standardized validation m ethods 
for C O  m onitoring tools.
Besides validation studies, random ized trials o f C O  guided hem odynam ic therapy should 
dem onstrate w hether C O  m onitoring is a useful adjunct to the existing clinical arsenal with 
respect to m orbidity and mortality in  critically ill children.
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K ey  is s u e s
• M easurem ent o f cardiac output (CO) is im perative to determ ine the hem odynam ic sta­
tus of the patient, to initiate the appropriate therapy, to subsequently follow the patien t’s 
response to instituted therapies and thereby trying to prevent organ dysfunction.
• In the last decade, m ore technologies have becom e available for m easurem ent of CO, in 
part applicable in  pediatric patients. As a result hem odynam ic m onitoring in  children is 
now slowly evolving in  the pediatric critical care and anesthesia area.
• The ideal C O  m onitor does not exist.
• The choice of C O  m easuring device in  children is m ainly determ ined by the clinical 
indication and situation. Thereafter, the balance between invasiveness, risks, instrum en­
tation, user expertise, additional param eters that can be collected and costs will finally 
be decisive.
• M ore research is needed  to  further adapt algorithms and technologies for the pediatric 
population.
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CHAPTER X
A b stra c t
Shock is an im portant cause of pediatric m orbidity and m ortality and requires early recog­
nition and prom pt institution of adequate treatm ent protocols. Unfortunately, the hem o­
dynam ic status o f the critically ill child is poorly reflected by physical exam ination, heart 
rate, blood pressure or laboratory blood tests. A dvanced hem odynam ic m onitoring consists, 
am ong others, of m easuring cardiac output, predicting fluid responsiveness, calculating sys­
tem ic oxygen delivery in  relation to oxygen dem and and quantifying (pulmonary) edema. 
We discuss the potential value of these hem odynam ic m onitoring technologies in relation 
to pediatric physiology.
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In tro d u ctio n
Shock is an im portant cause of pediatric m orbidity and m ortality (1-3). Therefore, early 
recognition, prom pt treatm ent and, when applicable, subsequent transfer to  a tertiary care 
center are most im portant (3-5). C ardiac output and blood pressure in  pediatric circulatory 
shock can be either low, norm al or high (6-8). Obviously, this requires different therapeutic 
strategies. In  this respect aggressive fluid therapy in critically ill children can be advanta­
geous and is therefore advised by advanced support life courses and current sepsis protocols 
(4,9). O n  the other h and  overzealous fluid therapy can be detrim ental (10,11). Although 
physical exam ination is essential in  the prim ary assessment, physical signs and clinical ju d ­
gem ent poorly reflect cardiac output, preload status or the need for fluid or other hem o­
dynam ic therapy (12-23). Like in  adults, blood pressure does not reflect blood flow (24,25). 
Therefore advanced hem odynam ic m onitoring seems m andatory  to acquire insight into the 
circulatory status. In  contrast, the latest guidelines for treating sepsis in  children advises to 
m easure cardiac ou tput only at the end of the algorithm, when fluids and vasoactive m edi­
cation have already been given (9,26).
Nowadays, several m ethods are available for advanced hem odynam ic m onitoring in  chil­
dren. These include cardiac output m easurem ent, predicting fluid responsiveness, calculat­
ing systemic oxygen delivery in  relation to oxygen dem and and quantifying (pulmonary) 
edema. A dvanced hem odynam ic m onitoring in  critically ill children could be useful and 
m ay attribute to a lower m ortality rate and a shorter intensive care length of stay.
This review describes the potential clinical value of several advanced hem odynam ic m oni­
toring technologies in  children.
B a s ic  h e m o d y n am ic  p h y sio lo gy
D uring hum an  developm ent hem odynam ic physiology changes, especially in the first years 
of life. M ost im portantly oxygen and m etabolic dem ands are higher and show less variation 
com pared to older children or adults (27,28). C ardiac output, stroke volume and ejection 
fraction (indexed to body proportions) seem to decrease with age while at the same time 
heart rate is higher and blood pressure lower in young children (29,30). T he lower blood 
pressure in  conjunction with a relatively higher C O  implies that young children have a lower 
systemic vascular resistance (31). O xygenation of arterial and venous blood is equal at all 
ages.
The cardiac output o f young children is not strongly dependent on heart rate, as was pre­
viously thought (32,33). M any studies in  healthy children, in  children undergoing cardiac 
surgery or in  critically ill children have shown that changes in cardiac output are largely 
caused by changes in stroke volume (25,31,34-46). Therefore heart function in  young child­
ren  complies with general hem odynam ic physiology reflected in figure 1. Specific applied 
calculations are shown in table 1. However cardiac function in  young children m ay be cha­
racterized by a higher basal contractile state, a greater sensitivity to afterload and a higher 
oxygen consum ption at higher heart rate or higher preload state (31,47,48).
The relation between stroke volume and preload is reflected by the Frank-Starling curve 
(figure 2A). A fluid challenge will increase preload and stroke volume only on the steep part
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F igu re 1
Basic hemodynamic relations
SVR — systemic vascular resistance; CO — cardiac output; S V  — stroke volume; H R  — heart rate.
T ab le 1
Several hemodynamic calculations
ta b le p a r a m e te r fo rm u la
a SVR 80 x (MAP - CVP) /  CO
b C a 0 2 Hgb x 1.36 x SaO 2 + 0.0031 x PaO 2
c C v 0 2 Hgb x 1.36 x SvO2 + 0.0031 x PvO 2
d D 0 2 CO  x C aO 2
e V 0 2 CO  x (CaO 2 - C vO 2)
f O ER (SaO2 - SvO2) /  SaO 2
g Q SaO 2 /  (SaO2 - SvO2)
h Jv K f x ([Pc -  Pi] -  o [nc -  ni])
i PPV (%) (PPmax -  PPmin) /  [PPmax + PPm in/2] x 100
SVR = systemic vascular resistance (dyn s •cm-5); CO = cardiac output (l/min); M A P  = mean arterial pressure; CVP 
= central venous pressure; VO2 = oxygen consumption (ml/min); DO2 = oxygen delivery (ml/min); Hb = hemoglobin 
level (g/dl); CaO2 = arterial oxygen content (ml); CvO2 = central venous oxygen content (ml); SaO2 = arterial oxygen 
saturation (%); SvO2 = venous oxygen saturation (%); OER = oxygen extraction ratio; Q  = oxygen excess factor; Jv  
= the net fluid movement between compartments; K f  = the proportionality constant; Pc = capillary hydrostatic pressure; 
Pi = interstitial hydrostatic pressure; nc = capillary oncotic pressure; n i = interstitial oncotic pressure; K f  = filtration 
coefficient; O = reflection coefficient; PPV = pulse pressure variation.
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F igu re 2
Cardiac function curves
of the Frank-Starling curve. This situation is called fluid responsiveness. However when 
fluid is adm inistered when the heart perform s on the top of the curve (pulmonary) edem a 
may develop (figure 2B). W hile blood pressure is im portant as the driving perfusion pressure, 
cardiac output is an im portant determ inate of the delivery of oxygen to the tissues (D O 2) 
(table 1b,c,d). Arterial oxygen saturation is, under norm al conditions, close to 100%. Since 
the body extracts norm ally 25%  of oxygen from the arterial blood the oxygen saturation of 
venous blood is around 75% and thereby reflects the balance between oxygen delivery and 
oxygen consum ption (table 1b,c,e).
T he net driving force of fluid from the intravascular space to the interstitium  (or vice versa) 
is guided by the Starling’s law (table 1h) and reflects the balance between hydrostatic and 
oncotic pressures in relation to the capillary m em brane permeability. Also the am ount of 
lym phatic drainage is of im portance and young children seem to have a higher capacity to 
eliminate interstitial fluids (49,50).
Several therapeutic m easures m ay improve circulatory insufficiency. cardiac output can be 
increased with volume therapy by increasing preload, with vasoactive m edication by increas­
ing cardiac contractility and with vasodilating agents by decreasing afterload. Vasoconstric­
tive agents like nor-epinephrine can be used to increase blood pressure w hen vascular resis­
tance is too low. Fluid restriction and or diuretics are prescribed to decrease the am ount of 
(pulmonary) edem a. T he optim al intervention is clearly dependent on the circulatory state 
o f the child.
C a rd ia c  o u tp u t m o n ito r in g
In  adults the pulm onary artery catheter (PAC) is regarded as the gold standard for m ea­
suring cardiac output (CO) and the successful use of the PAC has also been described in 
young children (51). However because of technical problem s and size restraints the PAC 
is not practical, or sometimes impossible for use in (young) children. In  the last decade
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less invasive alternative m ethods have becom e available for m easuring C O  in bo th  adults 
and children. These C O  m ethods are based upon multiple techniques like D oppler signals, 
dilution m easurem ents or bioim pedance methods. In general, dilution techniques deliver 
a reliable C O  m easurem ent in children from  3.5 kg. However they all require insertion of 
central venous and arterial catheters. Less invasive m ethods are often less reliable. For in 
depth  technical inform ation we refer to dedicated reviews (52,53).
At present the transpulm onary therm odilution m ethod (TPTD) is considered to  be the clin­
ical gold standard (54). T he T P T D  technology also offers the m easurem ent o f global end 
diastolic volume (GEDV), which reflects preload, and extravascular lung water (EVLW) 
reflecting pulm onary edem a (55-57).
In  general, the bedside C O  techniques cannot be used in patients with intra- and extra­
cardiac shunts. However, transpulm onary dilution and the m odified C O 2 Fick m ethods may 
becom e feasible in this situation (58,59).
Unfortunately, in adults there is no evidence tha t use of the PAC improves m orbidity an d /o r  
mortality (60-62). Fluid therapy guided by C O  m easurem ent using esophageal D oppler may 
improve outcom e after m ajor surgery, but not in critically ill patients (63,64). Also C O  guid­
ed volume loading in  septic adults m ay prevent the increase in lung water (65,66). Likewise, 
the evidence that C O  m onitoring improves outcom e in critically ill children is also missing, 
although it provides the clinician with essential inform ation regarding the hem odynam ic 
situation (25,42,67-70). It allows for discrim ination between a low cardiac ou tput syndrome 
and a hyperdynam ic state, characterized by a high cardiac output and a low vascular resis­
tance, and subsequently may prevent overzealous fluid adm inistration and guide inotropic 
and vasopressor therapy. Clinical studies testing C O  guided hem odynam ic therapy in chil­
dren are therefore w arranted.
V en ou s o x y m etry
According to the Fick principle, total body oxygen consum ption (VO2) equals cardiac out­
put m ultiplied by the difference between arterial and mixed venous oxygen content (table 
1b,c,d,e). W hen oxygen consum ption, arterial saturation and hem oglobin level are relatively 
constant, a  change in C O  will thus cause a change in SvO2. However this relationship is 
not linear (table 1e) and therefore SvO 2, although strongly related to CO, is not the same 
as C O  (71,72). The most im portant p art o f the SvO2 - C O  curve lies betw een a SvO2 value 
of 60 and 80% . In  this steepest part o f the curve, a change in SvO2 m ay indicate a signif­
icant change in  C O  (figure 3). A low SvO2 with a norm al S a 0 2 is almost always a sign of 
a  low C O  (73). In  case of a low arterial oxygen saturation (SaO2) due to severe pulm onary 
dysfunction or in the presence of intra- and extra-cardiac shunts the oxygen extraction ratio 
(OER) is calculated (table 1f). A norm al O E R  is approxim ately 25%. O thers prefer to cal­
culate the oxygen excess factor (omega, Q)(table 1g), which is the opposite of the O E R  with 
a norm al value of approxim ately 75%.
Physiologically the true venous saturation is reflected by the “m ixed” venous oxygen satura­
tion in the m ain  pulm onary artery (SvO2). This requires the use of a PAC. Because the PAC 
is rarely used in children, central venous saturation m easurem ent (ScvO2) using a central 
venous catheter in  the superior caval vein (SCV) is taken instead. T he inferior caval vein
177
CHAPTER X
F igu re 3
M athematical relation between cardiac output and venous oxygen saturation in a 5  kg child
Assumptions: SaO2 — 100%; PaO2 — 90 mmHg; VO2 — 30  ml/min 
CO = cardiac output; SvO2 — central venous oxygen saturation
(ICV) is not a reliable sample site (74). T he ScvO2 reflects merely the saturation of venous 
blood from  the upper p art of the body (including the brain), while the SvO2 reflects satura­
tion of the mixed venous blood from  upper body, lower body and the coronary sinus. U nder 
norm al conditions the saturation in the IGV  is higher than  the s c V  due to the higher oxy­
gen consum ption by the brain  com pared to the abdom inal organs (especially the kidneys) 
(75,76). However during circulatory shock, perfusion of the m esenteric organs decreases 
m ore than  perfusion of the brain. This m ay cause saturation of the IC V  to decrease. Also 
m ixing of desaturated blood from  the coronary sinus will cause an additional decrease in 
s v o 2. As a result, in sepsis or liver transplantation the ScvO2 can be approxim ately 8% 
higher than  s v o 2 (72,76).
Both s c v o 2  and s v o 2 could be equally reliable in determ ining changes in venous oxygen 
saturation in adults and children (72,77-80). However these values are not interchangeable 
in all septic shock patients since s c v o 2 and s v o 2 not always change in the same direction 
(81,82). This can be explained by variable changes in  myocardial, cerebral or splanchnic 
oxygen consum ption under different situations.
Special venous catheters for continuous ScvO2 m onitoring are available even for (small) 
children, which replace the need for in term ittent sampling (83-86).
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The s c v o 2 can be used in  two ways. First, relating the absolute ScvO2 value to the O ER . 
For example, a low ScvO2 value (< 70%) accom panied by a high O E R  (> 0.25) could indi­
cate a relatively low cardiac output. Second, changes in ScvO2 m ay guide hem odynam ic 
therapy although this is difficult in hyperdynam ic conditions (72). In adult septic patients 
restoring s c v o 2 > 70% m ay improve outcom e (87). This m ay also be true for children 
with septic shock (88). Unfortunately studies in  septic adults have shown tha t m any patients 
already have a s c v o 2 value >70%  at the start of therapy although they m ay still need he­
m odynam ic im provem ent (89,90). Even adult septic patients with ScvO 2 level > 90%  had  a 
high m ortality (91). A lthough continuous ScvO2 m onitoring has been validated in children, 
there are no studies investigating the relation between s c v o 2 and cardiac output or clinical 
condition in  pediatric patients (83-86).
At present the additional value of ScvO2 m easurem ent in pediatric clinical practice is not 
clear. Nevertheless, ScvO2 m onitoring is already incorporated  in the surviving sepsis cam ­
paign algorithm  for bo th  adults and children (9,26). Preferably ScvO2 values should be 
com bined with cardiac output m easurem ent.
C ard iac sh u n ts
Venous saturation m onitoring, is almost always possible in  children with cardiac shunts. 
A low s c v o 2 can be caused by a low Qs but also by a low Qp. In  these clinical situations 
the o E R  or om ega need to be in terpreted  together with other hem odynam ic param eters 
(92). Pediatric studies during congenital cardiac surgery show tha t a  low ScvO2 predicts the 
occurrence of m ajor adverse events (35). ScvO2 values below 40%  were associated with a 
lower outcom e score in neonates after norw ood stage 1 surgery (35,93). T he peri-operative 
use of ScvO2 m onitoring is recom m ended in these patients (94-96).
In term ittent or continuous m onitoring of ScvO 2 in children is recom m ended when c o  
m onitoring is impossible (cardiac shunts) or not yet available. W hen using ScvO 2 in cases of 
shunt it is advised to calculate the oxygen extraction ratio and to  be cautious w ith “n o rm al” 
s c v o 2 values as they m ay still not reflect a norm al hem odynam ic state.
F lu id  r e sp o n s iv e n e s s
The effect o f fluid therapy can be determ ined by m easuring C O  before and after a fluid 
bolus. W hen C O  increases by approxim ately 10 - 15% the patient is considered fluid re­
sponsive. Results from  adult studies show that only half of the fluid challenges increase 
stroke volume (97-99). In  order to avoid unnecessary fluid overload there is a great interest 
in predicting fluid responsiveness (FR). Both static and dynam ic param eters are used for this 
purpose. Exam ples of static param eters are central venous pressure (CVP), heart rate (HR) 
and global end diastolic volume index (GEDVI). D ynam ic values are the result o f a phys­
iologic interactive process or a special maneuver. Examples are arterial pressure variations 
as a result of m echanical ventilation or changes in  stroke volume as a result o f a passive leg 
raising test (PLR).
CV P is often used to guide fluid therapy in bo th  adults and children and is considered to 
reflect cardiac preload. However cardiac output is mainly determ ined by the venous re­
tu rn  to the heart. Venous re tu rn  itself is determ ined by CVP, resistance to venous return, 
systemic vascular com pliance, stressed and unstressed blood volume and m ean systemic
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filling pressure (100,101). Except for CVP the other variables are impossible or difficult to 
measure. Furtherm ore the value of the CV P is influenced by the diastolic com pliance of 
the right ventricle, in tra abdom inal pressure, positive end expiratory pressure and forced 
expiration. CV P does not predict fluid responsiveness and poorly reflects preload in  adults 
(102,103). Also in children or in pediatric anim al models, C V P does not reflect preload 
(25,39,42,55,104).
The other static m easure is G ED V I or its counterpart the in tra  thoracic blood volume index 
(ITBVI). GEDVI is m easured using the transpulm onary therm odilution technique incor­
porated  in  the P iC C O  device (Pulsion, M unich, Germany). ITB V I is calculated by the 
P iC C O  device by m ultiplying G EDVI by 1.25. GEDVI is related to preload in  adult patients 
and experim ental animals (105,106). A treatm ent algorithm  based upon GEDVI m ay re­
duce catecholam ine use and IC U  stay in adults after cardiac surgery (107). Also in children 
GEDVI reflects preload (25,42,55,67,108). However these studies are potentially confound­
ed by m athem atical coupling as C O  is a  p art of the calculation of GEDV (109). Clinical 
studies in  children showing the value of GEDVI in  predicting fluid responsiveness are not 
available and it is unknow n w hat cutoff values for GEDVI should be used since GEDVI is 
lower in younger children com pared to older children or adults (42,110).
Dynam ic param eters are the result o f a tem porary  change in  stroke volume as a conse­
quence of a change in  the right a n d /o r  left ventricular pre - or afterload induced by various 
mechanisms. T he m agnitude of the effect depends on the position of the heart on the star­
ling curve. Two p henom ena have currently been studied: arterial pressure variations and the 
passive leg raising test (PLR).
Arterial pressure variations (APV) are mainly studied in  relation to m echanical positive pres­
sure ventilation. D uring the breath ing cycle the left ventricular filling varies thus influencing 
stroke volume and as a result fluctuations in  the arterial pressure curve occur. Figure 4 shows 
this phenom enon in  a lam b. The explanation is as follows: D uring inspiration the lung 
expansion causes an increase in  pericardial pressure. Subsequently several phenom ena de­
velop simultaneously. 1) Transm ural pressure over the left ventricular wall decreases there­
by dim inishing afterload resulting in  an im m ediate increase in  LV stroke volume. 2) At the 
same tim e lung inflation squeezes blood from  the venous side to  the left atrium  simulta­
neously enhancing LV stroke volume. 3) The increased alveolar pressure causes an increase 
in  pu lm onary  vascular resistance and  thereby increases right ventricle afterload, as a result 
RV stroke volum e decreases. 4) T he increase in pericardial pressure decreases venous 
re tu rn  thereby also decreasing RV stroke volume. 5) T he reduced  RV stroke volume leads, 
after several h ea rt beats to  a decrease in  LV preload and thus LV stroke volume (figure 
7). T he resultant calculation of A PV  can be done in  m ultiple w ay’s. First the variation 
in  systolic arterial pressure can be calculated (systolic pressure variation = SPV). Second 
the pulse pressure variation  (PPV) can  be calculated by taking the changing difference of 
systolic m inus diastolic pressure. Finally, w hen a continuous arterial pressure wave based 
cardiac ou tpu t device is used, the variation  in stroke volume (SVV) can  be calculated. 
Calculations are all based upon  the same form ula (table 1i). R espiratory tidal volume, 
cardiac a rrhy thm ia’s and the ratio  o f the respiratory  rate to  heart rate  strongly influence 
the m agnitude of arterial pressure variations (111).
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F igu re 4
Arterial pressure variations in a lamb o f  9 .2  kg during mechanical ventilation and apnea
It can be observed that during in- and expiration the flow in the pulmonary artery and the descending aorta fluctuate 
alternating. These fluctuations resolve when ventilation is paused.
Pao = arterial pressure in the aorta; Qpa = flow in the pulmonary artery; Qao = flow in the descending aorta; Paw = 
airway pressure.
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F igu re 5
M echanism o f  arterial pressure variations
LV afterload *---- Ppl it  ----- * RV Preload
1
inspiration
RV afterload ft— RV S v J J
LV preloadI
LVSVCI
L V  — left ventricle; R V  — right ventricle; SV — stroke volume; PVR — pulmonary vascular resistance; Ppl — pleural 
pressure.
A PV is a reliable indicator of fluid responsiveness in  adults (98,112,113). Reliability de­
creases w ith spontaneous respiration, a low tidal volum e or open chest conditions (114­
118). Also in children or experim ental pediatric anim al models APV appears to p re­
dict fluid responsiveness although specific cut off values have no t been  established yet 
(39,104,119,120).
T he passive leg raising test is a reliable indicator o f fluid responsiveness in adult patients 
regardless w hether during m echanical ventilation or spontaneous breathing (121-123). 
However there is currently no study available in children. In  the experience of the authors, 
in small children the P LR  test is not a reliable sign of fluid responsiveness m aybe due to the 
relatively low blood volume in the legs (unpublished data).
L u n g w ate r
P ulm onary  edem a can be quantified by m easuring extravascular lungw ater (EVLW). The 
extravascular fluid of the lung can be present in  the in terstitium  a n d /o r  in the alveolar 
com partm en t (124,125). Alveolar flooding probably occurs after an  initial increase of 
E V LW  of approxim ately 100% and  is enhanced  by the d isruption of the alveolar m em-
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brane (124,126). O nly w hen alveolar flooding appears, the oxygenation will be seriously 
im paired  and  clinical signs will becom e apparen t (127). Since fluid overload is a risk factor 
for m ortality  in  critically ill adults and  children, a tool for detecting and quantifying fluid 
overload m ay be advantageous (11,128-131).
EV LW  can be m easured  at the bedside using the transpulm onary  therm odilu tion  techni­
que (TPTD), incorporated  in  the P iC C O  device and is indexed to  body weight (EVLWI) 
(110,132-135). For the adult population  an EVLW I betw een 3 and 7 m l/k g  is considered 
norm al and levels above 10 m l/k g  are associated w ith pulm onary  edem a (133).
In  adults, EV LW I m easurem ent has been  validated in  m any studies (133,136-142); in 
children only one validation has been  published (110). EVLW I cannot be m easured re ­
liably in  patients w ith a significant left-to-right or right-to-left shunt. M easurem ent of 
EVLW I in children or pediatric anim al m odels showed higher values com pared  to adult 
norm al values (25,42,55,108,110). As a result, the validity of these m easurem ents in  chil­
d ren  has been questioned (143). T here  is still no  solid explanation why EV LW  values 
are higher in  young children. T here are th ree possible explanations. 1) T he greater body 
w ater content in  young children, although this only explains a small p a rt o f the higher 
EV LW  (144). 2) T he m ethod  o f calculation of EV LW I (110,133). 3) Younger children 
have relatively m ore lung  tissue mass and less air volume com pared  to older children. T he 
larger tissue volume implies th a t there is m ore in terstitial tissue in the lung  and  m ay result 
in  a larger quantity  o f fluids e.g. lung  water.
In  adults EV LW I is related  to  disease severity and outcom e, especially w hen indexed to 
p redicted  body weight instead of actual body weight (145-148). F urtherm ore, EVLW I 
divided by G EDV I, m ay distinguish betw een pulm onary  edem a due to  increased capillary 
perm eability  o r increased hydrostatic pressure (149,150). Therefore, EVLW I m ay be a 
useful tool to  guide fluid or diuretic therapy. U ntil the results o f a currently  executed trial 
are available, there is only circum stantial evidence in  adults to support this theory  (Clini- 
calTrials.gov identifier: N C T00624650) (151-153). Finally, EV LW  could be used as a tool 
for evaluating experim ental therapies for reducing  pulm onary  edem a (154).
T he clinical value of lungw ater estim ation in  children is unclear. A recent clinical study in  
a general population of critically ill children com paring EV LW I w ith a chest x-ray score 
of pulm onary  edem a showed no  correlation  betw een the two. Also there was no  correla­
tion betw een the p a o 2/ F i o 2 ratio  or A -a gradient and  EVLW I or the chest x-ray score. 
However EV LW I was significantly higher in  younger com pared  to  older children (155).
D isc u ss io n
U p to date several advanced hem odynam ic param eters in critically ill children are available 
for clinical use. Unfortunately, like in  adults, evidence that these devices m ay reduce m ortali­
ty is lacking. However m easurem ent o f cardiac output and venous oxymetry are adequately 
validated and could be incorporated  in  clinical guidelines.
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M any pediatric hem odynam ic param eters must be in terpreted  in  relation to age (156,157). 
Therefore, pediatric norm al values should be adapted  accordingly. Some advanced hem o­
dynam ic variables like lung water and global end diastolic volume also seem to be age 
related. U ntil no rm al values for these param eters are established, their use is lim ited to 
individual changes in  relation to  interventions or over time. Also m any technologies are not 
adapted  for use in  children or are still insufficiently validated. Since the pediatric market 
is less commercially interesting it rem ains uncertain  if these problem s will be solved in  the 
n ear future.
F igu re 6
Exam ple o f  a hemodynamic treatment protocol
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Besides the clinical use of these variables, they can also serve as research purposes to study 
for example, the effects o f various inotropic agents.
Since fluid therapy is the mainstay of hem odynam ic treatm ent in  critically ill children the 
determ ination of fluid responsiveness seems to be essential (4,9). For the m ajority of criti­
cally ill children in  shock the initial approach will rem ain  the prom pt adm inistration of fluid 
up to  40 m l/k g  (158,159). H ereafter predicting further fluid responsiveness could prevent 
fluid overload and its deleterious effects (11,128-130,160). Therefore the value of static and 
dynam ic param eters should be elucidated in  the near future.
Figure 6 is an example of an algorithm  of the various advanced hem odynam ic variables in 
the m anagem ent of the critically ill child. It should be m entioned that advanced hem ody­
nam ic m onitoring itself will never improve patient outcom e unless incorporated  in  proper 
treatm ent protocols (161).
In  sum m ary advanced hem odynam ic m onitoring in  pediatric patients is feasible and m any 
im portant param eters o f the circulation can nowadays be quantified. This m ay result in 
m ore rational and effective hem odynam ic treatm ent protocols.
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chapter 11
Summary, conclusions and future perspectives

CHAPTER X I
S u m m a ry
M any advanced hem odynam ic m onitoring  technologies are available for clinical use in 
adults. However, in  critically ill children advanced hem odynam ic m onitoring  is rarely 
em ployed due to  technical reasons, size restrain ts and differences in  physiology. A ccum u­
lating evidence suggests th a t critically ill children m ay also benefit from  these techniques. 
U nfortunately, validation in this patien t population is often absent. Also ped iatric  norm al 
reference values are frequently lacking.
In  this thesis we have focussed on two technologies. In  chapters 2 to 6 we studied the 
transpulm onary  therm odilu tion  technology (TPTD) using the P iC C O  device. T he goals 
o f these studies were to validate T P T D  m easurem ents in children, to  gain insight into 
their clinical use and to  establish this technique as a reference m ethod  for other, less­
invasive, m ethods.
Since hem odynam ic m onitoring  is also requ ired  w hen invasive catheters have not (yet) 
been inserted, the in terest in  non-invasive devices is increasing. For this reason we studied, 
in  chapters 7 and 8, the continuous non-invasive finger b lood pressure m easurem ent in ­
co rporated  in  the Nexfin device. This device has the capability o f continuously m easuring 
b lood pressure bu t also provides a  beat-to -beat cardiac ou tpu t value. Because this technol­
ogy is still under developm ent for use in  small children we focussed only on the ability to 
acquire a reliable arterial pressure curve and accurately m easure blood pressure.
In  c h a p te r  2 we conducted a validation study o f cardiac ou tpu t (CO) m easurem ent 
using the T P T D  technique (CO TpTD) in  11 new born  lam bs w eighting betw een 4.2 and 
12.5 kg. We used a  perivascular u ltrasound  flow probe around  the m ain  pu lm onary artery 
as the gold standard  (C O Ufp). C O tptd was determ ined  by taking the m ean  value of four 
bolus injections of 3—5 m l of ice-cold saline th rough  the central venous catheter w ith an 
injectate tem peratu re < 10°C. T he first therm odilu tion  m easurem ents were m ade shortly 
after instrum entation  w hen the anim als were stable and norm ovolem ic. Thereafter, the 
anim als were subjected to  a separate experim ent, at the end  of which the anim als were 
left in  hypovolem ic shock. Subsequently, several fluid challenges w ith 20 m l/k g  hydroxy- 
ethyl starch (Voluven) were given to  m im ic clinical volume loading and to achieve a  large 
range of cardiac ou tpu t values per anim al. C O TpTD and  c o Ufp were determ ined  before 
and after every fluid challenge. W hen the C O Ufp did no t increase w ith fluid loading, one 
or two additional fluid boluses were given. In  four animals, dobutam ine 10 ^ g /k g /m in  
was additionally adm inistered to  further increase cardiac output.
T he cardiac ou tpu t ranged  betw een 0.5 and 3.5 l/m in . T he correlation  coefficient between 
c o TpTD and  c o Ufp was 0.97. C O TpTD overestim ated c o Ufp w ith 0.19 l/m in  (12%) with 
limits of agreem ent o f ±0.23 l /m in  (14.7%). T he correlation  coefficient betw een changes 
in  c o TpTD and  c o Ufp was 0.97. T here was no correlation  betw een changes in  central 
venous pressure (CVP) and changes in  stroke volum e index (SVI). H ow ever the correla­
tion coefficient betw een changes in  global end  diastolic volum e index (GEDVI) and  SVI 
was 0.59. We conclude th a t the T P T D  technique adequately m easures cardiac output 
in  this new born  anim al m odel. Also during  volume loading, C O TpTD reflects changes in
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cardiac ou tpu t w ith acceptable accuracy. O ptim um  results were achieved w ith the m ean 
of th ree bolus injections w ith ice-cold saline.
C h ap ter 3 describes th e“cross-talk phenom enon” . Based upon a clinical and an experi­
m ental observation we describe this phenom enon and discuss the causes and the po ten­
tial clinical consequences. The cross-talk phenom enon is an im portant cause of erroneous 
T p T D  m easurem ent in  children tha t m ay occur when the injection catheter is positioned in 
the lower part o f the body when the tem perature indicator reaches the arterial therm istor 
directly after injection because of diffusion through tissues. After the indicator has travelled 
through the heart and great vessels it reaches the therm istor for the second tim e causing 
a biphasic therm odilution curve. This phenom enon occurs when the two catheters are in 
close proximity but also when the blood flow is low. We advise to perform  T P T D  m easure­
m ents with the use of a central venous catheter inserted in  the upper part o f the body. In 
case the central venous catheter is inserted in the lower half o f the body the therm odilution 
curve should always be inspected for signs of this cross-talk phenom enon since this will lead 
to erroneous m easurem ents.
In ch a p ter  4 we analyzed the m easurem ent of extravascular lung water using the T PT D  
technology (EVLWTpTD) in  11 children, between 2.5 m onths and 2 years, undergoing car­
diac catheterisation. We com pared EVLW TpTD with the transpulm onary double indicator 
dilution m ethod (TPDD) using injections of ice-cold indocyanine green as reference m ea­
surem ent (EVLWtpdd). EVLW tpdd is a suitable reference m ethod because it contains no 
assumptions in the calculation of EVLW  and the results have been validated against gravi­
m etry in  anim al models. In these relatively healthy children w ithout obvious pulm onary dis­
function and only tem porarily ventilated and anesthetized, the EVLW tpdd ranged between 
8 and 22 m l/kg. EVLW TpTD overestimated EVLW tpdd with 2.3 m l/k g  (18%). T he limits of 
agreem ent were ±2.97 m l/k g  w ith a  percentage error of 19%.
Global end diastolic volume (GEDV) is directly m easured with the T P T D  m ethod  while in­
tra  thoracic blood volume (ITBV) is directly m easured with the T PD D  m ethod. T he T PT D  
m ethod calculates ITB V  using the formula: ITB V  = GEDV  x 1.25. T he relation between 
ITB V  m easured with the TPD D  m ethod (ITBVtpdd) and GEDV m easured with the T P T D  
m ethod (GEDVTpTD) showed a correlation of 0.99. T he m ean ratio between ITB V tpdd and 
GEDV tptd was indeed approxim ately 1.25. However this ratio was related to  body weight 
with a correlation coefficient o f -0.72. We also com pared T P T D  m easurem ents with injec­
tion via the fem oral vein and directly into the right atrium. We showed tha t T P T D  m easu­
rem ents using the fem oral vein produces an overestimation of C O  of 3%, EVLW I of 0% 
and GEDVI of 8%. T he overestimation of GEDV is expected since the volume between 
injection and detection point is larger when the fem oral route is used.
We conclude that the m easurem ent o f EVLW I using the T P T D  technique is reliable in 
this subset o f patients. Also, m easured EVLW I values were higher in young children com ­
pared  to adult reference values. The conversion factor between GEDV  and ITB V  of 1.25 is 
related to body weight. T P T D  m easurem ents can be perform ed using a central venous 
catheter inserted in the fem oral vein.
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In  ch a p ter  5 we studied lung w ater m easurem ents in  critically ill children. We com pared 
m arkers o f oxygenation (P /F  index and A -a gradient) and a chest-x-ray score of pulm onary 
edem a with EVLW I. Besides these surrogate m arkers of pulm onary edem a we also collect­
ed data  on length of stay and severity of illness. We included 24 mechanically ventilated 
critically ill children with a  m ean  age of 2 years (range 2 m onths to 8 years) adm itted to 
our pediatric intensive care unit. No specific interventions for the purpose of the study were 
done. In  total we collected 103 simultaneous m easurem ents o f EVLW I, chest x-ray score, 
ventilatory param eters and blood gases within a  3-hour tim e frame. Two radiologists inde­
pendently assessed the chest x-ray and determ ined a score for pulm onary edema.
The m edian cardiac index was 4.00 (range 1.65 to  10.85) l /m in /m 2. M edian EVLW I was 
16 (range 6 to 31) m l/kg. T he weighted kappa between the chest x-ray scores o f the two 
radiologists was 0.53. T here was no  correlation between EVLW I and the chest x-ray score. 
T here was also no correlation between EVLW I or chest x-ray score and the num ber of 
ventilator days, severity o f illness or m arkers o f oxygenation. We analyzed serial m easure­
m ents per patient and found no correlation between changes in EVLW I on the one hand  
and changes in chest x-ray score, P /F  ratio or A-a gradient on the other. EVLW I correlated 
with age (correlation coefficient of -0.67; 95% C I -0.85 to -0.36; p < 0.001) and height (cor­
relation coefficient of -0.80; 95% C I -0.91 to -0.59; p <  0.0001). The chest x-ray score was 
no t correlated with age or height.
We conclude that EVLW I does not correlate with a chest x-ray score of pulm onary edem a 
in a general population of critically ill children. EVLW I and chest-x ray score did no t cor­
relate with m arkers of oxygenation, severity of illness or P IC U  length of stay. EVLW I was 
related to  height and age.
C h ap ter 6 is a  theoretical study, based upon  published data, concerning the indexing of 
lung w ater and global end diastolic volume. W hile EVLW I is higher and GEDVI is lower in 
young children, in terpretation  of these m easured values is difficult since reference or n o r­
m al values are lacking. We used existing autopsy data  available in the literature concerning 
lung development, lung mass, growth, cardiac dimensions and body dimensions in children 
and adults. Furtherm ore we collected basic age-weight and age-height relations from  a da­
taset provided by the W H O .
Extravascular fluid is dependent of the net driving force over the vessel wall and will be 
proportional to tissue mass. Therefore, when perfusion is equally distributed, an increase in 
organ tissue mass will lead to a proportional increase in  the am ount o f extravascular fluid.
The total weight o f new born lungs is approxim ately 100 gram s at one m onth  while the 
weight of adult lungs is approxim ately 1000 gram . T he relation between lung mass and age 
is expressed in a polynom ial function to  the fourth power com parable to the development 
o f body weight (lung mass = -0,0311x4 + 1,1257x3 - 12,857x2 + 83,453x + 98,605 [x = 
age in  years] w ith r 2 = 0.99). A lthough body weight and lung mass bo th  develop rapidly in 
young children, body weight increases faster and with a  greater m agnitude than  lung mass. 
Thus the lung mass to  body weight ratio decreases by a factor of approxim ately 0.6 during 
hum an  development. This implies that small children have relatively m ore lung tissue mass
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in relation to body weight com pared to older children or adults. This is the first explanation 
why young children have a higher EVLW I com pared to older children or adults.
For calculating EVLW  using the T P T D  technique ITB V  is calculated by: ITB V  = GEDV  x  
1.25. We showed in chapter 5 that this factor (1.25) is weight dependent and varies between 
approxim ately 1.5 in  younger and 1.25 in  older children. This is in  accordance with the rela­
tively larger lung mass in young children since a larger lung mass will be accom panied with 
a larger PBV W ith the use of a falsely low conversion factor, ITB V  will be too low and thus 
EVLW  will increase (EVLW = IT T V  - ITBV). This is the second explanation why EVLW I 
is higher in younger children.
D uring  grow th end diastolic cardiac volume (EDV), m easured using angiography, increas­
es from  25 ml w ith a BSA of 0.5 m 2 to 125 m l at 1.5m2. So EDV increases w ith a factor 
5 and  BSA w ith a factor 3. T here seems to  be an exponential relation betw een develop­
m en t of EDV and  BSA. Also during  hum an  developm ent left ventricular mass increased 
w ith a  factor 4 (from 35 to  130 gram) while BSA increased w ith a factor 2.5 (from 0.7 to 
1.7). In  contrast to EVLW, G ED V  increases w ith a greater m agnitude th an  its indexing 
factor BSA. We believe th a t this offers an explanation why younger children have a lower 
G ED V I com pared  to older children or adults. Since the calculation of G ED V  requires no 
assum ption and  is entirely based upon  physical properties, the absolute G EDV  value are 
likely to be reliable.
In conclusion we show that, based upon published data, EVLW I is higher and GEDVI is 
lower in young children because body proportions do not develop linearly to EVLW  and 
GEDV Subsequently we propose pediatric correction factors for use in  children.
C hap ter 7 describes the use of the Nexfin-pediatric system in young children. We com pared 
the Nexfin-pediatric blood pressure m easurem ent, using an inflatable finger cuff, with intra- 
arterially m easured blood pressure (IAP) in critically ill, sedated and mechanically ventilated 
children. Since the m easured blood pressure in the finger (FAP) arteries is lower than central 
blood pressure we used an algorithm that reconstructs FAP to blood pressure at the level o f the 
upper arm  (reBAP). We com pared IAP to FAP and reBAP. In  a subgroup, we also com pared 
IAP m easurem ents with the standard NIBP technique. Thirty-five children between 2 and 22 
kg body weight were included. In  total, 152 attempts to record FAP were perform ed of which 
4.6%  were unsuccessful. W hen com paring FAP to IAP, bias was -16.2, -7.7, and -10.2 m m  H g 
for systolic arterial blood pressure (SAP), diastolic arterial blood pressure (DAP), and m ean ar­
terial blood pressure (MAP). Limits o f agreement (LOA) were respectively 26.1 %, 30.1 %, and 
22.6%. W hen reBAP was com pared to IAP, bias was -11.8, 0.6, and -0.9 m m  H g with LOA of 
21.7%, 8.9%, and 8.9%. W hen NIBP was com pared to IAP, the results were: bias: -6.8, -0.9, 
and -3.8 m m  H g with LOA of 18.2%, 38.6%, and 22.1%  .
We conclude tha t this beta  type continuous noninvasive arterial blood pressure m onitoring 
device using a finger cuff and brachial arterial waveform reconstruction is reliable in stable 
critically ill children. T he accuracy for m easuring DAP and M AP seems at least equal to the 
noninvasive standard, upper arm  cuff oscillometric technique.
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In  ch a p ter  8 we studied the accuracy of Nexfin-pediatric system for detecting rap id  blood 
pressure changes in  young children undergoing congenital cardiac surgery. T hirteen anes­
thetized children with a m edian age of 11 m onths (2 m onths — 7 years) undergoing congeni­
tal cardiac surgery were included in this study. reBAP and IAP were recorded simultaneously 
during the surgical procedure. To assess the accuracy of reBAP in tracking blood pressure 
changes the four largest IAP variations within a 5-minute tim e interval were identified from 
each procedure. These variations were com pared offline with reBAP during a 10s control 
period before and a 10s period after a blood pressure change had  occurred. In  only 10 out 
o f 13 children a non-invasive blood pressure recording could be obtained. This resulted in 
40 data  points. T he correlation coefficient between reBAP and IAP in tracking m ean  blood 
pressure changes was 0.98. reBAP followed changes in IAP with a m ean bias for changes in 
systolic, diastolic and m ean arterial pressure of 0.0 m m H g (SD 5.8), 0.1 (SD 2.8) and 0.19 
(SD 2.7) respectively.
We conclude that reBAP from  finger blood pressure adequately reflects in tra-arterial blood 
pressure changes in children during cardiac surgery. However the use in the operating the­
atre using this prototype can, at the present state o f development, still be tim e-consum ing 
and has a significant failure rate.
C h a p ter  9 is a  review of all clinically available cardiac ou tput m easurem ent tech­
niques in children. T he ideal C O  m onito r should be accurate, reproducible, continuous, 
non-invasive, easy to apply, operator-independent, cost-effective and should have a rap id  
response tim e (beat-to-beat). T he choice of the m ethod  to  be used is m ainly determ ined  
by the clinical indication  and  situation. Subsequently, the balance betw een invasiveness. 
risks, instrum entation , user expertise, costs and  additional param eters tha t can  be col­
lected should be considered. In  choosing a device the physician should ask the following 
th ree questions: 1) is a reliable absolute m easurem ent o f C O  requ ired  or is tracking 
changes m ore appropriate. In  the first a m ore invasive approach  is required. In  the la tter 
a continuous technique could be applied. 2) Is an invasive m easurem ent feasible o r does 
the clinical situation require non-invasiveness. W hen non-invasiveness is required , the 
physician should be aware th a t the ob ta ined  results are often less reproducible. 3) Are 
o ther hem odynam ic m easurem ents also requ ired  (like extravascular lungw ater o r arterial 
pressure variations).
In  clinical practice, invasive dilution techniques should be considered for hem odynam ic 
m onitoring of septic and other (post-operative) circulatory com prom ised pediatric patients 
during P IC U  treatm ent. T he C O  value m ay help the clinician to  guide inotropic-, vasopres­
sor-, or fluid therapy. In  the setting of peri-operative hem odynam ic m onitoring, continuous 
C O  m easurem ent with an arterial pressure based m ethod or trans esophageal doppler de­
vice is probably m ore convenient. Tracking changes in these situations is particular infor­
mative and in some systems there is no  need  for interm ittent recalibration. Non-invasive 
m ethods, like echocardiography and other ultrasound techniques, can be very useful in the 
first phase of treatm ent o f an acute patient, because it is rapidly available and m ay guide 
the direction of treatm ent in the first phase. D epending on the severity o f the circulatory 
insufficiency, continuous and m ore invasive m onitoring should be considered thereafter.
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Most importantly, the physician should be thoroughly familiar with the technical back­
ground and pitfalls o f the chosen technology.
In C h ap ter 10 we present an overview over the currently available advanced hem odynam ic 
m onitoring technologies in children. We focus on physiological backgrounds and clinical 
usefulness. A dvanced hem odynam ic m onitoring consists, am ong others, of m easuring car­
diac output, predicting fluid responsiveness, calculating systemic oxygen delivery in relation 
to oxygen dem and and quantitating  (pulmonary) edema. Basic hem odynam ic physiology 
in young children resembles those in adults and differences are smaller than  previously 
thought. Specifically cardiac stroke volume is m ore variable than  generally believed. This 
implies tha t also in young children the heart operates on the Frank-Starling curve and is de­
pendent on preload. However, young children have higher m etabolic and oxygen dem ands 
and are m ore sensitive to cardiac afterload.
C ardiac output is a potentially im portant m easurem ent which is technically validated and 
available for children of all ages. Venous oxymetry is in particular im portant in cases of 
shunt while the im portance of GEDVI or EVLW I still needs to be determ ined. Fluid res­
ponsiveness will becom e an im portant param eter in children but arterial pressure variations, 
although useful in adults, have no t been studied clinically.
It should be m entioned tha t hem odynam ic m onitoring itself will never improve patient 
outcom e unless incorporated  in  proper treatm ent protocols (1). O n  the other h and  hem o­
dynam ic variables m ay give the clinician insight into the hem odynam ic situation of the 
critically ill child but m ay also show the response (or lack of response) to treatm ent.
In summ ary advanced hem odynam ic m onitoring in pediatric patients is feasible and m any 
im portant characteristics of the circulation can nowadays be quantified. Physiologically, by 
using these m onitoring devices, a m ore rational and effective hem odynam ic treatm ent can 
be deployed.
C o n c lu sio n s  an d  fu tu re  p e r sp e c t iv e s
Transpulmonary thermodilution in children 
C ard iac o u tp u t
C ardiac output is reliably m easured in  children using the transpulm onary therm odilution 
m ethod incorporated  in  the P iC C O  device (2-6). However further studies are necessary 
in two clinical situations. T he first is acute lung  injury (ALI) or adult respiratory distress 
syndrome (ARDS). In  these situations there m ight be an increased tem perature loss o f the 
indicator due to an increased density of pulm onary tissue. The m agnitude of this tem pera­
ture loss m ay be small but has no t been adequately assessed before. The second is a left-to- 
right or right-to-left circulatory shunt. In  the first the downslope tim e of the therm odilution 
curve will be altered while in  the second a biphasic curve will be observed (7,8). In  this way 
it m ay be possible to detect cardiac shunts with the use of a  T P T D  curve. W ith the use of 
a sufficient algorithm  it could be possible to correct the biphasic curve and m easure CO  
correctly in  cases of a right-to-left shunt. The P iC C O plus device has a build-in algorithm
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for situations with a right-to-left shunt, but validation has never been published. This could 
be investigated in an experim ental anim al study. In case of a left-to-right shunt the CO  
m easurem ent could be reliable although validation is lacking (9).
A part from  these rem aining validation studies the T P T D  m ethod can, and should be used 
clinically to guide fluid and inotropic therapy in  children since clinical signs of circulatory 
failure are unreliable (10-13). Besides clinical use, C O  m onitoring can in  this way support 
studies concerning volume responsiveness in  children, validate other (non- or less-invasive) 
C O  m ethods and quantify the hem odynam ic effects o f different inotropic agents.
O ne of the drawbacks of the T P T D  m ethod is the crosstalk phenom enon. Therefore cen­
tral venous catheters should, preferably, be inserted in  the upper part o f the body. W hen the 
fem oral vein is catheterized the therm odilution curves should therefore always be inspected. 
To avoid erroneous m easurem ents a software w arning algorithm  should be developed by 
the m anufacturer.
L ung w a ter
Edem a in critically ill patients is associated with an increased m ortality and a  restrictive, 
fluid strategy m ight therefore be beneficial in adults and children (14-20). Quantification 
of (pulmonary) edem a could therefore be a useful adjunct. (21-24). A random ized study of 
lung w ater guided hem odynam ic therapy in adults is currently underw ay (ClinicalTrials.gov 
identifier: N CT00624650).
In  children EVLW I values are higher com pared to adult reference values (25-27). However 
the ratio o f extravascular lung w ater per lung mass, expressed in  dry weight, seems to  be 
equal in children com pared to adults (28). Based upon growth models and the higher initial 
lung mass in new borns we have provided an explanation for the deviant EVLW I and posed 
possible correction factors (29). However before clinical decisions based upon EVLW I can 
be advised these corrections should be clinically evaluated.
Further studies concerning lung water in children m ay include the following. Lung water 
should be m easured using the TPDD, T PT D  and gravimetric technique in healthy new born 
animals and in various stages of growth. In this way it can be established if lung water is 
subject to development or growth. At the same time the reliability of EVLW  m easured with 
TPT D  can be established with special emphasis on the relation between PBV and GEDV. The 
same technologies should be used to determ ine lung water in pulm onary disease like A L I/ 
ARDS. To establish clinical norm al values of EVLW I (and GEDVI) T PT D  measurements 
should be collected from  children without a critical illness and with apparent norm al pulm o­
nary physiology. This can be done by collecting values at the end o f P IC U  treatm ent or before 
m ajor surgery A study with this designs is currently undertaken by us in collaboration with a 
colleagues from  the “Bambino Gesù Hospitale” in Rome. At last, clinical studies o f sequential 
measurem ents of EVLW I during fluid therapy or diuretic therapy should be undertaken.
GEDV
The m easurem ent of GEDV is likely reliable. Like extravascular lung water, norm al values 
are indispensable before clinical recom m endations can be m ade. Since GEDV has no  gold
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standard only clinical studies in healthy or less critically ill children can produce (near) 
norm al values. In  conjunction with the collection of “n ear norm al” lung water values we 
currently also collect GEDV or ITBV.
A part from  establishing the reference values or validating the correcting factor, the predic­
tive value of GEDVI for fluid responsiveness needs to be established. Furtherm ore changes 
of GEDVI values during fluid therapy or diuretic therapy could provide insight into the 
value of GEDVI in reflecting preload in children.
Continuous non-invasive blood pressure measurement
We have shown that the non-invasive blood pressure m easurem ent in children is accurate in 
assessing absolute blood pressure values and in tracking changes in blood pressure (30,31). 
However, especially, during anesthesia, accurate blood pressure registration failed in an im­
portan t num ber of subjects. Since this technology can also m easure cardiac ou tput this may 
be an im portant developm ent (32). However since the Nexfin-pediatric is still a  research 
prototype a lot o f work regarding R& D must be done. Developm ent should start w ith m an­
ufacturing of finger cuffs for small children and software for guiding the m easurem ents. In 
a second phase the cardiac ou tput algorithm  should be adapted  for children.
Fluid responsiveness
In adult patients volume loading only increases C O  in 50%  of cases (33,34). Since fluid 
overload is deleterious, predicting fluid responsiveness m ay be beneficial (14-17). This is 
probably also true for critically ill children Therefore the predictive value of GEDVI and 
arterial pressure variations (APV) for fluid responsiveness should be studied in children. 
The passive leg raising is, in our experience, no t usable in young children probably due to 
the low blood volume in the legs. Arterial pressure variation could, theoretically, be used in 
young children. U sing reliable C O  m easurem ent technologies the predictive value of APV 
on fluid responsiveness can and should be studied. Special em phasis should be placed upon 
the relation between heart rate and the controlled respiratory rate and on respiratory tidal 
volume (35).
Other variables
Although cardiac output and blood pressure determ ine oxygen transport and organ per­
fusion pressure these variables do no t directly reflect oxygen delivery to the m itochondria. 
Therefore, apart from  hem odynam ic studies, research into m icrocirculation or even m ito­
chondrial oxygen utilization m ight m ay provide further insight or even alternative endpoints 
o f fluid resuscitation (36,37).
Hemodynamic pediatric guidelines
W ith the developm ent and further validation of hem odynam ic m onitoring technologies it 
will be possible to develop rational guidelines for guiding hem odynam ic therapy in critically 
ill children. For the m ajority o f critically ill children in shock the initial approach will rem ain 
the prom pt adm inistration of fluid up  to 40 m l/k g  (38, 39). H ereafter a  guided approach 
m ust becom e available. Eventually this m ay reduce the length of stay or the need for m e­
chanical ventilation and finally even reduce mortality.
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Samenvatting, conclusies en 
toekomstige ontwikkelingen

CHAPTER XII
S am e n v attin g
Continue of interm itterende m etingen en bewaking van de bloedsomloop m et behulp van 
een speciaal apparaat w orden ook wel hem odynam ische m onitoring genoemd. Sommige 
m etingen, zoals bloeddruk of hartslag, zijn gewone of basale m etingen. M et geavanceerde 
technieken zijn tegenwoordig variabelen te kwantificeren die een dieper inzicht verschaffen 
in de bloedsomloop. D it zijn bijvoorbeeld het m eten van het hartm inuutvolum e (cardiac 
output, CO) of het m eten van het extravasculaire longw ater (EVLW). We spreken in  dit 
geval van geavanceerde hem odynam ische monitoring. Deze m onitoring vereist altijd een 
bepaald  apparaat en meestal ook een toegang to t de patiënt. E r zijn verschillende technolo­
gieën beschikbaar w aarm ee deze m etingen mogelijk zijn. Bij veel technieken is een toegang 
to t de b loedbaan van de patiënt een vereiste. H iervoor m oeten er bijvoorbeeld slangetjes 
(catheters) in  verschillende bloedvaten w orden ingebracht. We spreken dan van invasieve 
monitoring. D it in  tegenstelling to t de niet-invasieve monitoring, waarbij aan de oppervlakte 
van het lichaam  gem eten kan worden.
Voor ernstig zieke volwassen patiënten  zijn vele technieken van geavanceerde hem odyna­
mische m onitoring beschikbaar. Deze technieken zijn helaas niet altijd bruikbaar bij ernstig 
zieke kinderen vanwege technische aspecten, beperkingen in verband m et afmetingen of fy­
siologische verschillen. Toch is er toenem end bewijs dat ook ernstig zieke kinderen baat kun­
nen hebben bij geavanceerde hem odynam ische monitoring. De technieken die bruikbaar 
zijn bij kinderen zijn soms niet o f nauwelijks gevalideerd voor gebruik bij jonge kinderen, 
o f de praktische toepasbaarheid is niet goed onderzocht. O ok ontbreken veelal de op (jonge) 
kinderen toepasbare norm aalw aarden.
D it proefschrift spitst zich toe op twee technologieën. In de hoofdstukken 2 to t en m et 6 b e­
studeren we de transpulm onale therm odilutie techniek (TPTD), zoals deze is ingebouwd in 
het P iC C O  apparaat. De studiedoeleinden waren: a) T P T D  m etingen valideren in (jonge) 
kinderen, b) inzicht verkrijgen in de klinische toepasbaarheid en c) de T P T D  techniek ge­
schikt m aken als standaard m ethode w aarm ee andere, m inder invasieve m ethoden vergele­
ken kunnen worden.
H em odynam ische m onitoring is soms nodig  in  situaties, waarbij er (nog) geen in tra  arteri- 
ele en cen traal veneuze catheters (de slangetjes in  de bloedvaten) zijn ingebracht. O m  die 
reden  is er toenem ende belangstelling voor niet-invasieve hem odynam ische m onitoring. 
D aarom  hebben  we in  de hoofdstukken 7 en 8 de continue niet invasieve bloeddrukm e- 
ting  aan  de vinger bestudeerd. Deze techniek w ordt toegepast door het Nexfin apparaat. 
H ierm ee is he t mogelijk om  m et een opblaasbaar m anchet om  de vinger een continu 
b loeddruk signaal te verkrijgen. D aardoo r is niet alleen b loeddrukm eting mogelijk m aar 
ook het slag-op-slag m eten  van de cardiac output. Deze technologie is voor k inderen nog 
in  ontwikkeling en is de reden dat we ons in  eerste instantie beperkt hebben  to t de b e ­
studering van de m ogelijkheid om  m et deze m ethode een accuraat b loeddruk signaal te 
verkrijgen bij jonge  kinderen.
In  hoofdstuk 2 hebben we een validatie studie uitgevoerd naar de cardiac output (CO) 
m eting gebaseerd op de T P T D  techniek (COTpTD). We hebben deze studie uitgevoerd bij
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11 pasgeboren lam m eren (lichaamsgewicht tussen 4.2 en 12.5 kg). Als goudstandaard 
(meest precieze methode) hebben we een ultrageluid flowprobe om  de longslagader aan­
gebracht (CO Ufp). H ierm ee is heel nauw keurig de C O  te m eten. Voor de C O TpTD m eting 
nam en we het gem iddelde van 4 injecties ijskoude (< 10 C°) fysiologische zoutoplossing van 
3-5 ml. Deze werd via de centraal veneuze catheter ingespoten. De eerste m eting was aan 
het begin van het experim ent direct n a  instrum entatie. D aarna werd een ander experim ent 
uitgevoerd. N a afloop daarvan w aren de lam m eren in  verbloedingshock. We herhaalden 
vervolgens de T P T D  m etingen, terwijl de lam m eren vocht kregen toegediend om  de shock 
te bestrijden. D it lijkt op de behandeling van zieke kinderen in  shock. O p deze m anier werd 
de klinische praktijk nagebootst en w erden de m etingen uitgevoerd bij een zo groot mogelijk 
bereik van de cardiac output. De C O  varieerde van 0.5 to t 3.5 l/m in . De correlatie coëffici- 
ent tussen C O TpTD en C O Ufp was 0.97. C O TpTD overschatte de C O Ufp m et 0.19 l/m in  (12%) 
m et limits of agreem ent (hierbinnen liggen 95%  van alle m eetpunten) van ±0.23 l/m in  
(14.7%). De correlatie coëfficiënt tussen veranderingen van C O TpTD en C O Ufp was 0.97. 
E r was geen correlatie tussen veranderingen van centraal veneuze druk en veranderingen 
in  slagvolume van het hart. E r was wel een correlatie tussen veranderingen in  globaal eind 
diastolisch volume index (GEDVI) en de verandering in slagvolume (r = 0.59).
Wij concluderen dat de T P T D  techniek de cardiac output adequaat kan m eten in  dit pasge­
boren lam m eren model. D aarnaast kan deze m ethode de verandering van de cardiac out­
put goed vervolgen tijdens vochttherapie. De T P T D  m etingen zijn het m eest betrouw baar 
als het gem iddelde van 3 injecties m et een ijskoude zoutoplossing w ordt bepaald.
H o o fd s tu k  3 behandelt het “cross-talk” fenom een dat tijdens T P T D  m etingen kan optre­
den. We beschrijven dit fenom een aan de hand  van een klinische en een dier-experimentele 
observatie. Tevens w orden de oorzaken en klinische consequenties besproken. H et cross-talk 
fenom een is een belangrijke oorzaak van foutieve T P T D  m etingen. H et treedt op w an­
neer de centraal veneuze injectie catheter is ingebracht in de onderste lichaamshelft. Bij in­
spuiten kan de koude indicator door diffusie de arteriële therm istor (tem peratuur gevoelige 
weerstand) afkoelen. Als het injectaat door de bloedstroom  is m eegenom en en n a  enig tijd 
opnieuw de therm istor afkoelt, ontstaat een bifasische therm odilutie curve. H et cross-talk 
fenom een treedt vooral op w anneer de twee catheters dicht naast elkaar zijn ingebracht. 
m aar ook als de snelheid van bloedstroom  laag is.
Wij adviseren om  voor T p T D  m etingen een centrale catheter te gebruiken die in de bo­
venste lichaamshelft is ingebracht. Indien er toch gebruik gem aakt wordt van een lijn in 
de onderste lichaamshelft, m oet de therm odilutie curve goed geïnspecteerd w orden op een 
bifasisch verloop, aangezien dit to t foutieve m etingen kan leiden.
In h o o fd stu k  4 hebben we de m eting van het longwater bestudeerd bij 11 kinderen tus­
sen 2.5 m aand  en 2 jaar, die een hartcatheterisatie ondergingen. G eïndexeerd longwater 
(EVLWI) werd gem eten m et de T P T D  techniek (EVLWT ). Deze m etingen werden ver­
volgens vergeleken met longwater, gem eten met de transpulm onale dubbelindicator kleur­
stof dilutie techniek (EVLWTpDD). Deze m ethode m eet het longwater het m eest betrouwbaar, 
aangezien er geen aannam es in de berekening zijn verwerkt. Deze techniek is inmiddels bij 
proefdieren gevalideerd en kan als goudstandaard beschouwd worden. Bij de T PD D  me­
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thode w ordt gebruik gem aakt van injecties m et ijskoude indocyanine groen (ICG) oplossing 
ingespoten via een centrale catheter. Bij deze relatief gezonde kinderen zonder evidente 
longafwijkingen, die onder narcose werden gebracht en beadem d werden, varieerde het 
geïndexeerde longwater (EVLWItpDD) tussen 8 en 22 m l/kg. D at is aanzienlijk hoger dan de 
gepubliceerde norm aalw aarden voor volwassenen (3 to t 7 m l/kg). EVLW TpTD overschatte 
het longwater m et 2.3 m l/k g  (18%). De limits o f agreem ent w aren ±2.97 m l/k g  m et een 
procentuele m eetfout van 19%.
Voor de berekening van het longwater is de w aarde van het in tra  thoracale bloedvolume 
(ITBV) noodzakelijk. ITB V  kan wel m et de T PD D  techniek w orden gem eten m aar niet 
m et de T P T D  techniek. M et de T P T D  wordt wel het globaal einddiastolisch bloedvolume 
(GEDV) gem eten. H et verschil tussen beiden is het long bloedvolume (PBV). De T PT D  
m ethode berekent vervolgens ITB V  door: ITB V  = GEDV * 1.25. De relatie tussen ITB V  
gem eten m et de TPD D  m ethode (ITBVTpDD), en GEDV, gem eten m et de T PD D  m ethode 
(GEDVTpTD), liet een correlatie zien van 0.99. De gem iddelde ratio tussen ITB V TpDD en 
GEDV d was ongeveer 1.25. Echter, deze ratio was gerelateerd aan lichaamsgewicht met 
een correlatie coëfficiënt van -0.72.
Als laatste vergeleken we T P T D  m etingen waarbij de ijskoude oplossing via de vena femo­
ralis (lies ader) werd ingespoten m et de T P T D  m etingen waarbij de oplossing dicht bij het 
rechter atrium  (hartboezem) werd ingebracht. Bij gebruik van de vena femoralis w erden de 
m etingen in geringe m ate overschat: C O  m et 3%, EVLW I m et 0%  en GEDVI m et 8%. De 
laatste is in overeenstemming m et de fysiologie, aangezien het bloedvolume tussen inspuit 
en detectie pun t groter is bij inspuiting via de vena femoralis.
We concluderen dat m eting van het longwater m et de T P T D  techniek betrouw baar is in 
deze patiëntengroep. D aarnaast lijkt geïndexeerd longwater bij jonge kinderen hoger te zijn 
dan bij volwassenen. De berekeningsfactor tussen GEDV en ITB V  (1.25) lijkt gerelateerd 
te zijn aan lichaamsgewicht. T P T D  m etingen kunnen w orden uitgevoerd m et een centraal 
veneuze catheter in de vena femoralis.
H o o fd s tu k  5 betreft de m eting van longwater bij ernstig zieke kinderen op de kinder in­
tensive care. H et doel was om  de longwater m etingen te vergelijken m et afgeleide w aarden 
van longoedeem. D aartoe hebben we gekozen om  longwater te vergelijken m et bepaalde 
param eters van zuurstofvoorziening (ratio van zuurstofgehalte in het bloed en in de inge­
adem de lucht) en het verschil tussen zuurstofgehalte in de longblaasjes en in  het bloed (res­
pectievelijk de P /F  ratio en de A-a gradiënt). Deze geven deels de longfunctie weer en het is 
de verwachting dat bij toenam e van longoedeem  deze w aarden zullen verslechteren. Tevens 
bepaalden we aan de hand  van de röntgenopnam es van de longen (x-thorax) een score voor 
longoedeem. D aartoe w erden deze röntgenopnam es beoordeeld door twee radiologen en 
van een puntenscore voorzien. Vervolgens verzam elden wij gegevens betreffende opnam e 
duur, sterfte en ernst van ziekte. Al deze variabelen w erden vergeleken m et geïndexeerd 
longwater bij 24 beadem de kinderen op onze kinder intensive care m et een leeftijd tussen 2 
m aanden  en 8 jaar. E r w erden geen bijzondere interventies verricht. In  totaal verzamelden 
wij 103 gecom bineerde metingen.
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De gem iddelde cardiac index (CO gedeeld door lichaamsoppervlakte) was 4.00 (1.65 tot 
10.85) l /m in /m 2. De m ediane EVLW I was 16 (6 to t 31) m l/kg. De gewogen kappa tus­
sen x-thorax score van longwater tussen de twee radiologen was 0.53. Er werd geen cor­
relatie tussen EVLW I en de x-thorax score gevonden. Evenm in was er een correlatie tus­
sen EVLW I of x-thorax score aan de ene kant en beadem ingsdagen, ernst van ziekte of 
param eters van zuurstofvoorziening aan de andere kant. We analyseerden ook de opeen­
volgende longw aterm etingen per patiënt en vonden geen correlatie tussen veranderingen 
in EVLW I en x-thorax score, P /F  ratio o f A-a gradiënt. EVLW I correleerde m et leeftijd 
(correlatie coëfficiënt van -0.67; 95% C I -0.85 to t -0.36; p < 0.001) en lengte (correlatie coëf­
ficiënt van -0.80; 95% C I -0.91 to t -0.59; p <  0.0001). De x-thorax score was niet gerelateerd 
aan leeftijd o f lengte.
We concluderen dat EVLW I niet gecorreleerd is m et een score van longoedeem  gebaseerd 
op de x-thorax in  deze gem engde P IC U  populatie. D aarnaast correleren zowel EVLW I 
als de x-thorax score niet m et P /F  ratio, A-a gradiënt en andere verzam elde param eters. 
EVLW I is wel gerelateerd aan lengte en leeftijd.
H o o fd s tu k  6 is een theoretische studie, gebaseerd op eerder gepubliceerde gegevens b e ­
treffende de indexering van longwater en globaal einddiastolisch volume (GEDV). O m ­
dat EVLW I hoger is bij jonge kinderen en GEDVI lager, w ordt er getwijfeld aan de b e­
trouw baarheid en bruikbaarheid van deze m etingen bij kinderen. O ok ontbreken bruikbare 
norm aalw aarden. Wij m aakten gebruik van gepubliceerde autopsie studies en keken naar 
longgroei, longgewicht, h art gewicht en lichaam skenm erken bij kinderen en volwassenen. 
D aarnaast m aakten we gebruik van een dataset van de W H O  die de ideale relatie tussen 
leeftijd, gewicht en lengte weergeeft tijdens menselijke groei.
Longwater is afhankelijk van het evenwicht van hydrostatische en oncotische druk over de 
vaatw and van de longvaten en van de m ate van lymfe afvloed. De m ate van oedeem  is p ro­
portioneel aan de weefsel massa. Als de doorbloeding evenredig verdeeld is, zal een toenam e 
van weefsel massa ook een toenam e van oedeem  geven. H et gewicht van de long van een 
pasgeborene is ongeveer 100 gram  bij de leeftijd van 1 m aand. H et volwassen longgewicht 
is ca. 1000 gram . Wij vonden dat longgewicht gerelateerd is aan  leeftijd en dat deze relatie 
w ordt weergegeven door een exponentiële vergelijking (polynomaal to t de vierde macht): 
longgewicht = -0,0311x4 + 1,1257x3 - 12,857x2 + 83,453x + 98,605 (x = leeftijd in jaren). 
Zowel lichaamsgewicht als longgewicht nem en snel toe bij jonge kinderen. Echter, lichaam s­
gewicht neem t sneller toe zodat de ratio van longgewicht to t lichaamsgewicht in  de eerste le­
vensjaren afneem t m et een factor van ongeveer 0.6. Kleine kinderen hebben dus een relatief 
groter longgewicht dan  oudere kinderen. D it is de eerste verklaring w aarom  jonge kinderen 
een hoger EVLW I hebben.
Bij het berekenen van ITB V  (zie hoofdstuk 4) is gebruik gem aakt van de formule ITB V  = 
GEDV * 1,25. We lieten in  hoofdstuk 4 zien dat deze factor (1.25) gewicht en leeftijd afhan­
kelijk is en varieert tussen 1,25 en 1,5. D it lijkt logisch, om dat bij een grotere longm assa ook 
een groter longbloedvolume (PBV) past. Als de factor te laag is, zal ook het berekende ITVB 
te laag zijn. H et resultaat is een hoog longwater (want EVLW  = IT T V  - ITBV). D it is de 
tweede verklaring voor een hoger EVLW I bij kinderen.
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Tijdens de groei neem t het eind diastolisch hartvolum e (EDV), gem eten m et echo of angio- 
grafie, toe van 25 m l bij een lichaam soppervlak (BSA) van 0.5 m 2 to t 125 ml bij een BSA 
van 1.5m2. Dus EDV neem t toe m et een factor 5 en BSA m et een factor 3. E r lijkt een ex­
ponentiële relatie te bestaan tussen de toenam e van EDV en BSA. Eveneens neem t tijdens 
de groei het hartgew icht toe m et een factor 4 (van 35 naar 130 gram), terwijl BSA toeneem t 
m et een factor 2.5 (van 0.7 to t 1.7). In  tegenstelling to t longwater neem t het GEDV dus 
m eer toe dan de param eter w aarm ee het G EDV  wordt geïndexeerd (BSA). D it verklaart 
w aarom  kinderen een lager GEDVI hebben ten  opzichte van volwassenen. Aangezien er 
bij de berekening van G EDV  geen aannam es w orden gebruikt, lijkt de absolute w aarde van 
GEDV wel betrouwbaar.
Wij concluderen dat EVLW I hoger en GEDVI ju ist lager zijn bij jonge kinderen. D it wordt 
voornam elijk veroorzaakt doordat de lichamelijke proporties zich in  een ander tem po on t­
wikkelen dan longwater en GEDV Vervolgens hebben wij correctiefactoren voor gebruik bij 
kinderen ontwikkeld.
H o o fd s tu k  7 beschrijft het Nexfin-pediatric systeem bij jonge kinderen. Wij vergeleken 
de Nexfin m ethode, waarbij bloeddruk continu en niet invasief wordt gem eten met een 
opblaasbaar m anchet om  de vinger, met de bloeddruk gem eten met een catheter in  de slag­
ader (IAP). G em eten w erd bij ernstig zieke, gesedeerde en beadem de kinderen op de kinder 
intensive care. O m dat de bloeddruk aan de vinger (FAP) lager is dan de centrale bloeddruk 
past de Nexfin een bewerking toe waarbij het signaal w ordt omgezet naar de zogenaam de 
“reconsructed brachial arterial pressure” (reBAP). H ierm ee w ordt de arteriële druk in  de 
bovenarm  gereconstrueerd. Wij vergeleken FAP, reBAP en IAP m et elkaar. In  een subgroep 
vergeleken we ook reBAp en IAp m et de standaard interm itterende m ethode van bloed- 
drukm eting met een m anchet om  de bovenarm  (NIBP). Er werden 35 kinderen van 2 tot 
22 kg geïncludeerd m et in  totaal 152 m etingen. 4.6%  van de m etingen was niet succesvol. 
Bij de vergelijking tussen FAP en IAP was de bias (FAP - IAP) -16.2, -7.7 en -10.2 voor SAP, 
DAP en MAP. De limits o f agreem ent (LOA) w aren ±26.1% , 30.1% , en 22.6% . Bij het 
vergelijken van reBAP en IAP was de bias -11.8, 0.6, and -0.9 m m  H g m et LOA of 21.7%, 
8.9%, en 8.9%. Bij vergelijking van NIBP en IAP was de bias -6.8, -0.9, and -3.8 m m  H g 
m et LOA van 18.2%, 38.6%, en 22.1%  .
Wij concluderen dat deze beta type monitor, w aarm ee met een vingerm anchet continue 
bloeddruk m eting mogelijk is en waarbij een bloeddrukcurve gereconstrueerd w ordt naar 
het bovenarm  niveau, betrouw baar is bij ernstig zieke kinderen. De betrouw baarheid is 
minstens net zo goed als de standaard klinische NIBP methode.
In  h o o fd stu k  8 bestudeerden wij w ederom  het Nexfin-pediatric systeem. Bij dit onderzoek 
was het doel te onderzoeken of deze techniek snelle bloeddruk veranderingen bij jonge 
kinderen tijdens een hartchirurgische ingreep kan detecteren. H iervoor w erden 13 kinderen 
van 2 m aanden  to t 7 ja a r  geïncludeerd. We registreerden FAP en IAP sim ultaan tijdens de 
gehele procedure m et uitzondering van de fase aan hartlongm achine. A chteraf selecteer­
den wij de 4 grootste bloeddruk veranderingen in  het IAP signaal die b innen 5 m inuten 
optraden. Deze vergeleken wij vervolgens m et het reBAP signaal. Bij 10 van de 13 kinderen 
konden wij een Nexfin signaal verkrijgen, per kind w erden vervolgens 4 m eetpunten  gese­
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lecteerd. D it leidde to t 40 datapunten  bij 10 kinderen. De correlatie coëfficiënt tussen reBAP 
en IAP voor het volgen van bloeddrukveranderingen was 0.98. reBAP volgde veranderingen 
van IAP m et een gem iddelde bias van of 0.0 m m H g (SD 5.8), 0.1 (SD 2.8) and 0.19 (SD 2.7) 
voor respectievelijk SAP, DAP en MAP.
Wij concluderen dat reBAp via de m eting aan de vinger de bloeddrukveranderingen bij 
kinderen tijdens hartchirurgie goed weergeeft. Echter, de m etingen zijn op dit m om ent tijd­
rovend en in een belangrijk deel van de gevallen niet succesvol. D it prototype m oet verder 
ontwikkeld w orden voordat het klinisch toepasbaar is tijdens operaties.
H o o fd stu k  9 is een overzicht van alle klinisch beschikbare m ethoden om  de cardiac output 
bij kinderen te kunnen meten. De ideale technologie hiervoor zou nauwkeurig, reproduceer­
baar, continu, niet invasief, kosteneffectief en snel en gemakkelijk te gebruiken m oeten zijn. De 
keuze van de m ethode wordt meestal bepaald door de klinische situatie. D aarnaast moet een 
afweging gemaakt worden tussen invasiviteit, risico, instrumentatie, expertise van de gebruiker 
en kosten. Bij het m aken van een keuze m oeten de volgende vragen worden beantwoord: 
1) Is een betrouwbare m eting noodzakelijk o f is het volgen van de cardiac output al vol­
doende? In het eerste geval is een invasieve m ethode m eer geschikt. 2) Zijn invasieve metingen 
haalbaar o f m oet voornamelijk niet invasief worden gemeten? Bij niet invasieve m ethoden 
is de nauwkeurigheid over het algemeen m inder goed. 3) Zijn ook andere hemodynamische 
metingen gewenst (zoals longwater of GEDV)? In de klinische praktijk raden wij aan om  inva­
sieve verdunningsm ethoden te gebruiken bij kinderen m et ernstige hemodynamische instabi­
liteit en sepsis of bij kinderen n a  gecompliceerde chirurgie op de kinder intensive care. De CO  
m eting kan clinici helpen om  vocht en inotropie behoefte te sturen. Tijdens peri-operatieve 
m onitoring kan een op de arteriële druk gebaseerde C O  m ethode bruikbaar zijn, om dat het 
volgen van C O  verandering hierbij zinvol lijkt te zijn. O ok de slokdarm Doppler kan hierbij 
van nut zijn. Niet invasieve m ethoden, zoals echo of andere ultrageluid gebaseerde systemen, 
kunnen zinvol zijn in de eerste fase van de behandeling van ernstig zieke kinderen. Deze zijn 
snel inzetbaar. Afhankelijk van de ernst van ziekte kan het nuttig zijn om  vervolgens m et meer 
invasieve en betrouwbaardere metingen verder te gaan.
Voor alle technieken geldt dat het belangrijkste is dat de clinicus goed op de hoogte is van de 
werking van de gebruikte m ethode zodat onjuiste m etingen w orden voorkomen.
In h o o fd stu k  10 geven we een overzicht van de beschikbare m ethoden van geavanceerde 
hem odynam ische m onitoring bij kinderen. Daarbij beperken we ons to t de fysiologische 
achtergronden zonder teveel op de techniek in  te gaan. Geavanceerde hem odynam ische 
m onitoring bestaat onder andere uit het m eten van de cardiac output, het voorspellen van 
fluid responsiveness (vocht responsiviteit), het berekenen van zuurstof aanbod in  relatie tot 
zuurstof verbruik en het kwantificeren van (long)oedeem. Basale hem odynam iek bij kinde­
ren  lijkt sterk op die van volwassenen. M et nam e het slagvolume is m eer variabel dan tot 
nog toe werd aangenom en. D it betekent dat het h art van een jo n g  kind ook afhankelijk is 
van de voorbelasting of wel de hoeveelheid bloed die naar het hart terugstroom t. Echter, 
jonge kinderen hebben een hoger zuurstofverbruik en zijn gevoeliger voor een toenam e van 
de afterload (nabelasting, vergelijkbaar m et bloeddruk).
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De cardiac output is potentieel de belangrijkste m eting bij kinderen op dit moment. H et is 
technisch betrouwbaar en is beschikbaar voor kinderen van alle leeftijden. Veneuze saturatie 
m eting is vooral van belang bij situaties m et intra- of extracardiale shunts, terwijl de waarde van 
GEDV en EVLW  nog m oet worden bepaald. H et voorspellen van fluid responsiveness (FR), 
zal bij kinderen van belang worden. H ierm ee wordt bedoeld dat een param eter kan voorspel­
len of de cardiac output zal toenem en als gevolg van vochttoediening. Een van de param eters 
die bij volwassenen een belangrijke voorspellende waarde heeft met betrekking tot FR  zijn de 
arteriële bloeddruk variaties (APV). Deze zijn bij kinderen nog niet goed onderzocht.
H em odynam ische m onitoring m oet geen doel op zich zijn. H et zal alleen de uitkomst van 
de behandeling van ernstige zieke kinderen verbeteren als het wordt gekoppeld aan een ef­
ficiënt behandelingsprotocol (1). D aarnaast kan hem odynam ische m onitoring m eer inzicht 
geven in  de bloedsomloop en kan het eventueel aangeven of een reeds ingezette behande­
ling effectief is.
Sam envattend stellen we dat geavanceerde hem odynam ische m onitoring bij kinderen u it­
voerbaar is. Veel belangrijke aspecten van de bloedsomloop kunnen zo w orden vervolgd. 
D oor van deze mogelijkheden gebruik te m aken kan een m eer rationele en hopelijk effectie­
vere behandeling w orden toegepast.
C o n c lu s ie s  en to e k o m stig e  on tw ik k elin gen
Transpulmonale thermodilutie bij kinderen 
C ard iac o u tp u t
c o  kan betrouw baar gem eten w orden bij kinderen m et de T p T D  techniek zoals deze is in­
gebouwd in de P iC C O  (2-6). Een aantal studies is nog noodzakelijk om  de betrouw baarheid 
van T P T D  in een tweetal klinische situaties te analyseren. De eerste is “acute lung injury” 
(ALI) e n /o f  “adult respiratory distress syndrom e” (ARDS). H ierbij zou er door de toegeno­
m en dichtheid van longweefsel meer verlies van tem peratuur indicator kunnen optreden, 
hetgeen kan leiden to t een onnauwkeurige meting.
De tweede is een links-rechts o f rechts-links shunt. Bij de eerste zal het aflopende deel van 
de therm odilution curve veranderen terwijl in de tweede situatie een bifasiche curve zal op­
treden (7,8). D oor de vorm  van de curve te analyseren kan het mogelijk w orden om  shunts te 
detecteren en eventueel te kwantificeren. D oor gebruik te m aken van een algoritme kan het 
daarnaast mogelijk w orden om  de bifasische curve te corrigeren en toch correct te blijven 
m eten bij de rechts-links shunt. De P iC C O plus m achine heeft een dergelijk algoritme, dit is 
echter nooit gevalideerd. D it zou alsnog onderzocht kunnen w orden in  een dierexperim ent. 
In  geval van een links-rechts shunt zou de T P T D  m ethode toch de C O  betrouw baar kun­
nen m eten, m aar validatie hiervan is nog niet gepubliceerd (9).
Onafhankelijk van deze resterende validatie studies kan en m oet de T P T D  m ethode ge­
bruikt w orden om  vocht en inotropie beleid bij kinderen te sturen. D it is vooral van belang, 
nu  steeds duidelijker w ordt dat klinische tekenen bij kinderen onbetrouw baar zijn (10-13). 
N aast de klinische w aarde van C O  m eting kunnen deze m etingen ook gebruikt w orden om
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FR  te onderzoeken, andere C O  m ethoden te valideren en de effecten van inotrope m edica­
m enten te kwantificeren.
Een van de nadelen van de T P T D  m ethode is het optreden van het cross talk fenomeen. 
O m  die reden m oeten centrale lijnen m et nam e in  de bovenste lichaamshelft w orden inge­
bracht. Indien dit niet mogelijk is, m oet de T P T D  curve geïnspecteerd w orden op dit feno­
m een, aangezien dit to t foutieve resultaten leidt. Een algoritme dat de gebruiker waarschuwt 
als dit fenom een optreedt, zou door de fabrikant m oeten  w orden ingebouwd.
L on gw ater
Toegenom en oedeem  bij ernstige zieke patiënten  is geassocieerd m et een hogere kans op 
overlijden. D aarom  zou een restrictief vochtbeleid van voordeel kunnen zijn bij volwas­
sen en kinderen (14-20). O m  die reden zou kwantificering van (long)oedeem een nuttige 
aanvullende m eting kunnen zijn (21-24). Een gerandom iseerde studie naar het effect van 
longwater gestuurde behandeling w ordt m om enteel uitgevoerd (ClinicalTrials.gov identi- 
fiergNCT00624650). g g ( g
Bij kinderen is het geïndexeerde longwater vaak hoger dan bij volwassenen (25-27). Echter, 
de ratio van longwater en droog longgewicht is gelijk bij pasgeboren lam m eren en volwassen 
schapen (28). G ebaseerd op groei patronen  en de initiële grotere longm assa van kinderen bij 
de geboorte hebben wij een verklaring gegeven w aarom  EVLW I hoger is bij jonge kinde­
ren, D aarnaast hebben we correctie factoren opgesteld (29). Voordat deze klinisch worden 
toegepast, m oeten  deze correcties eerst in  een dier- of m ensgebonden onderzoek worden 
gevalideerd.
N ader onderzoek n aa r longwater is als volgt mogelijk. Longwater zou gem eten m oeten 
w orden m et de TPD D , T P T D  en de gravimetrische techniek in  gezonde pasgeboren proef­
dieren gedurende verschillende m om enten in de groei. O p  deze m anier kan bepaald  wor­
den of longwater inderdaad  gelijk blijft als hoeveelheid per gram  droog longgewicht en hoe 
de indexering per lichaamsgewicht verloopt. Tegelijkertijd kan de betrouw baarheid van de 
longw aterm eting zelf bepaald  worden, m et nam e betreffende de relatie tussen PBV, GEDV 
en ITB V  Dezelfde opzet kan gebruikt w orden bij proefdieren m et A L I/A R D S.
O m  norm aalw aarden te bepalen zouden longw aterm etingen verzam eld m oeten worden 
van kinderen in de herstel fase van een ernstige ziekte waarbij de longfunctie niet m eer lijkt 
aangedaan. Zo kunnen “b ijna norm aal” w aarden w orden bepaald. D it kan plaatsvinden bij 
kinderen voor grote operaties waarbij n a  de inleiding van de narcose een vrijwel norm aal 
longwater te verw achten is o f bij kinderen in  de herstelfase van de intensive care behande­
ling. M om enteel voeren wij een dergelijke studie uit om  de “b ijna norm aal” w aarden te 
verzam elen in  samenwerking m et collega’s in het “Bam bino Gesù H ospitale” in Rome.
Als laatste zouden opeenvolgende longw aterm etingen tijdens de behandeling en verloop 
van de ziekte m eer inzicht kunnen verschaffen in  het klinische beloop en de w aarde van 
deze m etingen.
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GEDVI
De m eting van absolute w aarden van GEDVI m et behulp van de T P T D  techniek lijkt be­
trouwbaar. N et als bij longwater zijn ook hier norm aalw aarden onm isbaar voordat klinische 
aanbevelingen kunnen w orden gedaan. Aangezien GEDVI geen anatom isch substraat heeft 
is er geen goud standaard  om  deze m etingen m ee te vergelijken. Gelijk aan de boven ge­
schetste situatie van EVLW I m oeten GEDVI w aarden w orden verzam eld van “vrijwel” ge­
zonde kinderen. N aast EVLW I verzam elen wij bij de eerder genoem de studie ook gegevens 
betreffende GEDVI en ITBVI.
Los van de norm aalw aarden m oet ook de w aarde van GEDVI in relatie to t fluid responsive­
ness w orden bepaald. O ok veranderingen van het GEDVI in  relatie to t vochttoediening en 
ontw atering kunnen m eer inzicht geven in de klinische w aarde van deze meting.
Continue niet-invasieve bloeddruk meting
We hebben aangetoond dat de niet-invasieve bloeddrukm eting bij kinderen betrouw baar is 
m et betrekking to t het m eten van absolute bloeddrukw aarden op de intensive care (30,31). 
M et nam e tijdens anesthesie faalde de techniek in  een belangrijk deel van de onderzochte 
kinderen. Aangezien m et deze technologie ook de C O  gem eten kan worden, kan dit in de 
toekomst een belangrijke m onitoring w orden (32). O m dat de Nexfin-pediatric een research 
prototype is m oet er nog veel research en ontwikkeling w orden gedaan om  dit geschikt te 
m aken voor de klinische praktijk. Zo m oeten betere vinger m anchetjes voor kinderen w or­
den ontwikkeld en m oet de software w orden aangepast. In  een volgende fase zou ook de CO  
m eting m oeten w orden gevalideerd.
Fluid responsiveness
Bij volwassen patiënten is slechts de helft van alle extra vocht toedieningen effectief, dat wil 
zeggen dat m aar bij de helft van de patiënten de C O  toeneem t ten gevolge van toediening 
van vocht (33,34). Aangezien een overdadig vochtbeleid schadelijk is, kan een goede voor­
spelling van het effect van vochttoediening behulpzaam  zijn (14-17). D it is waarschijnlijk 
ook het geval bij ernstig zieke kinderen. D aarom  m oet het voorspellen van de fluid respon­
siveness m et behulp van GEDVI en arteriële drukvariaties nader onderzocht worden. De 
passive leg raising test waarbij de benen w orden opgetild en het effect daarvan op de CO  
wordt bepaald  is in onze ervaring niet werkzaam bij jonge kinderen. D it kom t mogelijk 
doordat het bloedvolume van de benen  van jonge kinderen te klein is.
Arteriële drukvariaties kunnen theoretisch wel zinvol zijn. G ebruik m akend van betrouw ba­
re C O  technieken zou de voorspellende w aarde van arteriële drukvariaties m oeten worden 
onderzocht. Daarbij m oet m et nam e w orden gekeken n aa r de relatie tussen de voorspel­
lende w aarde van arteriële drukvariaties en de ratio van hartfrequentie en beadem ings- 
frequentie (35). D aarnaast zou ook het minim ale beademingsslagvolume m oeten worden 
gekwantificeerd.
Andere variabelen
Hoewel cardiac output en bloeddruk het zuurstoftransport en de weefseldoorbloeding be­
palen zijn deze factoren mogelijk niet bepalend voor het uiteindelijk zuurstofaanbod aan 
de cel en het in  de cel gelegen stofwisselingproces. O m  die reden is ook onderzoek naar de
219
CHAPTER XII
microcirculatie en de stofwisseling in de cel noodzakelijk. H et is mogelijk dat daarbij een 
beter eindpunt gevonden kan w orden voor de vochttoediening (36,37).
Hemodynamische richtlijnen
N a verdere validatie en ontwikkeling van hem odynam ische m onitoring bij kinderen kunnen 
uiteindelijk richtlijnen w orden ontwikkeld waarbij de ondersteuning van de bloedsomloop 
beter kan w orden bijgestuurd dan vandaag de dag het geval is. Voor de m eerderheid van de 
ernstig zieke kinderen zal bij de eerste opvang de initiële aanpak blijven om  m inim aal 40 
m l/k g  vocht toe te dienen (38,39). D aa rn a  zal het beleid afhankelijk kunnen en m oeten wor­
den van de juiste monitoring. Een dergelijke aanpak kan leiden to t een kortere opnam eduur 
of een verm inderde noodzaak to t m echanische beadem ing en eventueel zelfs een afname 
van de sterfte.
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